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SCIENTIFIC OPINION 
Risks for public health related to the presence of chlorate in food
1
 
EFSA Panel on Contaminants in the Food Chain (CONTAM)
2,3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the risks to human health related to the presence of chlorate 
in food were assessed by the EFSA Panel on Contaminants in the Food Chain (CONTAM Panel). The presence 
of chlorate in food can arise from the use of chlorinated water for food processing and the disinfection of food-
processing equipment. Inhibition of iodine uptake in humans was identified as the critical effect for chronic 
exposure to chlorate. A tolerable daily intake (TDI) of 3 µg chlorate/kg body weight (b.w.) was set by read-
across from a TDI of 0.3 µg/kg b.w. derived for this effect for perchlorate, multiplied by a factor of 10 to 
account for the lower potency of chlorate. Formation of methaemoglobin was identified as the critical acute 
effect of chlorate. An acute reference dose (ARfD) of 36 µg chlorate/kg b.w. was derived from a no-observed-
effect-level for chlorate in a controlled clinical study. Chronic exposure of adolescent and adult age classes did 
not exceed the TDI. However, at the 95th percentile the TDI was exceeded in all surveys in ‘Infants’ and 
‘Toddlers’ and in some surveys in ‘Other children’. Chronic exposures are of concern in particular in younger 
age groups with mild or moderate iodine deficiency. Mean and 95th percentile acute exposures were below the 
ARfD for all age groups indicating no concern. Based on the current practices in food industry, application of a 
hypothetical maximum residue limit (MRL) of 0.7 mg/kg for all foodstuffs and drinking water would only 
minimally reduce acute/chronic exposures and related risks. Assuming chlorate concentrations of 0.7 mg/kg for 
all foods and drinking water consumed in a day, acute exposures would increase by up to about 5-fold and the 
ARfD be exceeded at mean estimates in  ‘Infants’ and ‘Toddlers’ and at 95th percentile also in ‘Other 
children’and ‘Adults’. 
© European Food Safety Authority, 2015 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Contaminants in the Food 
Chain (CONTAM Panel) was asked to deliver a scientific opinion on the risks for public health related 
to the presence of chlorate in food from all sources taking into account also its presence in drinking 
water.  
Chlorate (ClO3
-
) is a substance that is no longer approved as a pesticide according to Commission 
Decision No 2008/865/EC. No specific maximum residue levels (MRLs) have been established for 
chlorate under Regulation (EC) No 396/2005. Therefore, a default MRL of 0.01 mg/kg is applicable to 
all foods listed in its Annex. 
Chlorate is formed as a by-product when using chlorine, chlorine dioxide or hypochlorite for the 
disinfection of drinking water, water for food production and surfaces coming into contact with food. 
Chlorination of animal-derived food is not allowed in the EU, while washing of plant-derived food 
with chlorine disinfected water can be permitted under national regulations. No maximum levels for 
chlorate in drinking water have been set in the European Union (EU) while the World Health 
Organisation (WHO) has established a guideline level for chlorate in drinking water of 0.7 mg/L. 
In many fruit and vegetable commodities chlorate levels exceeding the default MRL of 0.01 mg/kg are 
found.  
Based on the available information, the CONTAM Panel assumes that chlorate residues in food result 
mainly from the use of chlorinated water for food processing (e.g. washing) and from the disinfection 
of surfaces and food processing equipment coming into contact with food.  
The EFSA Evidence Management Unit (DATA Unit) launched a call for data on chlorate levels in 
food and drinking water. After a quality assessment of the analytical data and their evaluation, 
8 028 samples remained for analysis of which about 5% were drinking water samples.  
The majority of the samples (n = 4 838) came from Germany. The food groups represented best were 
‘Vegetable and vegetable products’ (n = 3 752), followed by ‘Fruit and fruit products’ (n = 2 607). 
The highest mean concentrations were observed for ‘Chilli pepper’ (lower bound, LB = 164 µg/kg, 
upper bound, UB = 169 µg/kg,), ‘Aubergines’ (LB = 157 µg/kg, UB = 164 µg/kg,) and ‘Vegetable and 
vegetable products, unspecified’ (LB = 216 µg/kg, UB = 222 µg/kg). A total of 453 samples of 
‘Drinking water’ were available. Mean chlorate values for ‘Drinking water’ were 28 µg/L and 39 µg/L 
at the LB/UB scenarios, respectively. The 99th percentile UB concentration in drinking water used to 
estimate acute exposure was 196 µg/L.  
Food commodities reported as ‘frozen’ showed the highest levels of chlorate within each food group. 
However, in many samples reported as ‘frozen’ the chlorate levels were below the limit of 
quantification, indicating that chlorate levels may depend on how food is actually processed (levels of 
chlorine in water and rinsing). 
There were indications that high levels of chlorate might be present in yoghurt and infant/follow-on 
formula but the data were insufficient for exposure assessment.  
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
updated in 2015 was used to estimate dietary exposure to chlorate.  
The CONTAM Panel concluded that a variability factor accounting for residue variation within 
composite samples of food commodities for acute exposure assessment of chlorate is not needed, 
mainly since the unit weight in frozen vegetables is small. Additionally, chlorate residues are highly 
soluble and an even distribution in processing water is expected.  
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The CONTAM Panel performed the exposure assessment of chlorate using chronic and acute exposure 
scenarios. Highest chronic exposures were estimated for the youngest population groups (‘Infants’, 
‘Toddlers’ and ‘Other children’).The mean chronic dietary exposure ranged between 0.5 µg/kg b.w. 
per day in ‘Adolescents’ (LB) and 4.1 µg/kg b.w. per day in ’Infants’ (UB). At the 95th percentile, the 
lowest dietary exposure of 1.0 µg/kg b.w. per day (LB) was estimated for the age classes  ‘Elderly’ 
and ‘Very elderly’. The highest 95th percentile exposure was in ‘Infants’ (6.6 µg/kg b.w. per day, UB). 
The estimates of chronic dietary exposure to chlorate in the available dietary survey on ‘Pregnant 
women’ and the one on ‘Lactating women’ were similar or lower than those calculated in the general 
population.  
Overall, in all age classes and vulnerable population groups (pregnant and lactating women) the main 
average contributor to the chronic dietary exposure to chlorate was ‘Drinking water’. Range of 
contribution at the LB estimation across surveys: ‘Infants’ (25–58 %), ‘Toddlers’ (12–48 %), ‘Other 
children’ (0–38 %), ‘Adolescents’ (0–38 %), ‘Adults’ (6.2–48 %), ‘Elderly’ (8.1–35 %), ‘Very 
elderly’ (5.5–39 %). 
Considering all available occurrence data, mean acute exposure (UB) ranged between 1.0 µg/kg b.w. 
per day in ‘Adolescents’ and 13 µg/kg b.w. per day in ‘Infants’. The 95th percentile acute exposure 
estimates were between 2.6 µg/kg b.w. per day in ‘Adolescents’ and 31 µg/kg b.w. per day in 
‘Infants’. Acute 95th percentile exposure (UB) through the daily consumption of individual foods was 
highest for ‘Drinking water’ (32 µg/kg b.w. per day), ‘Broccoli’ (21 µg/kg b.w. per day), and ‘Whey 
and whey products, excluding whey cheese’ (19 µg/kg b.w. per day). 
Acute and chronic estimates of exposure when excluding the occurrence data above a hypothetical 
MRL of 0.7 mg/kg were only slightly lower than those using all available occurrence data. This is 
explained by the fact that only few commodities were excluded and most of them belong to food 
groups with a relatively low contribution to the exposure.  
It should be emphasised that the occurrence data set applies to current practice in the food industry 
under which the occurrence is, in general, substantially lower than 0.7 mg/kg. It cannot be predicted 
whether application of a MRL of 0.7 mg/kg would result in different practices leading to higher 
residue levels and higher exposures to chlorate.  
In a hypothetical scenario, acute exposures were estimated assuming that all food items consumed 
have an occurrence value of 0.7 mg/kg. This led to a substantial increase of the acute exposure 
estimates as compared to the scenario using the reported occurrence levels.  
Estimating acute exposure assuming an occurrence value of 0.7 mg/kg for individual food 
commodities generally results in lower acute exposure as compared to the use of the reported 
occurrence data. Important exceptions were the estimates of acute exposure calculated through the 
daily consumption of ‘Drinking water’ and ‘Cow milk’ that reached values up to 111 µg/kg and 
56 µg/kg b.w. per day, respectively. 
Following oral exposure, chlorate is rapidly absorbed, widely distributed throughout the body, 
metabolised to chloride and eliminated via the urine in rats. Chlorate is of very low acute toxicity in 
rats, (LD50 ≥ 3 861 mg/kg b.w.). The thyroid gland and the haematological system are the primary 
targets of chlorate toxicity in repeat oral dose studies with laboratory animals. Decreases in 
erythrocytes, haemoglobin and haematocrit were observed in mice, rats, dogs and monkeys. Next to 
altered thyroid hormone levels (decreases in triiodothyronine and thyroxine, increases in thyroid-
stimulating hormone), histopathological changes in the thyroid gland (follicular cell hypertrophy, 
increase in colloid depression and in follicular cell hyperplasia) were observed in rats after repeated 
exposure. Chronic exposure to sodium chlorate induces also bone marrow hyperplasia, and 
haematopoietic cell proliferation in spleen of rodents. There is equivocal evidence of carcinogenic 
activity of sodium chlorate in mice based on marginally increased incidences of pancreatic islet cell 
adenoma and carcinoma in female mice and some evidence in rats based on increased incidences of 
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thyroid gland neoplasms. Chlorate is unlikely to pose a genotoxic hazard. Overall, the CONTAM 
Panel concluded that the thyroid tumours observed are induced via a non-genotoxic mode of action 
and are not relevant for humans. Chlorate has not been shown to have reproductive or developmental 
effects in rats and rabbits.  
No long term studies on chlorate in humans or adequate epidemiological studies were identified. Like 
perchlorate, chlorate is a competitive inhibitor of iodine uptake in the thyroid. Chronic adaptive 
changes compensating sustained inhibition of thyroid iodine uptake could lead to long term effects 
such as the development of toxic multinodular goitre, in particular in populations with mild to 
moderate iodine deficiency. Fetuses, neonates, individuals with low iodine intake or genetically 
predisposed to develop hypothyroidism, are potentially more susceptible to these effects. The 
CONTAM Panel considered the inhibition of thyroid iodine uptake as the critical effect for the chronic 
hazard characterisation. Humans are less sensitive than rats towards the effects of agents that disrupt 
thyroid hormone homeostasis. However, there are no in vivo human studies on the inhibition of iodine 
uptake by chlorate. Therefore the CONTAM Panel derived a tolerable daily intake (TDI) of 3 µg/kg 
b.w. per day for chlorate by reading across from the TDI of 0.3 µg/kg b.w. per day established for 
perchlorate for this effect based on human data and by by multiplying by a factor of 10 for the 
difference in potency between the two substances in rats.  
Chlorate is of high acute toxicity in humans as lethality is reported from oral doses of approximately 
50 mg chlorate/kg b.w. and toxicity from doses of 11–23 mg chlorate/kg b.w. onwards. The critical 
acute effect in humans identified in cases of poisoning is induction of methaemoglobinaemia, followed 
by lysis of red blood cells that can lead eventually to renal failure. The CONTAM Panel considers that 
the no observed effect level (NOEL) of 36 µg chlorate/kg b.w. per day from a controlled clinical study 
can be the basis for the establishment of an ARfD. The CONTAM Panel concludes that the differences 
between the NOEL in the controlled clinical study and the effect levels in poisoning cases are 
sufficiently large that no uncertainty factor is required for more vulnerable individuals (e.g. glucose-6-
phosphate dehydrogenase deficient individuals or hereditary methaemoglobinaemia) and established 
an ARfD of 36 µg chlorate/kg b.w. 
As for perchlorate, the CONTAM Panel noted that a single acute exposure to chlorate at levels found 
in food and water is unlikely to cause adverse effects in thyroid function, including in the more 
vulnerable groups of the population. 
The mean and 95th percentile chronic exposure estimates for surveys from adolescent and adult age 
classes did not exceed the TDI of 3 µg/kg b.w. per day. In the younger populations (‘Infants’ and 
‘Toddlers’), the TDI was exceeded at the 95th percentile in all surveys and in some surveys for the UB 
mean exposure estimates. At the 95th percentile at median LB, the TDI was also exceeded in the 
group ‘Other children’. Thus, chronic dietary exposure to chlorate is of potential concern in particular 
at high exposure in the younger age groups of the population with mild to moderate iodine deficiency. 
Fetuses, neonates, and individuals with low iodine intake or genetically predisposed to develop 
hypothyroidism are likely to be more sensitive to the effects of exposure to chlorate.  
Mean and 95th percentile acute exposure estimates for all age groups are below the ARfD of 36 µg/kg 
b.w. and do not indicate a concern. 
For chronic exposures based on the current occurrence data, removing foods containing more than 
0.7 mg/kg chlorate from the exposure assessment would have a minimal impact on the exposure and 
consequently on the risk characterisation based on current occurrence data.  
Likewise, for acute exposure based on the current occurrence data, removing foods and drinking water 
containing more than 0.7 mg/kg chlorate from the exposure assessment would also have a minimal 
impact on the exposure. Mean and 95th percentile acute dietary exposures would all remain below the 
ARfD. The occurrence data used for assessment applies to current practice in the food industry and it 
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cannot be predicted whether application of an MRL of 0.7 mg/kg would result in different practices 
leading to higher residue levels and higher exposures to chlorate. 
When assuming an occurrence value of 0.7 mg/kg for all foods covered by Annex I of Regulation 
396/2005 and drinking water, acute exposures would increase by up to approximately five-fold, and 
the ARfD would be exceeded at mean exposure in ‘Infants’ and at 95th percentile exposures also in 
‘Toddlers’, ‘Other children’,  and ‘Adults’. The CONTAM Panel considered that such exceedances of 
the ARfD resulting from this scenario are unlikely, because it is highly implausible that all foods 
consumed on a single day would have chlorate concentrations in the range of 0.7 mg/kg. A potential 
exception would be drinking water, which by itself contributes to a large extent to the intake of 
chlorate.  
When considering food commodities one by one, mean acute chlorate exposure did not exceed the 
ARfD from any food item, with the exception of drinking water. The scenario indicated that if the 
chlorate concentration in drinking water would be 0.7 mg/kg, the exposure to chlorate could be similar 
to the ARfD at mean water consumption and up to 3-fold the ARfD at high ( 95th percentile) water 
consumption. . 
The CONTAM Panel identified a need for human data on inhibition of iodine uptake by chlorate and 
relative potency compared to perchlorate and information on levels of chlorate in humans and 
association with possible effects. The CONTAM Panel recommended that more information about the 
impact of food processing (e.g. blanching) on chlorate residues in food be collected. More occurrence 
data are needed for foods for which there are currently no data (e.g. animal derived foods, tea, coffee, 
beer). More data are also needed on chlorate in foods where there are currently indications of high 
chlorate levels such as infant/follow-on formula and yoghurt. Any efforts to reduce chlorate residues 
in food should take into account whether these would have an impact on microbiological food safety. 
There is also a need for a better understanding of the contribution of various dietary factors and 
contaminants to the overall thyroid iodine uptake inhibition. 
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1. Introduction 
Background and Terms of reference as provided by the requestor 
BACKGROUND 
Chlorate 
Chlorate is a substance that is no longer approved as a pesticide according to Commission Decision 
No 2008/865/EC.
4
 Since no specific MRL was fixed under Reg. (EC) No 396/2005,
5
 the default MRL 
of 0.01 mg/kg is applicable to all food products included in Annex I to that Regulation.  
In many fruit and vegetable commodities chlorate levels exceeding the default MRL have been found. 
It is unlikely that these residues result from the illegal use of chlorate as a pesticide. Chlorate is 
formed as a by-product when using chlorine, chlorine dioxide or hypochlorite for the disinfection of 
drinking water or water for food production. Especially in food production lines where the washing 
water is recycled and chlorine disinfection is used to keep the microbial quality of the water at an 
acceptable level, chlorate residues have a tendency to concentrate, resulting in residues in food. 
However, also in products that have only been treated with drinking water, the chlorate levels exceed 
the legal limit of 0.01 mg/kg. For drinking water a guideline level of 0.7 mg/L
6
 chlorate in drinking 
water has been established by the World Health Organisation (WHO) based on a TDI of 0.03 mg/kg 
b.w. per day (WHO, 2005
7
). Chlorate levels of up to the level of 0.7 mg/L can be found depending on 
the extent of chlorination, which varies amongst Member States. Furthermore, chlorate residues can 
also arise from their uptake by plants resulting from: 
 the use of chlorine-disinfected irrigation water; 
 the use  of  potassium nitrate and monopotassium phosphate fertilisers which contain certain 
amounts of chlorate; 
 the chlorate present in the soil or groundwater. 
Findings in the European Union 
In a survey performed by the CVUA (Chemisches und Veterinäruntersuchungsamt) Stuttgart, 
600 samples of products of plant origin were analysed. In 19.8 % of them, residue levels were found 
between 0.01 and 0.92 mg/kg.  
Both food business operators and the German authorities have been further investigating the 
occurrence of these residues and the reasons for their unexpected presence. The continued monitoring 
indicated that the levels of chlorate residues in fruits and vegetables can go up to 5 mg/kg. 
As a toxicological reference value for chronic risk assessment, JECFA established an ADI of 
0.01 mg/kg b.w. per day in 2007.
8
 As JECFA considered it unnecessary to establish an ARfD and as 
                                                     
4  2008/865/EC: Commission Decision of 10 November 2008 concerning the non-inclusion of chlorate in Annex I to Council 
Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance. OJ L 
307, 18.11.2008, p. 7–8. 
5  Regulation (EC) No 396/2005 of the European Parliament and of the Council of 23 February 2005 on maximum residues 
levels of pesticides in or on food and feed of plant and animal origin and amending Council Directive 91/414/EC. OJ L 70, 
16.3.2005, p. 1–16. 
6  Guidelines for drinking-water quality, fourth edition. World Health Organization, 2011. Available at: http://www.who.int/
water_sanitation_health/publications/2011/dwq_guidelines/en/ 
7  Background document for the development of WHO Guidelines for Drinking-water Quality WHO/SDE/WSH/05.08/86. 
8  Evaluation of certain food additives and contaminants. Sixty-eighth report of the Joint FAO/WHO Expert Committee on 
Food Additives. WHO Technical Report Series 947. Available at: http://whqlibdoc.who.int/publications/2007/
9789241209472_eng.pdf 
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no EFSA opinion is available so far, some Member States are currently using the value of 0.01 mg/kg 
b.w. per day also for the ARfD, as a conservative approach. 
In 2014, so far 7 findings resulted in a RASFF (Rapid Alert System for Food and Feed) notification. 
The risk assessment was performed by making use of the Pesticide Residue Intake Model (PRIMo) for 
acute effects applying a variability factor for fruits and vegetables with a high unit weight and using 
the value of 0.01 mg/kg b.w. per day as an ADI and ARfD.  
The European Commission would like to request from EFSA a scientific opinion on the risk for public 
health as the consequence of the presence of chlorate in food, taking also into account its presence in 
drinking water, with a view to taking permanent risk management measures.  
The opinion should address the possible acute and chronic health effects, including risks for specific 
vulnerable population groups, and address the question whether an Acute Reference Dose (ARfD) is 
needed. It should also address the question whether the use of a variability factor would be 
appropriate. 
The scientific opinion should be available by 30 April 2015.  
In order to enable EFSA to carry out such risk assessment, Member States with the active involvement 
of food business operators were requested to monitor the presence of chlorate in food as well as 
drinking water and to submit those data to EFSA and the Commission before 31 December 2014. 
Monitoring guidelines, defining the data to be submitted and their format, have been circulated among 
Member States and food business operators. 
TERMS OF REFERENCE 
In accordance with Art. 29 (1) (a) of Regulation (EC) No 178/2002, the Commission asks EFSA for a 
scientific opinion on the risks to human health related to the presence of chlorate in food from all 
sources, taking also into account its presence in drinking water. 
The scientific opinion as regards the presence of chlorate in food from all sources, taking also into 
account its presence in drinking water, should, inter alia, comprise the following: 
a)  the evaluation of the toxicity of chlorate for humans, considering all relevant adverse chronic and – 
if applicable – acute health effects, including the need to establish any health based guidance values 
such as an Acute Reference Dose (ARfD), Acceptable Daily Intake (ADI), etc.; 
b)  the estimation of the dietary exposure (chronic and acute dietary exposure, if applicable) of the EU 
population to chlorate, considering the consumption patterns of specific (vulnerable) groups of the 
population (i.e. high consumers of certain fruits and vegetables, (young) children, pregnant 
women,…). The assessment of dietary exposure should include the assessment of the need for a 
specific variability factor; 
c)  the assessment of the chronic and acute (if applicable) human health risks as the consequence of the 
presence of chlorate in food, taking into account its presence in drinking water, with particular 
attention to specific (vulnerable) groups of the population (i.e. high consumers of certain fruits and 
vegetables, (young) children, pregnant women, iodine deficient people), based on the above points 
a) and b); 
d)  based on the above points a), b) and c) an evaluation of the safety of a hypothetical maximum 
residue level of 0.7 mg/kg
9
 for chlorate in foods covered by Annex I to Regulation (EC) No 
396/2005. 
                                                     
9  In analogy with the WHO guideline level for drinking water of 0.7 mg/L. 
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1.1. Interpretation of the Terms of reference  
The CONTAM Panel concluded that the terms of reference provided by the European Commission 
were clear.  
1.2. Additional information  
1.2.1. Previous assessments 
The most recent risk assessments for chlorate are described below. 
In the context of its drinking water guidelines, the World Health Organization (WHO, 2005) identified 
a no-observed-adverse-effect level (NOAEL) of 30 mg/kg body weight (b.w.) per day expressed as 
chlorate, from a 90-day study of sodium chlorate in rats, in which thyroid gland colloid depletion was 
reported at the next higher dose of 100 mg/kg b.w. per day (McCauley et al., 1995). Application of an 
uncertainty factor of 1 000 to this NOAEL (10 each for inter- and intraspecies variation and 10 for the 
short duration of the study) resulted in a tolerable daily intake (TDI) of 30 μg/kg b.w. per day. WHO 
noted that this TDI was supported by the results of human volunteer studies, in which repeated 
administration of chlorate at 36 μg/kg b.w. per day did not result in any adverse effects (including 
blood and urine analysis, electrocardiograms and physical examination, e.g. blood pressure, respiration 
rate, pulse and temperature) (Lubbers et al., 1981). Assuming that drinking water contributes 80 % of 
the total exposure and a typical consumption of 2 litres (L) of water per day by a 60 kg person, the 
WHO proposed a provisional guideline value of 0.7 mg/L. This guideline value was designated as 
provisional ‘because use of chlorine dioxide as a disinfectant may result in the chlorate guideline value 
being exceeded, and difficulties in meeting the guideline value must never be a reason for 
compromising adequate disinfection’. It was noted that a long-term study was in progress that should 
provide more information on the effects of chronic exposure to chlorate.
10
 
The EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food 
(AFC Panel) evaluated the toxicological risks to public health from possible reaction products of 
acidified sodium chlorite (ASC) applied on poultry carcasses as an antimicrobial agent. Chlorite and 
chlorate were identified as the main residues, and the AFC Panel concluded that there was no safety 
concern but did not specifically refer to a health-based guidance value for chlorate (EFSA, 2006a). 
The US Environmental Protection Agency (US EPA) has published a Reregistration Eligibility 
Decision (RED) for inorganic chlorates (US EPA, 2006). A 95 % lower confidence limit for the 
benchmark dose response of 10 % extra effect (BMDL10) for chlorate of 0.9 mg/kg per day was 
calculated for increased thyroid gland follicular cell hypertrophy and follicular cell mineralisation in 
the National Toxicology Program (NTP) carcinogenicity study of sodium chlorate in rats (NTP, 2005). 
The US EPA applied an uncertainty factor of 30 (three for interspecies and 10 for intraspecies 
differences) and established a chronic reference dose (RfD) of 0.03 mg/kg b.w. per day. The selection 
of the interspecies uncertainty factor of three, rather than the default factor of 10, was due to the 
quantitative dynamic differences between rats and humans with respect to thyroid function. The US 
EPA noted that the half-life of thyroid hormone thyroxine (T4) in rats is approximately 12 hours, 
whereas it is five to 9 days in humans. The shorter half-life in rats is likely related to a high-affinity 
binding globulin for T4 that is present in humans, but absent in rodents. In the absence of a functional 
thyroid gland, a rat requires approximately 10-times more T4 than an adult human for full 
reconstitution. Constitutive thyroid stimulating hormone (TSH) levels are nearly 25-times higher in 
rats than in humans, reflecting the increased activity of the thyroid-pituitary axis in rats. An Acute 
Reference Dose (ARfD) was not established because effects attributable to a single dose were not seen 
in the available data. 
                                                     
10  It is assumed that this reference was to the NTP (2005) study on the toxicity and carcinogenicity of sodium chlorate. 
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Health Canada (2008) set a TDI of 30 μg/kg b.w. for chlorate, with the same justification as WHO 
(2005). 
The Joint FAO/WHO Expert Committee on Food Additives (JECFA) evaluated the safety of chlorate 
residues in the context of its review of ASC as an antimicrobial agent used primarily as a spray or 
dipping solution for poultry, meats, vegetables, fruits and seafood, and in poultry chilling water 
(FAO/WHO, 2008). Like the AFC Panel, JECFA focussed its AFC safety evaluation on the residues, 
chlorite and chlorate. For chlorate, JECFA concluded that the most sensitive effects were changes to 
the thyroid gland of male rats, noting that rats are highly sensitive to the effects of agents that disrupt 
thyroid hormone homeostasis. A BMDL10 of 1.1 mg/kg b.w. per day was calculated for non-neoplastic 
effects on the thyroid of male rats in the carcinogenicity study of sodium chlorate conducted by the 
National Toxicology Program (NTP, 2005). JECFA considered that humans are likely to be less 
sensitive than rats to these effects and that a safety factor for interspecies variation was not required. 
However, in addition to the safety factor of 10 to allow for intraspecies variability, an additional factor 
of 10 was required to allow for the deficiencies in the database, particularly with respect to 
investigation of possible neurodevelopmental effects. JECFA therefore established an acceptable daily 
intake (ADI) of 0–0.01 mg/kg b.w. for chlorate. JECFA noted that the estimated dietary exposure of 
0.6 μg/kg b.w. per day, representing high consumers including children, was less than 10 % of the 
ADI and compatible with the exposure allocated to other sources within the WHO drinking-water 
guidelines for chlorate (FAO/WHO, 2008). 
The European Chemicals Agency (ECHA) has provided risk assessments for sodium and potassium 
chlorate (ECHA, 2015a, b).  For sodium chlorate a derived no effect level (DNEL)
11
 of 0.036 mg/kg 
b.w. per day was identified for oral exposure of the general population, based on the finding of thyroid 
gland follicular cell hypertrophy in the NTP carcinogenicity study (NTP, 2005), incorporating an 
assessment factor of 100 (ECHA, 2015a).  For potassium chlorate a DNEL of 0.06 mg/kg b.w. per day 
was identified for oral exposure to the general population, apparently by read-across from sodium 
chlorate (ECHA, 2015b). 
A Draft Assessment Report (DAR) was prepared for sodium chlorate by the rapporteur Member State 
France in the context of the review programme referred to in Article 8(2) of Council Directive 
91/414/EEC
12
 (EU DAR, 2008). The DAR noted that two main targets of sodium chlorate have been 
identified in animal studies: the thyroid gland and red blood cells (RBCs). Based on acute toxicity, the 
DAR concluded that humans are obviously more susceptible to toxicity of sodium chlorate than 
laboratory animals. No ADI or ARfD was proposed because sodium chlorate was not used in cropping 
areas. An Acceptable Operator Exposure level (AOEL) of 0.35 mg/kg b.w. per day was proposed, 
based on the lowest relevant NOAEL of 70 mg/kg b.w. per day in male and female rats treated by 
gavage in a reproduction toxicity study. A safety factor of 200 was used allowing for a potential higher 
sensitivity of glucose-6-phosphate-deficient individuals.  
The German Federal Institute for Risk Assessment (BfR) recommended using the ADI of 0.01 mg/kg 
body weight derived by JECFA as the basis for both chronic and acute risk assessments of chlorate 
residues in food (BfR, 2013). The BfR noted that there was a need for an acute risk assessment for 
chlorate due to the high acute oral toxicity of chlorate to humans, resulting from the harmful effects on 
erythrocytes (methaemoglobin formation, haemolysis). In addition, the possibility of a one-time intake 
of chlorate triggering adverse effects on thyroid function could not be ruled out. This applied 
particularly to more sensitive subpopulations such as persons with thyroid function disorders or iodine 
deficiency, as well as to newborn infants and children. Pregnant women exhibiting manifest or 
subclinical thyroid function disorders were considered to constitute a particularly critical group since 
thyroid hormones play a key role in early childhood development, especially in brain development. 
                                                     
11  REACH legislation defines the Derived No-Effect Level (DNEL), as the level of exposure above which humans should not 
be exposed. 
12  Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market. OJ L 
230, 19.8.1991, 1–32. 
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The ADI was used for the acute risk assessment since there were no toxicology data adequate for 
deriving an ARfD for chlorate.  
The assessment of the chronic risk indicated that the health of European consumer groups is not 
adversely affected by the reported chlorate residues in foods. In the absence of data available on the 
possible origin of the reported chlorate residues, the BfR estimated short-term intake in accordance 
with its recommendations for perchlorate,
13
 using the EFSA Pesticide Residue Intake Model (PRIMo). 
On the basis of this worst case approach, the BfR estimation of short-term intake for certain product 
groups led to an exceedance of the ADI proposed for the acute risk assessment of chlorate. The BfR 
noted that refinement of both the toxicological assessment and the residue assessment would be 
possible with a better database (BfR, 2013). 
1.2.2. Chemistry 
Chlorate (ClO3
-
) is an anion that can form salts, e.g. with sodium. Since all the Cl-O bonds are the 
same length and the chlorine atom is hypervalent, chlorate it is often thought of as a hybrid of multiple 
resonance structures (Figure 1). Chlorate anions have trigonal pyramidal structures. 
 
Figure 1:  Resonance structures of chlorate 
Since sodium chlorate is generally used in toxicity studies to assess chlorate toxicity, this section 
shortly summarizes the chemistry of sodium chlorate. Sodium chlorate has a white or colourless 
crystal structure and is highly soluble in water (Table 1). It has a melting point of 248 °C and a 
decomposition point of ~ 300 °C. Above 300 °C, sodium chlorate decomposes exothermically to NaCl 
releasing O2. Although sodium chlorate is a strong oxidizer and can be explosive when mixed with 
strong reducing agents, aqueous solutions of chlorate can be handled safely. In the environment and 
drinking water, chlorate can persist as a product from chlorine, chlorine dioxide and chlorite chemical 
reactions in an aqueous environment. 
Table 1:  Some relevant physico-chemical properties of sodium chlorate 
Molecular formula:  ClNaO3  Density: 2.54 g/cm
3
 (20.2 °C) 
Molecular mass: 106.44 g/mol  Melting point: 248 °C 
CAS Number: 7775-09-9   Boiling point: ~ 300 °C  
Oxidations state of chlorine: +5  
Solubility in water:  960-1 000 g/L 
dissociation into sodium an chlorate ions 
Properties at room temperature:   
odourless, white or colourless  
crystal structure, hygroscopic  
 
 
 
1.2.3. Analytical methods 
Analytical methods for the quantification of chlorate are typically based on spectrophotometric or 
colorimetric, electrochemical and chromatographic techniques, especially ion chromatography, also 
coupled with mass spectrometry (Michalski, 2006; Rao et al., 2010) These methods have been 
                                                     
13  Available at: http://www.bfr.bund.de/cm/343/empfehlung-des-bfr-zur-gesundheitlichen-bewertung-von-perchlorat-rueck
staenden-in-lebensmitteln.pdf 
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developed in the first line for relative clean matrixes, especially drinking water (summarized in Health 
Canada, 2008).  
In complex matrices of animal origin, liquid chromatography-mass spectrometry (LC-MS) utilizing a 
Cl
18
O3
-
 internal standard has been demonstrated to be applicable to sensitively quantify chlorate 
(Smith and Taylor, 2011). In foods of plant origin chlorate is recommended to be analysed by a multi-
residue method for polar pesticides (Quick Polar Pesticides Method, QuPPe). Chlorate is extracted 
from the test portion following water adjustment and the addition of acidified methanol. The mixture 
is centrifuged, filtered and directly analysed by liquid chromatography – tandem mass spectrometry 
(LC/MS-MS) (Anastassiades et al., 2013).  
1.2.4. Legislation  
Article 2 of Council Regulation (EEC) No 315/93
14
 stipulates that food containing a contaminant in an 
amount unacceptable for public health shall not be placed on the market, that contaminant levels 
should be kept as low as can reasonably be achieved and that, if necessary, the European Commission 
(EC) may establish maximum levels for specific contaminants. These maximum levels are laid down 
in the Annex of Commission Regulation (EC) No 1881/2006
15
 and may include limits for the same 
contaminants in different foods, analytical detection limits and reference to the sampling and analysis 
methods to be used. No maximum levels for chlorate are presented in this regulation.  
Chlorate was previously listed as an active substance approved for use in plant protection products in 
Annex I of Directive 91/414/EC (now replaced by Regulation (EC) No 1107/2009.
16
 In accordance 
with Commission Decision 2008/865/EC
17
 the approval of chlorate for use in plant protection products 
has been withdrawn and thus chlorate cannot be used anymore in plant protection products.  
In Annexes II, III, and V of Regulation (EC) No 396/2005 maximum residue levels (MRLs) for active 
substances currently or formerly used in plant protection products are listed. For those substances for 
which no specific MRLs are listed in these annexes, the default MRL value of 0.01 mg/kg is 
applicable to all food products listed in Annex I of that Regulation. For chlorate no specific MRLs 
were set, thus the default MRL is applicable. 
The disinfection of drinking water, or surfaces in contact with food, falls within the scope of the 
Biocidal Product Regulation (EU) No 528/2012.
18
 For these uses, various active substances are 
currently under assessment in the review programme of biocidal active substances established under 
Regulation (EU) No 1062/2014, including chlorine, chlorine dioxide, active chlorine, sodium 
hypochlorite, calcium hypochlorite. Clarifications are also currently on-going within the biocides 
legislation with regards to the in-situ generation of biocides, which covers situations where the active 
substance is generated from the use of one or several chemical precursors. For instance, chlorine 
dioxide is currently under assessment as being generated from sodium chlorite or sodium chlorate. The 
placing on the market and use of all these biocidal products are subject to national rules of each 
Member State. Once a decision on the approval of the active substances is taken at European Union 
(EU) level, biocidal products will be subject to the evaluation and authorisation scheme established 
under the Biocidal Product Regulation.  
                                                     
14  Council Regulation (EEC) No 315/93 of February 1993 laying down Community procedures for contaminants in food. OJ 
L 37, 13.2.1993, p. 1–3. 
15  Regulation (EC) No 1881/2006 of the European Parliament and the Council of 19 December 2006 setting maximum levels 
for certain contaminants in foodstuffs. OJ L 364, 20.12.2006, p. 5–24. 
16  Regulation (EC) No 1107/2009 of the European Parliament and of the Council  of 21 October 2009 concerning the placing 
of plant protection products on the market and repealing Council Directives 79/117/EEC and 91/414/EEC. OJ L 309, 
24.11.2009, p. 1–50. 
17  Commission Decision of 10 November 2008 concerning the non-inclusion of chlorate in Annex I to Council Directive 
91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance OJ L 307, 18.11. 
2008, p. 7–8. 
18  Regulation (EU) No 528/2012 of the European Parliament and of the Council of 22 May 2012 concerning the making 
available on the market and use of biocidal products. OJ L 167, 27.6.2012, p. 1–123. 
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According to Regulation (EC) No 852/2004
19
 for prevention of contamination of plant products 
potable or clean water should be used. 
Regulation (EC) No 853/2004
20
 laying down general rules for food business operators on the hygiene 
of foodstuffs stipulates that food business operators shall not use any substance other than potable 
water to remove surface contamination from products of animal origin besides those approved in 
accordance with the Committee procedure described in Art. 12 of this Regulation. Currently only 
lactic acid is approved.  
Food business operators in the EU importing products of animal origin from third countries shall 
ensure that importation takes place only if (inter alia) the product satisfies the requirements laid down 
in the regulation. 
Products used for decontamination of food of plant origin qualify as processing aids which are 
regulated under national legislation. Chlorate yielding substances such as chlorine (gas), chlorine 
dioxide or hypochlorite can fall under this definition. In the absence of EU rules it is possible for 
Member States to adopt specific measures to control microbial contamination. Such is the case for 
instance in France where the use of water treated with sodium hypochlorite for the washing of fruit 
and vegetables is listed in a positive list together with a mandatory rinsing of the treated product with 
water. 
Sodium chlorate and potassium chlorate are used in industrial and manufacturing processes and are 
registered substances under Regulation (EC) No 1907/2006
21
 with a tonnage band of 100 000–
1 000 000 tonnes per annum and 1 000–10 000 tonnes per annum, respectively. 
Council Directive 98/83/EC
22
 on the quality of water intended for human consumption does not 
provide for maximum levels of chlorate.  
For drinking water a guideline level of 0.7 mg/L chlorate in drinking water has been established by the 
WHO. However, this level is not legally binding in the EU. 
2. Data and methodologies 
2.1. Data 
2.1.1. Occurrence data 
Following a request of the European Commission to the European Food Safety Authority (EFSA) for a 
scientific opinion concerning the risks for public health related to the presence of chlorate in food, the 
EFSA Evidence Management Unit (DATA Unit) started an ad hoc collection of data on chlorate levels 
in food and drinking water. European national food authorities and similar bodies, research 
institutions, academia, and food business operators submitted analytical data. The data submission to 
EFSA followed the requirements of the EFSA Guidance on Standard Sample Description for Food and 
Feed (EFSA, 2010a).  
                                                     
19 Regulation (EC) No 852/2004 of the European Parliament and of the Council of 29 April 2004 on the hygiene of 
foodstuffs.  OJ L 139, 30.4.2004, p. 1–54. 
20 Regulation (EC) No 853/2004 of the European Parliament and of the Council of 29 April 2004 laying down specific 
hygiene rules for food of animal origin. OJ L 139, 30.4.2004, p. 55– 96. 
21 Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals 
Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation 
(EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 
93/105/EC and 2000/21/EC. OJ L 396, 30.12.2006, p. 1–98. 
22 Council Directive 98/83/EC of 3 November 1998 on the quality of water intended for human consumption. OJ L 330, 
5.12.98, p. 32–54. 
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By the end of March 2015, a total of 8 774 samples of food and drinking water with analytical data on 
chlorate were available in the EFSA database. Approximately 7 % of the samples were reported as 
drinking water and the rest as food samples. Data received after that date were not included in the 
dataset to estimate dietary exposure. 
To guarantee an appropriate quality of the data used in the exposure assessment the initial dataset was 
carefully evaluated applying several data cleaning and validation steps (e.g. exclusion of duplicates 
and samples without complete information). When the information on the sampling strategy was 
described as ‘Suspect sampling’, the samples were excluded from the final dataset since they do not 
represent random sampling (644 samples). Samples collected outside Europe were not considered for 
the dietary exposure estimations (27 samples). Likewise, food samples codified as ‘Grain as crops’, 
which refer to unprocessed grains of undefined end-used, were also excluded (18 samples), together 
with 49 samples of ‘Drinking water’, some 48 reported as process water used in industry and one non-
quantified sample that reported a limit of quantification (LOQ) of 1 000 µg/L.  
For the food groups ‘Meat and meat products’, ‘Fish and other seafood’ and ‘Eggs and egg products’ 
(all at FoodEx Level 1) only eight samples were available in total. Theses samples refer to two 
samples of chicken, two of pork, and one each of beef, unspecified fish, prawns and egg powder. Due 
to the very limited number of samples, they were not considered representative of these food groups 
and they were also excluded. 
2.1.1.1. Data collection on food including drinking water 
After the quality assessment of the analytical data and their evaluation, a total of 8 028 samples of 
food and drinking water were available to estimate dietary exposure to chlorate. Most of the analytical 
data were derived from samples collected in Germany (4 838 samples). In total, 19 different European 
countries were reported as sampling country, with 1 513 samples reported as collected in the European 
Union without further details (Figure 2). The samples were mainly collected between 2013 
(1 871 samples) and 2014 (6 096 samples), although few were also collected in 2011 (61 samples). 
 
Figure 2:  Country of sampling of food and drinking water samples analysed for chlorate  
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2.1.1.2.  Analytical methods used 
Figure 3 shows the analytical methods reported for the different samples of food and drinking water. 
Information on the analytical method was not provided for approximately 12 % of the samples. High 
performance liquid chromatography (HPLC) was the separation method selected for almost all 
samples that provided information on the analytical method used. For 161 samples the reported 
analytical method was ion chromatography with suppressed conductivity detection. The preferred 
option for detection was tandem mass spectrometry (MS/MS) with 6 695 samples (83 %), followed by 
electrical conductivity detection (ECD) and mass spectrometry detection (MS). Few samples only 
reported the use of HPLC without further information on the detection method.  
 
Figure 3:  Analytical methods used in the analysis of chlorate in samples of food and drinking water 
Among the samples that reported information, the most sensitive analytical method was HPLC-
MS/MS that reported a minimum LOQ of 2 µg/kg in the analysis of ‘Fruit and fruit products’. The 
highest LOQ was also reported for HPLC-MS/MS (100 µg/kg) in the analysis of drinking water and 
diverse food commodities, such as ‘Vegetables and vegetable products’ and ‘Herbs, spices and 
condiments’, among others. The broadest ranges of LOQs within one specific food commodity was 
observed for ‘Fruit and fruit products’ (n= 2 366), with a range of LOQs between 2 µg/kg and 
100 µg/kg, and for ‘Drinking water’ (n= 453) with a range between 3 µg/kg and 100 µg/kg, always 
using HPLC-MS/MS. 
The left-censored data (analytical data below the limit of detection (LOD)/LOQ) accounted for 71 % 
of the analytical results on chlorate. The proportion of left-censored data among the different food 
groups (FoodEx Level 1) ranged between 0 % (Non-alcoholic beverages, n = 2) and 97 % (Alcoholic 
beverages, n = 37). More details for the different food groups are shown in Figure 4. 
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Figure 4:  Percentage of quantified and left-censored data across different food groups (at FoodEx 
Level 1) 
2.1.1.3. Food consumption data  
The EFSA Comprehensive European Food Consumption Database (Comprehensive Database) 
provides a compilation of existing national information on food consumption at individual level. It 
was first built in 2010 (EFSA, 2011b; Huybrechts et al., 2011; Merten et al., 2011) and then updated in 
2015 (EFSA, 2015). Details on how the Comprehensive Database is used are published in the 
Guidance of EFSA (EFSA, 2011a).  
The database contains data from 41 surveys in 23 different European countries for a total of 
78 990 participants (Appendix C). Data from six surveys were available for ‘Infants’ (< 12 months 
old), eleven for ‘Toddlers’ (≥ 12 months to < 36 months old), from 19 surveys for ‘Other children’ 
(≥ 36 months to < 10 years old), from 19 surveys for ‘Adolescents’ (≥ 10 years to < 18 years old), 
from 21 surveys for ‘Adults’ (≥ 18 years to < 65 years old), from 15 surveys for the ‘Elderly’ 
(≥ 65 years to < 75 years old) and from 13 surveys for the ‘Very elderly’ (≥ 75 years old). Two 
additional surveys provided information on specific population groups: ‘Pregnant women’ (Latvia) 
and ‘Lactating women’ (Greece).  
In the surveys above, consumption data were collected using single or repeated 24- or 48-hour dietary 
recalls or dietary records covering from 3 to 7 days per subject. Owing to the differences in the 
methods used for data collection, direct country-to-country comparisons must be taken with caution.  
2.1.2. Toxicokinetic and toxicological data 
All data were obtained as described in Section 2.2.3.1. 
2.2. Methodologies 
2.2.1. Collection and appraisal of previous occurrence results 
For the present evaluation the CONTAM Panel considered literature made publicly available until the 
30 January, 2015. A comprehensive literature search was conducted in September 2014 and has since 
been updated in November 2014, December 2014 and January 2015 focusing on research and reports 
related to occurrence of chlorate, focusing on food and drinking water. The references obtained were 
screened using title and abstract to identify the relevant literature.  
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Grains and grain-based products
Vegetables and vegetable products…
Starchy roots and tubers
Legumes, nuts and oilseeds
Fruit and fruit products
Milk and dairy products
Sugar and confectionary
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All information retrieved as described in the previous paragraph has been reviewed and used for the 
present assessment using expert judgement. No studies on the occurrence of chlorate in fruit, 
vegetables and food of animal origin were identified. Experimental studies on the direct treatment of 
fruit, vegetables and food of animal origin with ASC and chlorine dioxide, and for which the resulting 
chlorate levels in the food were reported, were considered. Studies on the administration of chlorate to 
livestock were not considered in the present opinion. For drinking water and other beverages, only 
data from European countries were considered. 
2.2.2. Exposure assessment 
The EFSA Panel on Contaminants in the food Chain (CONTAM Panel) considered that both chronic 
dietary and acute exposure to chlorate had to be assessed. As suggested by the EFSA Working Group 
on Food Consumption and Exposure (EFSA, 2011b), dietary surveys with only one day per subject 
were only considered for acute exposure as they are not adequate to assess repeated exposure. 
Similarly, subjects who participated only one day in the dietary studies, when the protocol prescribed 
more reporting days per individual, were also excluded for the chronic exposure assessment. Thus, for 
chronic exposure assessment, food consumption data were available from 35 different dietary surveys 
carried out in 19 different European countries (Appendix C). Six additional dietary surveys with only 
one day per subject from six different countries (covering all age classes except infants) were 
considered for acute exposure assessment (Appendix C). In the Appendix, the number of available 
days for each age class used in the acute exposure assessment are described beside the number of 
subjects available for the chronic exposure assessment. 
In line with the outcome of the hazard characterization, the CONTAM Panel decided to estimate 
chronic and acute dietary exposure (see Table 2). First, dietary chronic exposure to chlorate was 
estimated using all available occurrence data (scenario A.1). Acute exposure was also estimated as 
total exposure and food by food using all available occurrence data (scenario B.1). Then, based on the 
Terms of Reference, a hypothetical MRL of 0.7 mg/kg for chlorate in food and drinking water was 
considered and all samples with reported higher concentrations were excluded before estimating 
dietary exposure (scenarios A.2 and B.2). Finally, a scenario assuming the presence of 0.7 mg/kg 
chlorate in all food commodities was also assessed (scenario B.3). For acute exposure assessments 
variability factors were not applied (see Section 3.2.3). 
Table 2:  Different scenarios used to estimate chronic and acute dietary exposures to chlorate 
 Dietary exposure scenarios 
A. Chronic exposure 
assessments 
 
A.1. Chronic dietary exposure using the available occurrence data 
 
A.2. Chronic dietary exposure applying a cut-off of 0.7 mg/kg to the 
available occurrence data 
 
B. Acute exposure 
assessments 
 
B.1. Acute dietary exposure using the available occurrence data 
B.1.1. Total acute dietary exposure 
B.1.2. Acute dietary exposure food by food 
 
B.2. Acute dietary exposure applying a cut-off of 0.7 mg/kg to the 
available occurrence data 
B.2.1. Total acute dietary exposure 
B.2.2. Acute dietary exposure food by food 
 
B.3. Acute dietary exposure assigning a value of 0.7 mg/kg to all 
samples of food and drinking water 
B.3.1. Total acute dietary exposure 
B.3.2. Acute dietary exposure food by food 
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2.2.3. Hazard assessment 
2.2.3.1. Strategy for literature search 
For the present evaluation the CONTAM Panel considered literature made publicly available until 
30 January 2015. A comprehensive search for literature was conducted for peer-reviewed original 
research pertaining to the occurrence of chlorate in food and drinking water and adverse health effects 
on (experimental) animals and humans. The search strategy was designed to identify scientific 
literature dealing with chemical analysis, chemistry, occurrence, exposure, toxicity, mode of action, 
toxicokinetics and epidemiology of chlorate.  
Additionally, research or reports related to compounds that can yield chlorate upon transformation 
processes were considered, i.e. sodium chlorate, potassium chlorate, chlorine dioxide and 
hypochlorite. Literature search was not restricted to publications in English language, however, 
literature in other languages was only considered if an English abstract was available. A first literature 
search was performed in September 2014 and has since been updated in November 2014, December 
2014 and January 2015. Web of Science
23
 and Pubmed
24
 were identified as databases appropriate for 
retrieving literature for the present evaluation. The references resulting from the literature search were 
imported and saved using a software package (EndNote
25
), which allows effective management of 
references and citations. Additionally, reviews, relevant scientific evaluations by national or 
international bodies were considered for the current risk assessment i.e. previous evaluations of ECHA 
(2015a, b), BfR (2013), WHO (2005), FAO/WHO (2007, 2008, 2011), NTP (2002, 2005) and the 
US EPA (2002, 2006). Particular consideration has been given to the scientific opinion on perchlorate 
(EFSA CONTAM Panel, 2014). Furthermore, the unpublished original studies summarized in the 
Draft Assessment Report (EU DAR, 2008) have been reviewed for the present assessment as the data 
owner has granted full access to these.  
2.2.3.2. Appraisal of studies 
Information retrieved has been reviewed by the CONTAM WG on chlorate in food and used for the 
present assessment using expert judgement. Any limitations of the information used are clearly 
documented in this opinion. Human case-studies and reports, including accidental or intentional 
exposure followed by death or illness were only included in the assessment when the exposure to 
chlorate was well documented or recorded. The available epidemiological studies were only related to 
disinfection of drinking water by chlorination. Studies not providing information on chlorate 
concentrations were excluded. Studies solely focusing on the efficacy of chlorate as anti-microbial 
agent or herbicide were excluded from analysis. 
2.2.4. Methodology applied for risk assessment 
The CONTAM Panel applied the general principles of the risk assessment process for chemicals in 
food as described by WHO/IPCS (2009), which include hazard identification and characterization, 
exposure assessment and risk characterization. Additionally to the principles described by WHO/ICPS 
(2009), EFSA guidance pertaining to risk assessment (EFSA SC, 2012b) has been applied for the 
present assessment. In brief, the EFSA guidance documents  cover the procedures currently used 
within EFSA for the assessment of dietary exposure to different chemical substances and the 
uncertainties arising from such assessments (EFSA, 2006b). For details on the specific EFSA guidance 
applied see Appendix A.  
                                                     
23  Web of Science (WoS), formally ISI Web of Knowledge, Thomson Reuters. Available at: 
http://thomsonreuters.com/thomson-reuters-web-of-science/ 
24 PubMed, Entrez Global Query Cross-Database Search System, National Center for Biotechnology Information (NCBI), 
National Library of Medicine (NLM), Department of the National Institutes of Health (NIH), United States Department of 
Health and Human Services. Available at: http://www.ncbi.nlm.nih.gov/pubmed/ 
25 EndNote X5, Thomson Reuters. Available at: http://endnote.com/ 
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3. Assessment 
3.1. Occurrence data  
3.1.1. Previously reported occurrence results 
3.1.1.1. Fruit and vegetables 
No studies on the occurrence of chlorate in fruit and vegetables were identified in the scientific 
literature. Instead, only experimental studies on the direct treatment of fruit and vegetables with ASC 
and chlorine dioxide and the resulting chlorate levels in the fruit or vegetables were identified. 
Biocides such as chlorine dioxide are mainly used in the EU to maintain the quality of potable water 
used by food industry at an acceptable microbial level. This is allowed in some EU Member States 
under national legislation (see Section 1.3.4). Therefore, the CONTAM Panel considered these studies 
relevant for the current evaluation.  
The JECFA evaluated the use of ASC as an antimicrobial agent on fruits and vegetables (see 
Section 1.3.1). The manufacturer had reported the residual chlorate levels in fruit and vegetables 
following treatment with ASC solutions applied under different conditions. Cut up and sliced carrots, 
melons, lettuce, strawberries, onions and potatoes were dipped in or sprayed with ASC (1 200 mg 
sodium chlorite/L, pH 2.5) for 30 seconds, followed by a washing step. Chlorate concentration was 
determined after 24 hours, and was below 10 µg/kg. Chlorate was detected at a concentration of 
500 µg/kg in pre-processed produce (fruit or vegetable not specified) that was sprayed with ASC 
(1 200 mg sodium chlorite/L, pH 2.5) for 5–10 seconds and then immersed in water. Application of a 
high-volume wash for 30 seconds reduced the chlorate levels below the LOD of 100 µg/kg 
(FAO/WHO, 2008).  
Chen et al. (2011) immersed mulberries in chlorine dioxide solutions at different concentrations (20, 
60 and 80 mg/L) for 5, 10 or 15 minutes, followed by a rinsing step with potable water for 1 minute. 
The chlorate concentration was determined for the treatment with 60 mg/L during 15 minutes and was 
below the LOD (300 µg/kg). 
Tomatoes (100 g/trial, three trials) were exposed to approximately 5 mg 
36
Cl-labelled chlorine dioxide 
gas during 2 hours and rinsed afterwards. The Na
36
ClO3 concentration ranged between 0.4 and 
1.3 mg/kg in the liquid fraction of tomato puree, between < 0.51 and 2.1 mg/kg in the solid fraction of 
tomato puree and between 117 and 125 mg/kg in the stem scar tissue (Smith et al., 2014).  
3.1.1.2. Food of animal origin 
No studies on the occurrence of chlorate in food of animal origin were identified in the scientific 
literature. Instead, only experimental studies on the direct treatment of food of animal origin with ASC 
and chlorine dioxide and the resulting chlorate levels were identified which are summarised below.  
The AFC Panel evaluated the use of ASC as an antimicrobial agent on poultry carcasses (see Section 
1.3.1). The manufacturer had reported chlorate levels in the carcasses between 11 and < 200 µg/kg 
depending on the treatment. For chlorine dioxide treatment, a residual chlorate concentration of 
60 µg/kg was reported (EFSA, 2006a). The studies on ACS were also evaluated by the JECFA in 2007 
(FAO/WHO, 2008). 
The use of ASC as an antimicrobial agent on red meat was also evaluated by the JECFA. Chlorate 
levels of 45 and 220 µg/kg were reported by the applicant for different treatments (FAO/WHO, 2008).  
For seafood and fish, the use of ASC as an antimicrobial agent resulted in chlorate levels < 100 µg/kg 
depending on the treatment (FAO/WHO, 2008). 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 21 
The CONTAM Panel noted that the use of ASC and chlorine dioxide as antimicrobial agents on food 
of animal origin is not allowed in the EU (see Section 1.3.4). 
3.1.1.3. Food supplements and flavour enhancing ingredients 
Chlorate was analysed in dietary supplements (n = 31) and flavour enhancing ingredients (kelp 
granules, iodized salt, sea salt; n = 4) by LC-MS/MS (LOD = 4–30 µg/kg). Samples were collected 
from commercial vendors in the USA but no information was available on whether they had been 
treated with chlorine products. Chlorate was detected in 26 samples of dietary supplements at 
concentrations ranging from 25 to 10 300 µg/kg and in all tested flavour enhancing ingredients at 
concentrations ranging from 45 to 65 µg/kg (Snyder et al., 2006). 
3.1.1.4. Drinking water 
Fantuzzi et al. (2007) analysed chlorate in drinking water (n = 1 199) from different Italian cities by 
ion chromatography with conductivity detection. Samples had been collected between October 1999 
and September 2000. Chlorate was detected in 34 % of the samples (LOD = 20 µg/L) with a median 
concentration of 76 µg/L (range: 20–1 500 µg/L).  
Chlorate was measured by ion chromatography with conductivity detection (LOD = 1.0 µg/L) in 
509 drinking water samples taken in 2007 and 2008 in Castilla y Léon, Spain. Chlorate was detected 
in 65 % of the samples with a mean concentration of 224 µg/L (range: 2–4 340 µg/L) (Garcia-
Villanova et al., 2010). 
In addition, studies on the occurrence of chlorate in drinking water and other beverages are available 
in the scientific literature for non-European countries. However, since the chlorate levels in drinking 
water and beverages depend on the drinking water treatment, these studies were not considered 
relevant for the current evaluation.  
3.1.2. Food processing 
There are two major sources of chlorate residues in food: 
i) the use of chlorinated water for various food processing steps (drinking water, potable 
water and processing water), and  
ii) the disinfection of surfaces and food processing equipment.  
To ensure microbiological safety and to prevent contamination of food from the production process, 
surfaces and equipment are cleaned by disinfectants. Regarding milk for example, after use surfaces of 
equipment that are intended to come into contact with milk (utensils, containers, tanks, etc. intended 
for milking, collection or transport) must be cleaned and, where necessary, disinfected. According to 
Regulation (EC) No 853/2004 on specific hygiene rules for hygiene on foodstuffs, at least once a day, 
containers and tanks used for the transport of milk must be cleaned and disinfected before re-use.  
Drinking water and potable water can contain substantial amounts of chlorate (CVUA, 2014a) and 
thus increase chlorate levels in food when used as ingredient water.  
Various food commodities are rinsed, sprayed and washed with potable water, that can contain 
substantial amounts of chlorate as a consequence of water disinfection (e.g. chlorination). In a recent 
small study lettuce and green onions were washed for 1 minute with water supplemented with chlorate 
(0.66 mg/L) and subsequently homogenized and analysed by LC-MS/MS for chlorate. In the non-
washed controls no chlorate (< 0.01 mg/kg) was detectable. The washed lettuce (n = 4) contained 
chlorate concentrations of 0.068–0.078 mg/kg, the washed green onions (n = 4) 0.018–0.027 mg/kg. 
(Labor Friedle, 2014, unpublished report). Moreover, in EU countries the use of a chlorine-based 
disinfectant solution can be allowed for the dipping or spraying of fruits or vegetables under national 
legislation (see Section 1.3.4).  
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‘Hydro-cooling’ is a procedure, in which freshly harvested but also prepared vegetables/fruits are 
quickly cooled in ice water (to 10 °C), mainly to minimize the loss of moisture and to extend shelf life. 
The CVUA Stuttgart has recently shown that prepared carrots from the USA have high chlorate 
residue levels (up to 0.54 mg/kg), which likely result from the use of chlorinated water in the hydro-
cooling process (CVUA, 2014b).  
In a recent update the CVUA provided additional evidence, that especially the postharvest treatment 
contributes to the high levels of chlorate in processed and frozen carrots (CVUA, 2014c).  
In frozen vegetables chlorate residues might originate from both washing procedures with potable 
water but also the use of processing water e.g. for blanching and hydro-cooling procedures (CVUA, 
2014b, c). For the washing, blanching and cooling, a closed water circuit is applied. Since the water is 
not refreshed continuously it is repeatedly chlorinated to keep its microbial quality within safe limits. 
During the re-circulation chlorate therefore concentrates into the processing water as a by-product 
from chlorine disinfection.  
Changes to the chlorate content might also take place during the preparation of food at private 
households. The CONTAM Panel has not identified reliable literature about this aspect. Nevertheless, 
from a chemical point of view it is likely that the washing with, and especially the cooking procedure 
in, drinking water decreases the chlorate levels in chlorate-polluted vegetables and fruits. In contrast, a 
non-appropriate use of chlorine-containing cleaning agents, e.g. for cookware and dinnerware, might 
increase chlorate levels in food.  
3.1.3. Current occurrence results 
The left-censored data were treated by the substitution method as recommended in the ‘Principles and 
Methods for the Risk Assessment of Chemicals in Food’ (WHO/IPCS, 2009). The same method is 
indicated in the EFSA scientific report ‘Management of left-censored data in dietary exposure 
assessment of chemical substances’ (EFSA, 2010b) as an option in the treatment of left-censored data. 
The guidance suggests that the lower-bound (LB) and upper-bound (UB) approach should be used for 
chemicals likely to be present in the food (e.g. naturally occurring contaminants, nutrients and 
mycotoxins). At the LB, results below the LOQ and LOD were replaced by zero; at the UB the results 
below the LOD were replaced by the LOD and those below the LOQ were replaced by the value 
reported as LOQ. 
Despite the presence of a high percentage of left-censored data (71 %) no substantial differences were 
observed in most of the food groups when LB and UB estimations were compared at the different 
FoodEx levels. The highest differences between LB and UB estimates were for drinking water, and 
were around 26 % (LB = 28.3 µg/L; UB = 38.5 µg/L).  
All analytical results were reported based on whole weight. In terms of number of samples the best 
represented food group was ‘Vegetable and vegetable products’ (n = 3 752), followed by ‘Fruit and 
fruit products’ (n = 2 607). Other food groups that were well represented were ‘Drinking water’ 
(n = 453) and ‘Herbs, spices and condiments’ (n = 374). Table 3 shows summary statistics for chlorate 
concentration (µg/kg) with the different food samples aggregated at FoodEx level 1. 
Among ‘Vegetable and vegetable products’, the best represented food group was ‘Fruiting vegetables’ 
(n = 1 654). Within ‘Fruiting vegetables’ several food commodities stood out due to their mean high 
levels of chlorate, in particular ‘Chilli pepper’ (LB = 164 µg/kg, UB = 169 µg/kg, n = 27) and 
‘Aubergines’ (LB = 157 µg/kg, UB = 164 µg/kg, n = 73). High levels of chlorate were also reported 
for ‘Vegetable and vegetable products, unspecified’ (LB = 216 µg/kg, UB = 222 µg/kg, n = 25) and 
‘Brassica vegetables’ (LB = 160 µg/kg, UB = 165 µg/kg, n = 416). Detailed information on the 
chlorate levels in the different foods is shown in Appendix D. For certain food samples (~ 10 % of the 
total) information was reported on the fact that they underwent freezing processes. Most of these foods 
belong to the food group ‘Vegetable and vegetable products’ although samples of ‘Fruit and fruit 
products’ among others were also reported. It was noticed that for certain food groups there was an 
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association between high levels of chlorate and being reported as frozen. This was particularly evident 
for ‘Broccoli’ where all the samples with the highest concentrations (samples above 1 000 µg/kg, 
n = 15) were reported as being frozen products. A similar situation is found for ‘Carrots’ where the 
two samples with the highest concentrations were frozen products (720 µg/kg and 1 500 µg/kg) or for 
‘Peppers, paprika’ where one of the samples with the highest chlorate levels were also reported as 
frozen product. However, it is important to indicate that in the above mentioned food categories many 
samples described as frozen presented levels of chlorate very low or below the LOD. For example, 
60 % of the samples of ‘Peppers, paprika’ reported as frozen were below the LOQ. Chlorate levels in 
the frozen food samples seems to derive from the blanching/washing process carried out previous to 
freezing the foods, a process to stop enzyme actions which can cause loss of flavour, colour and 
texture. Since blanching/washing in chlorinated water prior to freezing seems to be a common practice 
in food industry, the differences in the reported chlorate levels in the frozen foods may be explained 
by the use of water with different concentrations of chlorine.  
Table 3:  Summary statistics for chlorate concentrations (µg/kg) with the different samples 
aggregated at FoodEx level 1 (detailed description of the occurrence values grouped at the appropriate 
FoodEx level to calculate dietary exposure is shown in Appendix D). Values were rounded off to the 
nearest whole number (0 decimal places). 
FoodEx level 1 food groups n 
LC 
(%) 
LB/UB 
Concentration (µg/kg)
(a) 
Mean P5 P25 P50 P75 P95 
Grains and grain-based products 91 60 
LB 27 0 0 0 22 180 
UB 31 2 5 10 22 180 
Vegetables and vegetable products 
(including fungi) 
3 756 72 
LB 76 0 0 0 13 250 
UB 83 2 5 10 16 250 
Starchy roots and tubers 122 88 
LB 13 0 0 0 0 88 
UB 18 2 2 5 10 98 
Legumes, nuts and oilseeds 263 55 
LB 143 0 0 0 46 910 
UB 147 2 2 10 50 910 
Fruit and fruit products 2 607 84 
LB 8 0 0 0 0 31 
UB 13 2 2 5 10 41 
Milk and dairy products 130 57 
LB 85 0 0 0 54 510 
UB 91 10 10 10 54 510 
Sugar and confectionary 12 67 
LB 65 - 0 0 49 - 
UB 79 - 10 25 54 - 
Animal and vegetable fats and oils 3 67 
LB 85 - - - - - 
UB 92 - - - - - 
Fruit and vegetable juices 67 54 
LB 42 0 0 0 18 177 
UB 46 2 5 10 18 177 
Non-alcoholic beverages (excepting 
milk based beverages) 
2
(b) 
0 
LB 62 24 24 62 100 100 
UB 62 - - - - - 
Alcoholic beverages 37
(c)
 97 
LB - - - - - - 
UB 3 2 2 2 2 5 
Drinking water 453 31 
LB 28 0 0 11 30 118 
UB 39 2 10 22 50 118 
Herbs, spices and condiments 372 53 
LB 413 0 0 0 125 2 700 
UB 417 2 5 10 125 2 700 
Food for infants and small children 44 80 
LB 5 - 0 0 0 - 
UB 9 - 5 5 10 - 
Products for special nutritional use 3 67 
LB 18 - - - - - 
UB 25 - - - - - 
Composite food (including frozen 
products) 
66 6 
LB 111 0 25 42 84 566 
UB 112 10 25 42 84 566 
LB: lower bound; LC: left-censored; n: number of samples; UB: upper bound.  
(a):  The different percentiles were only described when a minimum number of samples were available, 60 samples for the 
5th and 95th percentile, 11 samples for 25th and 75th percentile, and six samples for the median. Otherwise, the 
percentiles may not be statistically robust (EFSA, 2011b). 
(b):  Before estimating dietary exposure the chlorate levels reported for 453 samples of drinking water were assigned to tea 
and coffee. 
(c):  Before estimating dietary exposure the chlorate levels reported for 453 samples of drinking water were assigned to beer. 
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In the FoodEx classification system (EFSA, 2011a) the different types of water (bottled water, tap 
water, water ice and well water) are grouped under the generic name ‘Drinking water’. Therefore, the 
generic term ‘Drinking water’ as used in this opinion includes both water intended for human 
consumption (Council Directive 98/83/EC) and natural mineral waters (Commission Directive 
2003/40/EC
26
). Bottled water as used in this opinion includes natural mineral water, but also spring 
water and other bottled drinking water, products that must comply with Council Directive 98/83/EC. 
Most of the samples of ‘Drinking water’ were reported as unspecified (83 %, n = 376) without further 
details. Only 28 and 46 samples of drinking water were reported as bottled and tap water, respectively. 
As most of the consumption data in the EFSA Comprehensive Database refers to tap water (63 %), 
and the chlorate levels in this type of drinking water did not differ much from those reported for 
unspecified drinking water, it was decided to group all samples at FoodEx level 1 before estimating 
dietary exposure.  
To avoid underestimation of the dietary exposure to chlorate due to the lack of occurrence data, 
chlorate levels were imputed to particular foods that are relatively highly consumed. Accordingly, the 
453 samples of drinking water were also used to derive chlorate levels for tea, coffee, and beer. In 
addition, when estimating the dietary exposure to chlorate it was also considered the potential 
contribution of the water used during the preparation of certain foods such as dry legumes, rice and 
pasta. The amount of water used for cooking was based on described weight yield factor for the 
different foods; for pasta and rice it was estimated that two parts of water per part of food are used 
while for dry legumes it should be 1.5 parts of water per part of food (Bognár, 2002). By doing this it 
is assumed that chlorate is non-volatile and that it remains stable during cooking as it has been 
recently reported (Asami et al., 2013). 
Two samples of low-fat yoghurt (˂ 1 % fat) reported relatively high chlorate values (180 µg/kg and 
380 µg/kg). The CONTAM Panel considers that these two samples are insufficient and not 
representative of a food commodity that is relatively highly consumed; therefore they were excluded 
before the dietary exposure to chlorate was estimated. Instead, the occurrence values reported for 
‘Liquid milk’ were used when the consumption of yoghurt was reported (10-17 µg/kg, LB-UB). 
One analytical result on infant/follow-on formula was received by EFSA, with a reported value of 
2.5 mg chlorate/kg dry weight. This sample was not included in the exposure scenarios as it was 
received at a very late stage during the preparation of this scientific opinion, but is notable because of 
the high chlorate level. High levels of chlorate (in the order of mg/kg dry weight) have been reported 
also from infant/follow-on formula in Japan (Asami et al., 2013). 
Appendix D shows a more detailed description of the occurrence values selected to calculate the 
dietary exposure to chlorate, and in the scenarios described in Table 2 and how the samples were 
grouped before the exposure estimations were carried out.  
3.2. Exposure assessment  
3.2.1. Previously reported exposure assessments 
Both the AFC Panel (EFSA, 2006a) and the JECFA (FAO/WHO, 2008) estimated the potential dietary 
exposure to chlorate based on data submitted by an applicant for the use of biocides such as chlorine 
dioxide as a processing aid. However, this use is not allowed in the EU and the CONTAM Panel 
considered these exposure assessments not relevant for the current evaluation.  
                                                     
26 Commission Directive 2003/40/EC of 16 May 2003 establishing the list, concentration limits and labelling requirements 
for the constituents of natural mineral waters and the conditions for using ozone-enriched air for the treatment of natural 
mineral waters and spring waters OJ L 126, 22.5.2003, p. 34–39. 
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Snyder et al. (2006) estimated the dietary exposure from dietary supplements and flavour enhancing 
ingredients (kelp granules, iodized salt, sea salt) (see Section 3.1.1.3). Based on the recommended 
daily dose of the supplements, it was estimated that the daily exposure to chlorate ranged from 0.046 
to 20 µg per day. Exposure from the flavour enhancing ingredients considered in this study was 
estimated to be between 0.072 and 0.2 µg per serving. 
3.2.2. Non-dietary exposure  
In humans, there is a potential for additional exposure to chlorate from shower water and swimming 
pool water. Righi et al. (2014) analysed 24 water samples taken from indoor swimming pools in Italy 
and detected chlorate in all samples  at concentrations ranging from 5 to 19 537 µg/L (mean: 3 661 
µg/L and median: 1 235 µg/L). In Poland, also Michalski and Mathews (2007) detected chlorate in all 
water samples (n = 7) taken from indoor swimming pools and reported concentrations between 2 140 
and 31 920 µg/L (mean: 19 086 µg/L and median: 22 230 µg/L). 
3.2.3. Current exposure assessment 
3.2.3.1.  Chronic dietary exposure to chlorate  
For calculating the chronic dietary exposure to chlorate, food consumption and body weight data at the 
individual level were accessed in the Comprehensive Database. Occurrence data and consumption data 
were linked at the lowest FoodEx level possible. In addition, the different food commodities were 
grouped within each food category to better explain their contribution to the total dietary exposure to 
chlorate. For each country, exposure estimates were calculated per dietary survey and age class. 
Chronic exposure estimates were calculated for 35 different dietary surveys carried out in 19 different 
European countries. Not all countries provided consumption information for all age groups, and in 
some cases the same country provided more than one consumption survey.  
The mean and the high (95th percentile) chronic dietary exposures were calculated by combining 
chlorate mean occurrence values for food and drinking water samples collected in different countries 
(pooled European occurrence data) with the average daily consumption for each food at individual 
level in each dietary survey.  
Chronic dietary exposure using the available occurrence data (Scenario A.1, see Table 2) 
Table 4 shows summary statistics of the chronic exposure assessment to chlorate using the available 
occurrence data. Detailed mean and 95th percentile dietary exposure estimates calculated for each of 
the 35 dietary surveys are presented in Appendix F. 
The highest chronic exposure to chlorate was estimated for the youngest population groups (‘Infants’, 
‘Toddlers’ and ‘Other children’). For the mean exposure, the estimates ranged between 0.5 µg/kg b.w. 
per day in adolescents (LB) and 4.1 µg/kg b.w. per day in ‘Infants’ (UB). In the highly exposed 
population (95th percentile) the lowest dietary exposure was estimated in 1.0 µg/kg b.w. per day (LB) 
in diverse age classes (‘Elderly’ and ‘Very elderly’) and ‘Lactating women’, and the highest exposure 
in ‘Infants’ (6.6 µg/kg b.w. per day, UB). 
Overall, in all age classes and vulnerable population groups (‘Pregnant and lactating women’) the 
main average contributor to the dietary exposure to chlorate was ‘Drinking water’. It is important to 
mention that when considering ‘Drinking water’ also the water used for cooking pasta, rice and 
legumes is included. In few dietary surveys drinking water was not the main contributor, as observed 
for instance in ‘Toddlers’ where soft drinks and fruit juices were the main contributors in two 
countries. In some dietary surveys the consumption of drinking water is missing (‘Regional Crete’, 
Diet Lactation GR, ‘Childhealth’) or underreported (‘National Dietary Survey’ and ‘National Repr 
Surv’) resulting in different food commodities becoming the main average contributors (further 
information on the contributors across the different dietary surveys and age classes is provided in 
Appendix E). 
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Further information of the different contributors to chlorate exposure, under this scenario and across 
the different age classes, is detailed in Appendix E. 
The ranges of contribution of ‘Drinking water’ across age classes and vulnerable groups were as 
follow (at the LB estimations): ‘Infants’ (24.9–58 %), ‘Toddlers’ (11.6–47.8 %), ‘Other children’ 
(0.02–37.9 %), ‘Adolescents’ (0.03–37.9 %), ‘Adults’ (6.2–48 %), ‘Elderly’ (8.1–34.8 %), ‘Very 
elderly’ (5.5–39.1 %). 
Since ‘Drinking water’ was the main contributor in most of the dietary surveys, the differences 
observed in the LB and UB exposure estimates (mean difference = 25 %) are in line with those 
reported at the occurrence level in drinking water (see Section 3.1.3.1). 
With regards to the distribution of the level of contamination for drinking water, the Panel noted that 
the 95th percentile of 118 µg/L is approximately six times lower than the guideline level of 0.7 mg/L 
set by the WHO. It is also noted that the mean concentration level used in the exposure calculations 
(LB of 28 µg/L–UB of 39 µg/L) is approximately 20 times lower than this guideline level of.0.7 mg/L. 
Table 4:  Summary statistics of chronic exposure assessments to chlorate across European dietary 
surveys (µg/kg b.w. per day). Estimates were rounded to one decimal place. 
Mean dietary exposure (µg/kg b.w. per day) 
Age class
(a)
 n 
Lower bound (LB) Upper bound (UB) 
Min Median Max Min Median Max 
Infants 6 1.6 1.9 2.9 2.0 2.6 4.1 
Toddlers 10 2.1 2.6 2.8 2.8 3.2 3.5 
Other children 18 1.3 1.9 2.3 1.5 2.4 2.8 
Adolescents 17 0.5 1.1 1.6 0.6 1.4 1.9 
Adults 17 0.7 1.0 1.3 0.8 1.3 1.6 
Elderly 14 0.6 0.9 1.1 0.7 1.1 1.4 
Very elderly 12 0.6 0.9 1.2 0.7 1.1 1.6 
Pregnant women 1 0.8 -
(b)
 -
(b)
 -
(b)
 -
(b)
 1.0 
Lactating women 1 0.6 -
(b)
 -
(b)
 -
(b)
 -
(b)
 0.7 
95th percentile dietary exposure
(c)
 (µg/kg b.w. per day) 
Age class
(a)
 n 
Lower bound (LB) Upper bound (UB) 
Min Median Max Min Median Max 
Infants 6 3.3 3.4 5.0 4.1 4.3 6.6 
Toddlers 10 3.2 4.1 4.7 4.2 5.2 5.4 
Other children 18 2.5 3.2 4.1 2.7 3.9 5.0 
Adolescents 17 1.1 2.0 2.6 1.2 2.3 3.0 
Adults 17 1.2 1.8 2.3 1.4 2.2 2.8 
Elderly 14 1.0 1.5 2.0 1.2 1.9 2.5 
Very elderly 12 1.0 1.4 1.7 1.2 1.8 2.2 
Pregnant women 1 1.4 -
(b)
 -
(b)
 -
(b)
 -
(b)
 1.8 
Lactating women 1 1.0 -
(b)
 -
(b)
 -
(b)
 -
(b)
 1.1 
b.w.: body weight; LB: lower bound; n: number of samples; UB: upper bound. 
(a):  Section 2.1.1.3 describes the age range within each age class.  
(b):  Not calculated since estimates were only available from one dietary survey.  
(c):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
 
Chronic dietary exposure applying a cut-off of 0.7 mg/kg to the available occurrence data 
(Scenario A.2, see Table 2) 
Table 5 shows summary statistics of the chronic exposure assessment to chlorate based only on 
available occurrence data with chlorate levels equal to or lower than 0.7 mg/kg.  
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As compared to the chronic dietary exposure without applying any cut-off (Section 3.2.3.1, subsection 
on ‘Chronic dietary exposure using the available occurrence data (Scenario A.1, see Table 2)’), the 
estimates of exposure were only slightly lower. This is explained by the fact that only 143 foods 
reported values above 0.7 mg/kg, and they mainly belong to the food groups ‘Vegetables and 
vegetable products’ and ‘Herbs, spices and condiments’ that do not contribute substantially to the 
chronic dietary exposure to chlorate. Only one sample of ‘Drinking water’ was excluded by applying 
this cut-off.  
Table 5:  Summary statistics of the chronic exposure assessment to chlorate across European dietary 
surveys (µg/kg b.w. per day). Occurrence values above 0.7 mg/kg were excluded before calculating 
exposure. Estimates were rounded to one decimal place. 
Mean dietary exposure (µg/kg b.w. per day) 
Age class
(a)
 n 
Lower bound (LB) Upper bound (UB) 
Min Median Max Min Median Max 
Infants 6 1.3 1.7 2.7 1.8 2.3 3.9 
Toddlers 10 1.8 2.1 2.3 2.5 2.7 3.1 
Other children 18 1.1 1.7 2.0 1.3 2.1 2.4 
Adolescents 17 0.4 1.0 1.4 0.5 1.2 1.7 
Adults 17 0.5 0.9 1.1 0.7 1.1 1.5 
Elderly 14 0.4 0.8 1.0 0.5 1.0 1.3 
Very elderly 12 0.4 0.7 1.0 0.6 1.0 1.4 
Pregnant women 1 0.7 –(b) –(b) –(b) –(b) 0.9 
Lactating women 1 0.4 –(b) –(b) –(b) –(b) 0.5 
95th percentile dietary exposure
(c)
 (µg/kg b.w. per day) 
Age class
(a)
 n 
Lower bound (LB) Upper bound (UB) 
Min Median Max Min Median Max 
Infants 6 2.6 2.9 4.6 3.5 4.0 6.2 
Toddlers 10 2.8 3.5 4.3 3.9 4.4 5.1 
Other children 18 2.2 2.8 3.4 2.5 3.4 4.4 
Adolescents 17 0.9 1.8 2.4 1.0 2.1 2.8 
Adults 17 1.0 1.5 2.0 1.2 2.0 2.5 
Elderly 14 0.8 1.3 1.6 1.0 1.7 2.3 
Very elderly 12 0.8 1.2 1.4 1.0 1.6 1.9 
Pregnant women 1 1.2 –(b) –(b) –(b) –(b) 1.6 
Lactating women 1 0.8 –(b) –(b) –(b) –(b) 0.9 
b.w.: body weight; LB: lower bound; n: number of samples; UB: upper bound. 
(a):  Section 2.1.1.3 describes the age range within each age class.  
(b):  Not calculated since estimates were only available from one dietary survey.  
(c):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
 
3.2.3.2. Consideration of the use of a variability factor for acute exposure assessment 
The CONTAM Panel discussed whether it was necessary to apply, in its acute exposure assessments, 
variability factors for residues in fruit and vegetables with a large unit weight (> 25 g) as is commonly 
performed for pesticides to account for variation within composite samples (EFSA, 2005). The 
CONTAM Panel considered that in some instances where measurements of contaminants were carried 
out with composite samples of foods with a large unit size and depending on the route by which the 
contaminant enters the food, application of variability factors could be appropriate in acute exposure 
assessments.  
 Chlorate residues (unlike pesticide residues) usually arise post-harvest through food processing and, 
thus, local contamination resulting in high variation of residues within individual food samples is less 
likely to occur. The practices leading to the presence of chlorate are most likely the use of chlorinated 
water for various food processing (e.g. for blanching and hydro-cooling procedures), and the treatment 
of food processing equipment with chlorate containing/yielding substances. Due to the high solubility 
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of chlorine and chlorate in water an even distribution of chlorate residues in processing water is 
expected.  
In addition, the acute dietary exposure estimations presented in the opinion are based on a data set of 
occurrence/monitoring data received upon a call for data. Variability in chlorate levels between 
samples is addressed by the use of the highest reliable percentile (often the 95th but for some of the 
food groups also the 99th
 
percentile) for the assessment of acute exposure.  
This approach is confirmed by the fact that food commodities with the highest reported levels of 
chlorate were mainly frozen vegetables (e.g. broccoli, cucumbers, carrots). The CONTAM Panel 
considers that these samples refer to small pieces of vegetables obtained from whole vegetables units 
that were washed  ¸chopped, blanched, cooled and then blended. Therefore, the potential variability in 
the levels of chlorate during food processing is minimised.  
Overall, the CONTAM Panel concludes that the use of variability factors for assessments of acute 
exposure to chlorate in food is not appropriate.  
3.2.3.3. Acute dietary exposure  
Acute exposure estimates were calculated for 41 different dietary surveys carried out in 23 different 
European countries. Acute dietary exposure to chlorate was estimated as total exposure and as 
exposure food by food. The different food commodities were grouped based on their occurrence 
values as done before estimating chronic dietary exposure (see Appendix D). Overall, foods were 
grouped at FoodEx level 2, although for certain commodities FoodEx level 1 (e.g. ‘Drinking water’) or 
level 3 (e.g. ‘Aubergines’, ‘Broccoli’) were used. 
In each dietary survey, total acute dietary exposure was estimated for each individual and reporting 
day by multiplying the total daily consumption amount for each food by their mean occurrence level 
(UB estimate), except for one food where the highest reliable percentile (UB estimate) was used as 
occurrence value (see Appendix D). This food refers to that with the highest contribution to the 
exposure when using highest reliable percentile occurrence levels. To estimate the acute dietary 
exposure food by food, the highest reliable percentile (UB estimate) was selected as occurrence value 
for each food at the appropriate FoodEx level, and linked to individual consumption data of that food 
in one single day.  
As in the estimation of the chronic dietary exposure to chlorate when considering ‘Drinking water’ as 
one of the contributors, the water used for cooking pasta, rice and legumes is also included. 
Acute dietary exposure using the available occurrence data (scenario B.1)  
Total acute dietary exposure (scenario B.1.1, see Table 2) 
Using all available occurrence data estimates of mean acute exposure to chlorate ranged between 
1.0 µg/kg b.w. per day and 13.2 µg/kg b.w. per day; for the 95th percentile exposure the estimates 
were between 2.6 and µg/kg b.w. per day and 30.9 µg/kg b.w. per day. The highest acute exposure to 
chlorate was estimated for the age class ‘Infants’, in both the average and the highly exposed 
population. Overall, the young population (‘Infants’, ‘Toddlers’ and ‘Other children’) showed the 
highest levels of acute exposure to chlorate. Table 6 shows the summary statistics of the total acute 
exposure assessment to chlorate using the available occurrence data.  
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Table 6:  Summary statistics of the acute exposure assessment to chlorate (at the upper bound 
estimate) across European dietary surveys (µg/kg b.w. per day). Estimates were rounded to one 
decimal place. 
Age class
(a)
 n 
Mean dietary exposure 
(µg/kg b.w. per day) 
95th percentile dietary exposure
(c)
 
(µg/kg b.w. per day) 
Upper bound 
Min Median Max Min Median Max 
Infants 6 4.8 7.6 13.2 13.9 17.3 30.9 
Toddlers 11 5.5 7.2 10.6 10.9 15.3 18.0 
Other children 20 2.5 5.2 7.0 4.9 11.0 16.9 
Adolescents 20 1.0 3.0 4.4 2.6 7.2 9.4 
Adults 22 1.4 2.9 4.7 3.6 6.9 12.2 
Elderly 16 1.3 2.9 3.9 3.6 6.0 8.0 
Very elderly 14 1.3 2.7 4.1 2.9 5.3 10.4 
Pregnant women 1 2.4 –(b) –(b) –(b) –(b) 5.8 
Lactating women 1 1.3 –(b) –(b) –(b) –(b) 3.9 
b.w.: body weight; n: number of samples.  
(a):  Section 2.1.1.3 describes the age range within each age class.  
(b):  Not calculated since estimates were only available from one dietary survey.  
(c):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
 
Acute dietary exposure food by food (scenario B.1.2, see Table 2) 
Table 7 shows the estimates of acute exposure, for consumers only, through the daily consumption of  
those 10 individual foods and food groups leading to the highest levels of acute exposure to chlorate. 
For each food, based on the number of samples reported, the highest reliable percentile was selected as 
the occurrence value and combined with the daily consumption of this specific food for each 
consumer.  
Table 7:  Estimates of acute exposure to chlorate (only consumers) through the daily consumption 
of individual foods/food groups and drinking water (µg/kg b.w. per day). Estimates were rounded to 
one decimal place. 
Food/Food group 
µg/kg, UB 
estimate
(a)  
(highest reliable 
percentile)  
Average 
percentage of 
consuming 
days
(b)
 
Range of acute exposure (µg/kg 
b.w. per day)
(c) 
Mean exposure 
P95 dietary 
exposure
(d)
 
Drinking water 196 (P99) – (e) 0.0(f)–12.6 0.2(f)–31.6 
Broccoli 2 400 (P95) 4.5 1.2–25.0 3.7–21.3 
Whey and whey products 
(excluding whey cheese) 
618 (P95) 4.3 0.0–8.1 0.0–18.8 
Legumes, beans, green, 
without pods 
1 100 (P95) 9.4 0.1–9.3 0.3–13.9 
Tea (Infusion) 196
(g)
 (P99) 32.6 0.2–4.4 1.0–13.2 
Beer and beer-like beverage 196
(g)
 (P99) 8.2 0.2–5.0 1.7–12.6 
Herbs 8 500 (P99) 24.1 0.1–4.8 0.1–8.5 
Peppers, paprika 1 400 (P99) 15.7 0.2–2.7 0.6–8.4 
Fruiting vegetables (except 
peppers, chili peppers and 
aubergines) 
420 (P99) 45.9 0.3–3.4 1.0–8.2 
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Food/Food group 
µg/kg, UB 
estimate
(a)  
(highest reliable 
percentile)  
Average 
percentage of 
consuming 
days
(b)
 
Range of acute exposure (µg/kg 
b.w. per day)
(c) 
Mean exposure 
P95 dietary 
exposure
(d)
 
Soft drinks 62 (mean) 23.9 0.1–1.7 0.4–5.3 
b.w.: body weight; P95, 99: 95th, 99th percentile; UB: upper bound. 
(a):  The highest reliable percentiles (at the UB) for each food/food group is shown in brackets. The selection of the highest 
reliable percentiles was based on the number of samples available, 60 samples for the 5th and 95th percentile, 
11 samples for 25th and 75th percentile, and six samples for the median. Otherwise, the percentiles may not be 
statistically robust. 
(b):  Average percentage of consumption days across dietary surveys and age classes.  
(c):  Range of acute exposure food by food across dietary surveys and age classes.  
(d):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
(e):  Not calculated as the contribution of drinking water also includes the water used for cooking;  
(f):  In specific dietary surveys the consumption of drinking water was missing (‘Regional Crete’, Diet Lactation GR and 
‘Childhealth’) or underreported (‘National Dietary Survey’ and ‘National Repr Surv’) 
(g):  The 453 samples of drinking water were used to derive chlorate levels for tea and beer. 
 
Acute dietary exposure applying a cut-off of 0.7 mg/kg to the available occurrence data (scenario 
B.2) 
Total acute dietary exposure (scenario B.2.1, see Table 2) 
Table 8 shows summary statistics of the total acute exposure assessment to chlorate using available 
occurrence data with chlorate levels equal or lower to 0.7 mg/kg. 
As compared to the acute dietary exposure using the whole data set, only small differences were 
observed when applying the cut-off of 0.7 mg/kg. Estimates of mean acute exposure to chlorate ranged 
between 0.7 µg/kg b.w. per day and 12.3 µg/kg b.w. per day; for the 95th percentile exposure the 
estimates were between 1.5 and µg/kg b.w. per day and 28.9 µg/kg b.w. per day. The highest acute 
exposure to chlorate was estimated in the age class ‘Infants’, in both the average and the highly 
exposed population. Overall, the young population (‘Infants’, ‘Toddlers’ and ‘Other children’) showed 
the highest levels of acute exposure to chlorate. Table 8 shows summary statistics of the total acute 
exposure assessment to chlorate using available occurrence data with chlorate levels equal or lower to 
0.7 mg/kg. 
Table 8:  Summary statistics of the acute exposure assessment to chlorate (at the upper bound 
estimate) across European dietary surveys (µg/kg b.w. per day). Occurrence values above 0.7 mg/kg 
were excluded before calculating exposure. Estimates were rounded to one decimal place. 
Age class
(a)
 n 
Mean dietary exposure  
(µg/kg b.w. per day) 
P95 dietary exposure
(c)
  
(µg/kg b.w. per day) 
Upper bound 
Min Median Max Min Median Max 
Infants 6 3.7 6.8 12.3 10.0 14.1 28.9 
Toddlers 11 4.2 6.1 9.6 9.6 13.6 16.5 
Other children 20 2.0 4.5 6.0 3.9 9.6 14.6 
Adolescents 20 0.7 2.6 4.1 1.5 6.3 8.6 
Adults 22 1.1 2.6 4.2 2.9 6.3 11.3 
Elderly 16 0.8 2.6 3.6 2.2 5.2 7.3 
Very elderly 14 0.8 2.4 3.8 2.2 4.5 9.7 
Pregnant women 1 2.1 –
(b)
 –(b) –(b) –(b) 5.2 
Lactating women 1 0.9 –
(b)
 –(b) –(b) –(b) 2.3 
b.w.: body weight; n: number of samples; P95: 95th percentile. 
(a):  Section 2.1.1.3 describes the age range within each age class.  
(b):  Not calculated since estimates were only available from one dietary survey.  
(c):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
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Acute dietary exposure food by food (scenario B.2.2, see Table 2) 
As commented in Section 3.2.3.1 (subsection on ‘Chronic dietary exposure applying a cut-off of 
0.7 mg/kg to the available occurrence data (Scenario A.2, see Table 2)’), the use of a cut-off of 
0.7 mg/kg for all available occurrence data leads to the exclusion of only 143 samples, among them 
one sample of ‘Drinking water’. 
Table 9 shows the same individual foods and food groups as reported in Table 7 when all occurrence 
data were used. It can be seen that the exposure estimations for certain groups such as ‘Drinking 
water’, ‘Tea (infusion)’, ‘Beer and beer-like beverage’ and ‘Soft drinks’ were similar to those reported 
in Table 7. This is because in these groups no samples or very few occurrence values were above 
0.7 mg/kg. On the contrary, several samples of ‘Broccoli’, ‘Whey and whey products (excluding whey 
cheese)’, ‘Peppers, paprika’ ‘Legumes, beans, green, without pods’ were excluded as a consequence of 
applying the cut-off of 0.7 mg/kg. As a result the estimates of acute exposure from daily consumption 
of these foods decreased as compared to those considering all occurrence data.  
Table 9:  Estimates of acute exposure to chlorate (only consumers) through the daily consumption 
of individual foods/food groups and drinking water (µg/kg b.w. per day). Occurrence values above 
0.7 mg/kg were excluded before calculating exposure. Estimates were rounded to one decimal place. 
Food/Food group 
µg/kg, UB 
estimate
(a) 
(highest reliable 
percentile) 
 
Average 
percentage of 
consuming 
days
(b)
 
Range of acute exposure  
(µg/kg b.w. per day)
(c) 
Mean 
exposure 
P95 dietary 
exposure
(d)
 
Drinking water 183 (P99) –(e) 0.0(f)–11.7 0.2(f)–29.5 
Tea (infusion) 183(g) (P99) 32.6 2.2–4.1 1.0–12.4 
Beer and beer-like beverage 183(g) (P99) 8.2 0.1–4.7 1.6–11.8 
Whey and whey products (excluding 
whey cheese) 
180 (P75) 4.3 0.0–2.4 0.0–5.5 
Soft drinks 62 (mean) 23.9 0.1–1.7 0.4–5.3 
Fruiting vegetables (except peppers, 
chili peppers and aubergines) 
260 (P99) 45.9 0.2–2.1 0.6–5.1 
Legumes, beans, green, without pods 300 (P95) 9.4 0.0–2.8 0.1–4.2 
Broccoli 400 (P95) 4.5 0.2–4.2 0.6–3.6 
Peppers, paprika 183 (P99) 15.7 0.1–1.0 0.2–3.2 
Herbs 330 (P95) 24.1 0.0–0.2 0.0–0.3 
b.w.: body weight; P95: 95th percentile; UB: upper bound. 
(a):  The highest reliable percentiles (at the UB) for each food/food group is shown in brackets. The selection of the highest 
reliable percentiles was based on the number of samples available, 60 samples for the 5th and 95th percentile, 
11 samples for 25th and 75th percentile, and six samples for the median. Otherwise, the percentiles may not be 
statistically robust.  
(b):  Average percentage of consumption days across dietary surveys and age classes  
(c):  Range of acute exposure food by food across dietary surveys and age classes  
(d): The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
(e):  Not calculated as the contribution of drinking water also includes the water used for cooking;  
(f):  In specific dietary surveys the consumption of drinking water is missing (‘Regional Crete’, Diet Lactation GR and 
‘Childhealth’) or underreported (‘National Dietary Survey’ and ‘National Repr Surv’. 
(g):  The 453 samples of drinking water were used to derive chlorate levels for tea and beer. 
 
3.2.3.4. Acute dietary exposure assuming an occurrence value of 0.7 mg/kg in all food commodities 
(scenario B.3) 
In line with the terms of reference in this hypothetical scenario, acute exposures were estimated 
assuming that all food items and drinking water consumed have an occurrence value of 0.7 mg/kg in 
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order to assess the potential impact of applying the guidance value of 0.7 mg/kg
27
 set by WHO (2005) 
for all food commodities included in the assessment covered by Regulation (EC) No 396/2005 and 
drinking water. 
Total acute dietary exposure (scenario B.3.1, see Table 2) 
Overall, the assumption of an occurrence value of 0.7 mg/kg for all commodities including drinking 
water led to substantially higher estimates of acute exposures in all age groups as compared to the 
scenario where actual occurrence levels were used. Highest relative increase (5.6-fold) of exposures 
applying this scenario was seen in ‘Infants’ at maximum mean dietary exposure, where exposure rose 
from 12.3 µg/kg b.w. per day (see Table 8, Section 3.2.3.3, subsection on ‘Total acute dietary 
exposure (scenario B.2.1, see Table 2)’) to 68.9 µg/kg b.w. per day.  
For certain food commodities the selected value of 0.7 mg/kg is lower than the highest reliable 
percentile derived from the reported occurrence data (e.g. herbs, paprika, broccoli). This in principle 
should lead to lower exposure estimations. However, since these food commodities are not consumed 
in high amounts their impact on the acute exposure to chlorate was not important. Contrarily, the use 
of 0.7 mg/kg as occurrence value in some highly consumed commodities such as ‘Drinking water’ and 
‘Liquid milk’ led to a dramatic increase of the acute exposure to chlorate. This is due to the fact that 
for ‘Drinking water’, for instance, the value of 0.7 mg/kg is almost more than 3.5 times higher than the 
highest reliable percentile derived from the reported occurrence data (99th percentile). Together with 
drinking water, other foods with relatively high consumption such as ‘Liquid milk’, ‘Beer’, ‘Tea 
(infusion)’ or ‘Soft drinks’ were important contributors to the acute exposure when using 0.7 mg/kg as 
chlorate level, a value far above the reported occurrence values.  
Table 10 provides an overview on the summary statistics of acute exposures in the different age 
groups when applying an occurrence value of 0.7 mg/kg for all food commodities. 
Table 10:  Summary statistics of the acute exposure assessment to chlorate (at the UB estimate) 
across European dietary surveys (µg/kg b.w. per day). Occurrence values were all set up at 0.7 mg/kg 
before calculating exposure. Estimates were rounded to one decimal place. 
Age class
(a)
 n 
Mean dietary exposure
(a)
 
P95 dietary exposure
(c) 
(µg/kg b.w. per day) 
Upper bound (UB) 
Min Median Max Min Median Max 
Infants 6 20.7 30.3 68.9 45.7 69.6 110.8 
Toddlers 11 20.9 24.5 36.0 37.4 53.4 62.2 
Other children 20 8.7 17.1 21.4 21.2 36.2 53.6 
Adolescents 20 4.1 10.1 15.4 9.4 23.3 32.0 
Adults 22 4.1 8.9 14.9 10.5 22.6 40.5 
Elderly 16 2.6 8.5 11.8 5.9 17.9 25.1 
Very elderly 14 2.9 7.8 13.2 6.9 15.1 35.1 
Pregnant women 1 7.0 –
(b)
 –(b) –(b) –(b) 18.0 
Lactating women 1 3.7 –
(b)
 –(b) –(b) –(b) 8.5 
b.w.: body weight; n: number of samples; P95: 95th percentile. 
(a):  Section 2.1.1.3 describes the age range within each age class.  
(b):  Not calculated since estimates were only available from one dietary survey.  
(c): The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
 
                                                     
27 In analogy with the WHO guideline level for drinking water or 0.7 mg chlorate/L. 
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Acute dietary exposure food by food (scenario B.3.2, see Table 2) 
An occurrence value of 0.7 mg/kg was used for all food commodities to estimate the acute exposure 
through the daily consumption of individual foods. The occurrence values were applied to all food 
commodities at FoodEx level 3 in order to assess the influence of individual foods in the acute 
exposure to chlorate.  
The use of the occurrence value of 0.7 mg/kg results in ‘Drinking water’ and some foods such as milk, 
juice or soft drink being the commodities that lead to the highest estimates of acute exposure to 
chlorate (Table 11). Since for all foods the same occurrence value is assigned the exposure estimates 
are only driven by consumption. This makes that the highest acute exposures are estimated from foods 
consumed as liquids and with relative high consumption. 
Table 11 shows the estimates of acute exposure, for consumers only, through the daily consumption of 
those ten individual food commodities (including drinking water) leading to the highest levels of acute 
exposure to chlorate. Estimates of acute exposure through the daily consumption (food by food) of all 
commodities at FoodEx level 3 are shown in Appendix G. 
Table 11:  Range of estimates of acute exposure to chlorate through the daily consumption of 
individual foods/food groups and drinking water (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. The ten commodities with the highest acute 
exposure estimates are shown. 
FoodEx Level 3 
Range of acute exposure  
(µg/kg b.w. day)
(a) 
Mean exposure 95th percentile dietary exposure
(b)
 
Drinking water 1.1(c)–47.7 3.3(c)–111.3 
Cow milk 0.9–25.4 3.1–55.9 
Beer and beer-like beverage 0.7–15.6 7.8–37.4 
Flavoured milk 0.2–11.9 4.7–30.3 
Juice, Apple 0.8–14.1 3.1–28.5 
Tea (Infusion) 0.8–13.8 3.6–26.7 
Soft drinks 0.2–12.3 2.9–26.2 
Fruit purée for children 0.8–12.4 12.4–25.7 
Juice, Orange 0.8–13.9 2.4–25.7 
Concentrated fruit juice 0.0–6.2 0.5–24.8 
b.w.: body weight; P95: 95th percentile.  
(a):  Range of acute exposure food by food across dietary surveys and age classes. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be 
statistically robust (EFSA, 2011b). Those estimates were not included in this table.  
(c):  In specific dietary surveys the consumption of drinking water is missing (‘Regional Crete’, Diet Lactation GR, and 
‘Childhealth’) or underreported (‘National Dietary Survey’ and ‘National Repr Surv’). 
3.2.4. Potential contribution to dietary exposure to chlorate of infant/follow-on formula and 
yoghurt 
As mentioned in Section 3.1.3, one analytical result on infant/follow-on formula and two of low-fat 
yoghurt (˂ 1 % fat) were not used in the assessments of the dietary exposure to chlorate reported in 
Section 3.2. 
The analytical result on infant/follow-on formula was received by EFSA at a very late stage during the 
preparation of this scientific opinion, with a reported value of 2.5 mg chlorate/kg dry weight. The 
presence of chlorate in the order of mg/kg dry weight in infant/follow-on formula is supported by 
published studies carried out in Japan (Asami et al., 2013). EFSA is informed that further analyses are 
currently on-going to confirm the presence of these high levels of chlorate in infant/follow-on formula. 
If confirmed, these levels would result in a substantial increase in acute and chronic exposures in 
‘Infants’ and ‘Toddlers’.  
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The CONTAM Panel excluded the two samples of low-fat yoghurt (˂ 1 % fat) with relatively high 
chlorate values (180 µg/kg and 380 µg/kg) because they were considered as not representative of a 
food commodity that is relatively highly consumed. However, it is important to note that, in certain 
populations, the high consumption of yoghurt containing the above described levels of chlorate may 
result in a substantial increase in acute and chronic exposures, especially in ‘Infants’ and ‘Toddlers’.  
3.3. Hazard identification and characterisation 
3.3.1. Toxicokinetics 
3.3.1.1. Laboratory animals 
In 1925, Ross orally administered 500 mg/kg b.w. potassium chlorate (equivalent to 390 mg 
chlorate/kg b.w.) to dogs and provided evidence for a rapid absorption and excretion by assessing the 
chloride content before and after an acid-catalysed reduction of urinary chlorate. Of the total amount 
excreted in urine > 67 % was excreted within 6 hours of dosing. Subsequent studies utilized 
36
Cl as a 
tracer for the chlorine and applied a fractionated or chromatographic methodology to separate the 
36
Cl 
species in the respective body fluids (Abdel-Rahman et al., 1982, 1984; Hakk et al., 2007). After 
administering 0.065 mg/kg 
36
ClO3
-
 orally to male rats a peak 
36
Cl plasma level was reached at 
30 minutes (Abdel-Rahman et al., 1984). Gastrointestinal absorption rates after oral dosing chlorate 
salts are summarized in Table 12 and clearly indicate that in rats and livestock animals (Smith et al., 
2006) after oral intake chlorate salts are rapidly and efficiently absorbed from the gastrointestinal tract.  
Table 12:  Gastrointestinal absorption after oral exposure assessed by urinary excretion of parent 
chlorate or of total radioactive residues (the sum of parent chlorate and metabolites) in studies in 
which 
36
ClO3
-
 salts were dosed 
Species 
(number) 
Dose 
residue measured 
Collection time 
(hours) 
Cumulative absorption 
(% of dose) 
Reference 
Dog  
(6) 
500 mg/kg b.w.  
KClO3 
chlorate 
4 
24 
48 
46.0 ± 6.9 
84.4 ± 7.0 
88.9 ± 7.4 
Ross et al. 
(1925) 
Rat 
(4) 
1.3
(a)
 mg/kg b.w.  
K
36
ClO3 
TRR 
8 
24 
48 
21.6 
37.4 
40.1 
Abdel-Rahman 
et al. (1984) 
Rat 
(4) 
3 mg/kg b.w.  
Na
36
ClO3 
TRR 
6 
24 
48 
36.1 
70.5 
74.9 
Hakk et al. 
(2007) 
Swine 
(2) 
20 mg/kg b.w.  
Na
36
ClO3 
 
40 mg/kg b.w.  
Na
36
ClO3 
 
60 mg/kg b.w.  
Na
36
ClO3 
12 
24 
 
12 
24 
 
12 
24 
50.8 ± 5.9 
77.7 ± 3.5 
 
62.7 ± 0.5 
75.4 ± 12.8 
 
55.1 ± 13.5 
81.0 ± 2.9 
Smith et al. 
(2006) 
b.w.: body weight; TRR: total radioactive residues. 
(a): dose calculated assuming an average rat weight of 235 g. 
 
Abdel-Rahman et al. (1980, 1982, 1984) reported that in rats chlorate is metabolized to chlorite   
(ClO2
-
) and chloride (Cl
-
), which are, next to the parent chlorate, excreted into rat urine. The authors 
considered chlorite as a significant metabolite making up to 4 % of the initial dose of chlorate. 
Subsequent toxicokinetics studies in rats (Hakk et al., 2007) and livestock animals (Smith et al., 
2005a, b, 2006, 2007) did not detect chlorite in tissue or excreta of animals. Furthermore, Hakk et al. 
(2007) demonstrated that the chemical methods used by Abdel-Rahman et al. (1980, 1982, 1984) 
which are based on the differential solubilities of chloride, chlorite and chlorate, were not capable of 
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distinguishing 
36
Cl
-
, 
36
ClO2
-
 and 
36
ClO3
-
 in biological matrices. Applying ion chromatography with 
radiochemical detection Hakk et al. (2007) provided strong evidence that in contrast to chloride, 
chlorite is not a significant urinary chlorate metabolite in rats. 
After absorption, both chlorate and its metabolite chloride are widely distributed throughout body 
tissues in animals. Distribution of radioactivity after 
36
ClO3
- 
administration showed that the highest 
concentrations were in plasma (0.68 %), followed by whole blood (0.57 %), and a total of 3.6 % in 
kidneys, lungs stomach, duodenum, ileum, liver, spleen, bone marrow, testes, skin and carcass (Abdel-
Rahman et al., 1982). Nevertheless, because the chloride ion is actively retained and chlorate is rapidly 
excreted, meaningful generalizations based on total radioactive residues are difficult to make. 
Excretion of chlorate and its metabolite chloride is rapid and mainly via urine, with very small 
amounts being excreted in faeces (Smith et al., 2012).  
In conclusion, following oral exposure chlorate is rapidly absorbed, widely distributed throughout the 
body, and evidence indicates that it undergoes metabolism to chloride. The main pathway of 
elimination is via urine.  
3.3.1.2. Humans 
The CONTAM Panel has not identified studies on the toxicokinetics of chlorate in humans after oral 
uptake. Two studies were identified in which chlorate concentrations in human urine and plasma after 
chlorate poisoning were quantified (Table 13).  
Table 13:  Chlorate concentrations in chlorate poisoning cases 
Cases Urinary concentrations
(a)
 Plasma concentrations
(a)
 Reference 
26 year old women 
Intake of 150–200g NaClO3 
in the form of the herbicide 
‘Unkraut-Ex’ 
 
 
Patient survived after several 
weeks of haemodialysis 
1–3 hours: 86 mM ClO3
-
 
3–5 hours: 24 mM ClO3
-
 
5–7 hours: 18 mM ClO3
-
 
7–9 hours: 10 mM ClO3
-
 
9–11 hours: 5 mM ClO3
-
 
 
70 mM ClO3
-
 (≈ 7.4 g NaClO3) 
were excreted before the 
production of urine subsided 
< LOD of 5 mM ClO3
-
 Steffen and 
Seitz (1981) 
49 year old male  
Chlorate poisoning unclear 
Patient died 12 hours after 
admission to hospital 
4 300 mg/L ClO3
-
 54 mg/L ClO3
-
 Eysseric et al. 
(2000) 
b.w.: body weight; LOD: limit of detection. 
(a): time points refer to hours after admission to the respective hospital. 
 
In conclusion, the data obtained after chlorate poisoning demonstrate that chlorate is bioavailable in 
humans after oral ingestion and that it is eliminated via the urine. 
3.3.2. Toxicity in experimental animals 
3.3.2.1. Acute toxicity 
Chlorate toxicosis has been reported in humans, horses, cows, sheep, chickens and dogs (Gregory et 
al., 1993). Chlorate compounds are locally irritating to the gastrointestinal tract. They are potent 
oxidizing agents and will cause methaemoglobin formation and haemolysis, followed by intravascular 
coagulation. Chlorate is toxic to renal tubules and may cause acute renal failure (Reubi, 1978). 
Reported clinical signs included nausea, vomiting, abdominal pain, ataxia, dyspnoea, cyanosis, 
haematuria, haemoglobinuria, and haemoglobinemia (Kaye, 1970; Sheaban at al., 1971; Steffen and 
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Seitz, 1981; Gregory et al., 1993). Affected animals can progress to anuria, coma, and death within 
hours of a lethal exposure.  
The acute oral toxicity of sodium chlorate was tested by oral gavage in CD (SD) BR rats at single 
dose-levels of 1 470 (males), 2 150, 3 160, 4 640, 6 810 (both sexes) and 10 000 (females) mg/kg b.w. 
(vehicle: deionised water). Death and treatment-related effects (ataxia, lower motor activity, 
prostration, yellow soft faeces, yellow wetness of inguinal and/or perianal region) were observed in 
both sexes. The oral LD50 was 4 950 mg sodium chlorate/kg b.w. in males and 6 250 mg sodium 
chlorate/kg b.w. in females (equivalent to 3 861 mg chlorate/kg b.w. in males and 4 875 mg 
chlorate/kg b.w. in females) (Damske and Meckler, 1981, unpublished study cited in EU DAR, 2008). 
Sodium chlorate (50 % w/w solution in distilled water) was administered once by gavage to Sprague-
Dawley rats at dose levels of 2 000 and 5 000 mg/kg b.w. (equivalent to 1 560 and 3 900 mg 
chlorate/kg b.w.). One dead animal was recorded in high-dose females and treatment-related effects 
were observed at both dose-levels (lethargy, hunched posture, slight to moderate red discoloration of 
the lungs). The LD50 was higher than 5 000 mg sodium chlorate/kg b.w. in both sexes (equivalent to 
3 900 mg chlorate/kg b.w.) (Shapiro, 1991, unpublished study cited in EU DAR, 2008). 
Sodium chlorate (1 g/kg b.w. equivalent to 0.78 mg chlorate/kg b.w.) was administered to New 
Zealand white rabbits by gavage. No methaemoglobin was detected in the blood. No changes in serum 
values of urea, creatinine, aspartate, or alanine aminotransferase were observed during the observation 
period of 7 days. After this period, the animals were killed and no adverse histopathological effects 
were observed in the kidneys 7 days after dosing (Steffen and Wetzel, 1993). 
Other publications reported oral LD50 for sodium chlorate to be 8 350 mg/kg b.w. (equivalent to 
6 513 mg chlorate/kg b.w.) in mice, 1 200 mg/kg b.w. (equivalent to 936 mg chlorate/kg b.w.) in rats, 
7 200 mg/kg b.w. (equivalent to 5 616 mg chlorate/kg b.w.) in rabbits and 700 mg/kg b.w. (equivalent 
to 546 mg chlorate/kg b.w.) in dogs (Lewis, 1996; HSDB, 2003). The oral LD50 of potassium chlorate 
for rats was 1 870 mg/kg b.w. (equivalent to 1272 mg chlorate/kg b.w.) (RTECS, 1994). 
Four dogs were given 1 g/kg b.w. sodium chlorate in a gelatine capsule and four dogs were given 
2 g/kg b.w. sodium chlorate (equivalent to 0.78 and 1.56 g/kg b.w. chlorate) in divided doses over a 
45 minute period. All dogs vomited between 5 and 15 minutes after dosing. With the exception of one 
dog receiving 2 g/kg b.w. which showed slight increases in methaemoglobin 1 hour after dosing, no 
significant change was noticed in methaemoglobin levels (Heywood et al., 1972). 
One female dog was offered a solution of sodium chlorate equivalent to 3.3 g/kg b.w. (equivalent to 
2.57 g/kg b.w. chlorate) over a 24 hour period and was found dead. Post-mortem examination showed 
the mucous membranes to be blue, the blood was dark chocolate brown, the liver was dark brown and 
all serous surfaces were blue-tinged. The appearance was consistent with acute sodium chlorate 
poisoning (Heywood et al., 1972). 
3.3.2.2. Short term toxicity 
Sodium chlorate was administered by drinking water to male and female B6C3F1 mice 
(10 animals/group) at concentrations of 0, 125, 250, 500, 1 000 or 2 000 mg/L for 22 days, resulting in 
daily doses of 0, 20, 45, 90, 175 and 350 mg/kg b.w. per day for males and 0, 20, 45, 95, 190 and 
365 mg/kg b.w. per day for females. These doses were equivalent to 0, 16, 35, 70, 137 and 273 mg 
chlorate/kg b.w. per day for males and 0, 16, 35, 74, 148 and 285 mg chlorate/kg b.w. per day for 
females. No effect was observed on body weight, body weight gain or water consumption. No clinical 
alteration was induced and only mean cell haemoglobin concentration was slightly reduced at high 
dose in males and females, but in absence of haemolysis it was not considered relevant. No exposure-
related lesions occurred in treated animals and in particular thyroid alterations were not present. The 
NOAEL was 350 mg/kg b.w. per day in males and 365 mg/kg b.w. per day in females, the highest 
dose tested (equivalent to 273 mg chlorate/kg b.w. per day for males and 285 mg chlorate/kg b.w. for 
females) (Hooth et al., 2001; NTP, 2005). 
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Female B6C3F1 mice (6 animals/group) were exposed to 0, 500, 1 000, 2 000, 4 000, or 6 000 mg/L 
sodium chlorate (equivalent to about 0, 50, 100, 200, 400 and 600 mg chlorate/kg b.w. per day) 
dissolved in deionized water for 105 days. There were no effects on thyroid histology, but no other 
details were reported (Hooth et al., 2001). 
Sodium chlorate was administered by drinking water to male and female F344/N rats 
(10 animals/group) at concentrations of  0, 125, 250, 500, 1 000 or 2 000 mg/L for 22 days, resulting 
in daily doses of 0, 20, 35, 75, 170 and 300 mg/kg b.w. per day for males and 0, 20, 40, 75, 150 and 
340 mg/kg b.w. per day for females. These doses were equivalent to 0, 16, 27, 59, 133 and 234 mg 
chlorate/kg b.w. per day in males and 0, 16, 31, 59, 117 and 265 mg chlorate/kg b.w. per day in 
females. No effect was observed on body weight, body weight gain or water consumption. At day 22, 
limited decrease in erythrocytes, haemoglobin and haematocrit were observed in males at high dose 
and haemoglobin was reduced in females at the two highest doses. In both males and females, 
segmented neutrophils were decreased. Heart weights (absolute and relative) were decreased by 15 % 
in males at high dose. Dose-related minimal to mild thyroid gland follicular cell hypertrophy occurred 
in males and females at doses ≥ 75 mg/kg b.w. per day. Significant increase in colloid depression and 
in follicular cell hyperplasia were also observed in males at doses ≥ 75 mg/kg b.w. per day and in 
females at doses ≥ 150 mg/kg b.w. per day. The NOAEL was 35 mg/kg b.w. per day in males and 
40 mg/kg b.w. per day in females (equivalent to 27 mg chlorate/kg b.w. per day in males and 31 mg 
chlorate/kg b.w. per day in females) (Hooth et al., 2001). 
Additional male and female F344/N rats (10 animals/group) were exposed via drinking water for 4, 21 
or 90 days to 0, 125, 1 000 or 2 000 mg sodium chlorate/L (equivalent to 0, 16, 133 and 234 mg 
chlorate/kg b.w. per day in males and 0, 16, 117 and 265 mg chlorate/kg b.w. per day in females). 
Thyroid hormone levels were altered significantly in male and female rats after 4 days (decreases of 
triiodothyronine (T3) and T4 and increases in TSH) at the two higher concentrations, and after 21 days 
at the highest dose. TSH levels also increased significantly in male rats after 21 days of treatment with 
1 000 mg sodium chlorate/L. TSH levels were higher in males than in females after 21 days of 
treatment. Although serum T3 and T4 levels were not different from controls in treated animals after 
90 days, TSH levels were increased in the high dose groups. Thyroid follicular cell hyperplasia (with 
mild severity) and significant colloid depletion were present in all males and females at the two higher 
doses following 21 days of treatment. These effects were not present in animals from the control or 
low dose groups. The NOAEL was 16 mg chlorate/kg b.w. per day (Hooth et al., 2001).  
Sodium chlorate was administered by drinking water to male and female F344/N rats 
(20 animals/group) at concentrations of 0, 125, 1 000 or 2 000 mg/L for 14 weeks, resulting in daily 
doses of 0, 11, 89 and 178 mg/kg b.w. per day for males and 0, 12, 93 and 186 mg/kg b.w. per day for 
females (equivalent to 0, 9, 69 and 139 mg chlorate/kg b.w. per day for males and 0, 9, 73 and 145 mg 
chlorate/kg b.w. per day for females). These additional groups were added to the 2-year study for 
thyroid hormone evaluations and histopathology. Serum concentrations of T4
 
and T3
 
were 
significantly reduced in 1 000 and 2 000 mg/L males and females on day 4 and in 2 000 mg/L males 
and females at week 3. Serum concentrations of TSH generally increased with exposure concentration 
and were significantly increased in 1 000 and 2 000 mg/L males on day 4 and at week 3, in 1 000 and 
2 000 mg/L females on day 4, in 2 000 mg/L females at week 3, and in 2 000 mg/L males and females 
at week 14. Slightly enlarged thyroid glands were observed in 1 000 and 2 000 mg/L male rats and 
2 000 mg/L female rats at 14 weeks. All rats in the 1 000 and 2 000 mg/L groups had follicular cell 
hypertrophy at 3 and 14 weeks; this lesion did not occur in control rats (NTP, 2005). 
Male F344 rats (10 animals/group) were exposed to 0, 1, 10, 100, 1 000, or 2 000 mg/L sodium 
chlorate (0, 0.07, 0.7, 7, 70 and 140 mg chlorate/kg b.w. per day) dissolved in deionized water for 
90 days. Sodium chlorate treatment induced a concentration-dependent increase in the incidence and 
severity of thyroid follicular cell hyperplasia. The increases were statistically significant at doses 
≥ 1 000 mg/L. Significant colloid depletion was diagnosed in most treated animals but the incidences 
were similar in all groups. Follicular cell hypertrophy was present in most animals, but the incidence 
did not increase in a concentration manner (Hooth et al., 2001).  
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Female F344 rats (six animals/group) were exposed to 0, 500, 1 000, 2 000, 4 000, or 6 000 mg/L 
sodium chlorate (equivalent to 0, 35, 70, 140, 281 and 421 mg chlorate/kg b.w. per day) dissolved in 
deionized water for 105 days. Sodium chlorate treatment induced a statistically significant increase in 
the incidence and severity of thyroid follicular cell hyperplasia and colloid depletion at doses 
≥ 2 000 mg/L. Follicular cell hypertrophy was observed at doses ≥ 2 000 mg/L, but the increase was 
statistically significant at the highest dose only (Hooth et al., 2001). 
Sodium chlorate was administered by oral gavage (vehicle: distilled water) to groups of 15 male and 
15 female Sprague-Dawley rats at dose levels of 0, 10, 100 and 1 000 mg/kg b.w. per day during 
13 weeks. These doses were equivalent to 0, 8, 79 and 780 mg chlorate/kg b.w. per day. No treatment-
related effects were observed in mortality, physical appearance or behaviour, food consumption, 
clinical chemistry, gross necropsy or organ histopathology. Body weights were significantly lower in 
females, without dose-response relationship. There was a slight, not statistically significant decrease in 
erythrocyte count and in haemoglobin in high dose males. Lower significant erythrocyte count 
(− 4 %), haemoglobin (− 6 %) and haematocrit (− 9 %) were recorded in high dose females, indicative 
of anaemia. Statistically significant decreases in adrenal weights were observed in high dose males 
and females (decrease of 22 % and 20 % absolute weights and 17 % and 11 % relative weights, 
respectively). The NOAEL was 100 mg sodium chlorate/kg b.w. per day (79 mg chlorate/kg b.w. per 
day) (Barrett, 1987a, unpublished study cited in EU DAR, 2008 and FAO/WHO, 2008). 
Sodium chlorate was administered via drinking water to groups of five male and five female Sprague-
Dawley rats during 13 weeks at concentrations of 3, 12 and 48 mM, corresponding to 38, 128 and 
654 mg sodium chlorate/kg b.w. per day for males and 53, 202 and 1 022 mg sodium chlorate/kg b.w. 
per day for females (based on water consumption) (30, 100 and 510 mg chlorate/kg b.w. per day for 
males and 41, 158 and 797 mg chlorate/kg b.w. per day for females). Each drinking water sample was 
completed with sodium chloride to reach the same sodium concentration in each group (48 mM). Two 
control groups were used, one distilled water control and one saline control (sodium chloride). Higher 
mean water consumption was noted in high dose females. Food consumption was lower in both sexes 
at the high dose and terminal body weights were significantly lower in high dose males (−24 %) and 
females (− 16 %). Significant decreased organ weights were observed in high dose animals for heart 
(males and females), kidney (males), spleen (females), adrenals (females), thymus (females) and liver 
(males). Testes and brain weights were increased in high dose males and brain weights in females. 
Statistically significant differences were noted in haematological (haematocrit concentration, red and 
white blood cell counts) and blood biochemistry (aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), calcium, creatinine, phosphorus and cholesterol) parameters in high dose 
males, however as values stayed within physiological limits, the effects were not considered to be 
biologically relevant. Higher severity (males) or incidence (females) of cytoplasmic vacuolization of 
chromophobic and acidophilic cells in the pars distalis of the pituitary gland was noted in the high 
dose groups. There was also a dose-related increase in severity and incidence of moderate to marked 
thyroid colloid depletion in both sexes. The authors established a NOAEL of 38 mg/kg b.w. per day in 
males and 53 mg/kg b.w. per day in females (corresponding to 30 mg chlorate/kg b.w. per day for 
males and 41 mg chlorate/kg b.w. per day for females) (McCauley et al., 1995).  
Male Sprague-Dawley rats (4 animals/group) were given 0, 10 or 100 mg/L chlorate per day in 
drinking water (equivalent to 0, 0.9 and 9 mg/kg b.w. per day) for 4 months. At 2 months, blood 
glutathione levels were decreased significantly in both exposed groups. At 4 months, blood osmotic 
fragility was decreased significantly in the high dose group and abnormal erythrocyte morphology, 
including the presence of codocytes and echinocytes, was observed in both exposed groups (Abdel-
Rahman et al., 1980). 
Couri and Abdel-Rahman (1980) studied the glutathione-dependent enzyme system in the erythrocytes 
of male Sprague-Dawley rats (4 animals/group) after exposure to chlorate in drinking water at 0, 10 or 
100 mg/L (equivalent to 0, 0.9 and 9 mg/kg b.w. per day) for up to 12 months. At 6 months, rats 
exhibited no change in glutathione reductase activity, an increase in glutathione peroxidase and a 
decrease in catalase activity at high dose and a decrease in glutathione concentration at both doses. 
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After 12 months, there was no significant difference in the activity of glutathione reductase, 
glutathione peroxidase or catalase in treated groups and the glutathione concentration was significantly 
higher in both exposed groups. 
Male Sprague- Dawley rats (10, 7 or 10 animals/group; measures generally represent means from 
4 animals/group) were exposed to drinking water containing 0, 10 or 100 mg chlorate/L (equivalent to 
0, 0.9 and 9 mg/kg b.w. per day) for up to one year. Mean body weights were significantly decreased 
(10 % to 20 %) in both treatment groups throughout the experiment. Blood osmotic fragility was 
significantly decreased in both exposed groups after 7 or 9 months. Reduced fragility of red blood 
cells was attributed to cross-linking of membrane components with haemoglobin and subsequent 
precipitation of haemoglobin. Reductions in blood glutathione levels were observed in the high dose 
group after 2, 7 and 9 months and in the low dose group after 2 and 9 months. At 2, 4 and 6 months, 
no significant haematologic changes were noted in treated rats compared to control. After 9 months, 
red blood cell count, haematocrit, and haemoglobin content were all significantly decreased at both 
dose levels. Evaluation of 
3
H-thymidine incorporation into the organs of rats exposed to 10 mg/L 
chlorate for 3 months indicated a decrease in incorporation in the testes but not in the liver, kidney, or 
intestinal mucosa (Couri et al., 1982; Abdel-Rahman et al., 1985). 
Adult male F344 rats (10 animals/group) were exposed, via their drinking water, to 0, 10, 100 and 
1 000 mg sodium chlorate/L or to 0.1, 1.0 or 10 mg/L ammonium perchlorate (containing 0.5, 0.65, 
0.82 and 0.51 mg sodium chlorate/L)
28
 for 7 days. Actual concentrations of sodium chlorate were 0.5, 
25, 119 and 931 mg sodium chlorate/L corresponding to 0.06, 3.3, 16 and 120 mg/kg b.w. per day 
(equivalent to 0.05, 2.6, 12 and 93 mg chlorate/kg b.w. per day). Actual concentrations of ammonium 
perchlorate were 0.17, 1.5 and 8.7 mg/L (corresponding to 0.024, 0.2 and 1.2 mg/kg b.w. per day 
(equivalent to 0.02, 0.17 and 1.01 mg perchlorate/kg b.w. per day). Serum T3 and T4 levels were not 
altered by treatment and TSH was only increased after the highest dose treatment with sodium 
chlorate. Histological examination of the thyroid gland showed colloid depletion of follicular 
epithelial cells and an increase in the incidence and severity of follicular cell hyperplasia in high-dose 
treated animals. Hypertrophy of thyroid follicular epithelial cells was present at all doses of sodium 
chlorate (in 5/6, 6/6 and 5/6 animals, respectively, compared to 1/6 in controls) and in high dose of 
ammonium perchlorate (in 6/6 animals). There was also an apparent increase in the number of 
basophils in rats treated at the high dose of both compounds. For ammonium perchlorate, the NOAEL 
was 0.17 mg/kg b.w. per day and the lowest-observed-adverse-effect level (LOAEL) was 1.01 mg/kg 
b.w. per day expressed as perchlorate. The LOAEL was 3.3 mg sodium chlorate/kg b.w. per day 
equivalent to 2.6 mg chlorate/kg b.w. per day (Khan et al., 2005). This study is the only study where 
chlorate and perchlorate were tested at the same time. However, it is a poorly reported study, with 
limitations in the number of animals examined (only six/dose group for histopathology), in the number 
of examinations and only 7 days of exposure. The study results did not allow a dose-response 
comparison of the two compounds.  
Sodium chlorate (as a commercial preparation) was administered by gavage over a 5-day period to 
four male and four female beagle dogs at doses of 200 to 326 mg/kg b.w. per day (equivalent to 156 to 
254 mg chlorate/kg per day). Two animals receiving more than 300 mg/kg b.w. per day (equivalent to 
234 mg chlorate/kg b.w. per day) displayed loss of appetite and body weight and had blood in their 
urine or faeces, and one died after 4 days of exposure. The surviving animal was allowed a 7-day 
recovery period. Post mortem examination of both animals revealed classic signs of chlorate 
poisoning, including cyanotic kidney surface and evidence of haemolysis in the liver. Dogs receiving 
less than 300 mg/kg per day sodium chlorate survived the exposure period and were allowed a week of 
recovery before necropsy. Three of these animals displayed slight weight loss. Some of these dogs 
exhibited extramedullary haematopoiesis in the spleen and evidence of haemolysis in the liver. Packed 
cell volume, haemoglobin content, and red blood cell count were all reduced in animals treated with 
greater than 200 mg/kg per day compared to pre-treatment values for each animal. Reticulocyte counts 
                                                     
28 The source of sodium chlorate in the deionized water supply was not determined. 
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were increased in all animals treated with greater than 200 mg/kg per day. Methaemoglobin values 
were little affected, the only animal showing significant elevation being the animal that died 
(Heywood et al., 1972). 
Sodium chlorate was administered by oral gavage (vehicle: distilled water) to groups of four male and 
four female Beagle dogs at dose levels of 0, 10, 60 and 360 mg/kg b.w. per day (0, 8, 47 and 284 mg 
chlorate/kg b.w. per day) during 13 weeks. The maximal dose was chosen because it produced emesis 
in a former range-finding study. No treatment-related effects were observed on clinical signs, body 
weight, food consumption, blood biochemistry parameters, organ weights or at necropsy. No relevant 
haematological effect was observed except individual increase in methaemoglobinemia in the two 
highest dose female groups at week 6 and in all treated female groups at week 13. This was judged to 
be within normal limits and therefore not treatment-related. The NOAEL was 360 mg/kg b.w. per day 
(281 mg chlorate/kg b.w. per day), the highest dose tested (Barrett, 1987b, unpublished study cited in 
EU DAR, 2008). 
Twelve adult African green monkeys (five males and seven females) were exposed to solutions of 
sodium chlorate at concentrations of 0, 25, 50, 100, 200 or 400 mg/L. If water consumption of 
580 mL/day and a mean body weight of 5 kg are assumed, the sodium chlorate consumption would be 
equivalent to 0, 3, 6, 12, 23 and 46 mg/kg b.w. per day (equivalent to 0, 2.3, 4.7, 9.4, 18, 36 mg 
chlorate/kg b.w. per day), respectively (FAO/WHO, 2008); the authors cited the top dose as being 
equal to 54 ± 38 mg/kg b.w. per day. The test substance was administered for 30–60 days at rising 
doses to the same group of animals with a 6- to 9-week resting period between testing of consecutive 
doses. Sodium chlorate induced a slight dose-dependent decrease in red blood cell count, reticulocytes 
and haemoglobin. Sodium chlorate did not induce significant changes in thyroid hormone (serum T4) 
levels (Bercz et al., 1982). Since this study was poorly conducted and reported it was not possible to 
precisely define the doses in mg/kg b.w. per day. 
Conclusions 
The thyroid gland and the haematological system are the primary target organs of toxicity of chlorate 
identified in animal species after repeated oral exposure. Decreases in erythrocytes, haemoglobin and 
haematocrit were observed in mice, rats, dogs and monkeys. Histopathological changes were noted in 
the thyroid gland of rats (follicular cell hypertrophy, increase in colloid depression and in follicular 
cell hyperplasia). Thyroid hormone levels were also altered significantly (decreases in T3 and T4 and 
increases in TSH). 
3.3.2.3. Long term toxicity and carcinogenicity  
Sodium chlorate was administered by drinking water to male and female B6C3F1 mice 
(50 animals/group) at concentrations of 0, 500, 1 000 or 2 000 mg/L for two years, resulting in daily 
doses of 0, 40, 80 and 160 mg/ kg b.w. per day for males and 0, 30, 60 and 120 mg/kg b.w. per day for 
females (equivalent to 0, 31, 62 and 125 mg chlorate/kg b.w. per day for males and 0, 23, 47 and 
94 mg chlorate/kg b.w. per day for females). Survival of exposed mice was similar to that of the 
control groups. Mean body weights of exposed groups of males were similar to those of the control 
group throughout the study. Mean body weights of 500 and 1 000 mg/L females were less than those 
of the controls after week 84 (88 % and 90 % of control at the end of the study) and those of 
2 000 mg/L females were less after week 88 of the study (90 % of control at the end of the study). 
Water consumption by exposed mice was generally similar to that by controls throughout the study. 
No clinical findings related to sodium chlorate exposure were observed. There was a positive trend in 
the incidences of pancreatic islet cell adenoma or carcinoma (combined) in female mice that was 
composed primarily of adenomas (three of four neoplasms in the 2 000 mg/L group). The incidences 
of pancreatic islet adenoma and adenoma or carcinoma (combined) in 2 000 mg/L females exceeded 
the historical ranges for drinking water controls (adenoma: 0 %, 4 %, 4 % and 6 %, adenoma or 
carcinoma: 0 %, 4 %, 4 % and 8 %, historical incidence: 1.4 % ± 2.3 %, range: 0–4 %). The incidences 
of pancreatic hyperplasia decreased with increasing exposure concentration. The incidences of 
hepatocellular carcinoma were significantly greater in 500 and 1 000 mg/L females than in the control 
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group (3/49, 13/50, 15/49 and 9/50). Although not statistically significant, the incidence in 2 000 mg/L 
females was also increased. The incidences in all exposed groups of females exceeded the historical 
range for drinking water controls (8 %, range 4–14 %). When incidences of hepatocellular adenoma 
(30/49, 19/50, 26/49, 23/50) and carcinoma were combined (31/49, 26/50, 31/49, 26/50), there was no 
effect. Due to this fact and because the increases were not exposure concentration-related, these 
carcinomas were not considered to be induced by sodium chlorate. The incidence of minimal thyroid 
follicular cell hypertrophy was significantly increased in 2 000 mg/L female mice when compared to 
the control group (3/48, severity grade 1.3; 2/50, severity grade 2.0; 5/49, severity grade 1.0; 14/50, 
severity grade 1.4). The incidence of thyroid gland cystic degeneration was significantly increased in 
1 000 mg/L females when compared to the control group (25/48, 28/50, 34/49, 32/50). Thyroid gland 
cystic degeneration was considered an aging change and not related to sodium chlorate administration. 
The incidences of bone marrow hyperplasia were significantly increased in all exposed groups of 
female mice when compared to the control group (14/50, 28/50, 29/50, 31/50). The severity of this 
lesion in exposed females was slightly greater than in the controls (2.4, 2.6, 2.9 and 2.7). The 
incidence of granulosa cell hyperplasia of the ovary was significantly increased in 2 000 mg/L female 
mice when compared to the control group (0/45, 0/45, 3/47, 7/50). In general, these were considered 
not to be preneoplastic lesions. 
In conclusion, there was a positive trend in the incidences of pancreatic islet cell adenoma or 
carcinoma (combined) in female mice. Thyroid gland follicular cell hypertrophy was significantly 
increased in 2 000 mg/L females. The incidences of bone marrow hyperplasia were significantly 
increased in all exposed groups of females. There was no evidence of carcinogenic activity of sodium 
chlorate in male B6C3F1
 
mice. There was equivocal evidence of carcinogenic activity of sodium 
chlorate in female B6C3F1
 
mice based on marginally increased incidences of pancreatic islet 
neoplasms. A NOAEL was not identified in this study based on the decrease in body weight gain and 
the increase in incidence of pancreatic islet cell adenoma in females observed at the lowest dose. The 
LOAEL was 30 mg sodium chlorate/kg b.w. per day (equivalent to 23 mg chlorate/kg b.w. per day) 
(NTP, 2005). 
Sodium chlorate was administered by drinking water to male and female F344/N rats 
(50 animals/group) at concentrations of 0, 125, 1 000 or 2 000 mg/L for 2 years, resulting in daily 
doses of 0, 5, 35 and 75 mg/ kg b.w. per day for males and 0, 5, 45 and 95 mg/kg b.w. per day for 
females (equivalent to 0, 4, 27 and 59 mg chlorate/kg b.w. per day for males and 0, 4, 35 and 74 mg 
chlorate/kg b.w. per day for females). Survival of exposed rats was similar to that of the control 
groups. Mean body weights of all exposed groups were similar to those of the control groups 
throughout the study. Water consumption by exposed rats was generally similar to that by controls 
throughout the study. No clinical findings were attributed to sodium chlorate exposure. There were 
positive trends in the incidences of thyroid follicular cell carcinoma in male rats and in follicular cell 
adenoma or carcinoma (combined) in males and females. The incidences of follicular cell adenoma, 
follicular cell carcinoma, and follicular cell adenoma or carcinoma (combined) in 2 000 mg/L males 
and females (males: 2/47, 4/47 and 6/47 compared to 1/47, 0/47 and 1/47 in controls; females: 2/46, 
2/46 and 4/46 compared to 0/47, 1/47 and 1/47 in controls) exceeded the historical ranges
29
 for 
drinking water controls. The incidences of follicular cell hypertrophy in all exposed groups of males 
and in 1 000 and 2 000 mg/L females at two years were significantly greater than those in the control 
groups and the severity was increased in 2 000 mg/L males and females. The incidences of focal 
follicle mineralization in 1 000 and 2 000 mg/L females were significantly greater than that in the 
control group and the severity was increased in the 2 000 mg/L group. This is a common aging 
change, but the increased incidences may have been exacerbated by exposure to sodium chlorate. In 
the spleen, the incidence of hematopoietic cell proliferation was significantly increased in 2 000 mg/L 
males when compared to the control group (2/48, 6/49, 4/49 and 11/50, respectively). The incidences 
                                                     
29 Historical incidence follicular cell adenoma or carcinoma: males:  adenomas: mean: 2.2 %, range: 2 %; carcinomas: mean: 
1.0 ± 1.4 %, range: 0–2 %; combined: mean: 3.2 ± 1.1%, range 2–4 %; females: adenomas: mean: 1.0 ± 1.4 %, range:  
0–2 %; carcinomas: mean: 2.1 ± 0.2 %, range: 2 %; combined: mean: 3.1 ± 1.3 %, range 2–4 %. 
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of bone marrow hyperplasia were significantly increased in 1 000 and 2 000 mg/L males when 
compared to the control group (28/48, 35/48, 41/50 and 40/49, respectively). The severity grades of 
this lesion were greater in all treatment groups when compared to controls (1.9, 2.3, 2.4 and 2.7). The 
increases in hyperplasia incidence and severity suggest this was a treatment-related effect. The 
incidence of mononuclear cell leukaemia was significantly increased in the male 2 000 mg/L group 
when compared to controls (13/50, 21/50, 16/50, 23/50). However, the incidences of this lesion in all 
exposed groups fell within the historical range in controls (all routes) 43.1 % ± 12.8 %, range 22–
68 %. Because the incidence of mononuclear cell leukaemia in the control group was at the low end of 
the historical control range and near average in the exposed groups, this lesion was not attributed to 
sodium chlorate administration.  
In conclusion, a NOAEL was not identified in this study due to the increased incidence of follicular 
cell hypertrophy in males at the lowest dose. The LOAEL was 5 mg sodium chlorate/kg b.w. per day 
(equivalent to 4 mg chlorate/kg b.w. per day) (NTP, 2005). There was some evidence of carcinogenic 
activity of sodium chlorate in male and female F344/N rats based on increased incidences of thyroid 
gland neoplasms (NTP, 2005). 
Sodium chlorate and potassium chlorate were tested in male F344 rats (15/group) for potential 
promoting effects in two-stage rat renal carcinogenesis studies. Renal carcinogenesis was initiated 
with 500 mg/L N-ethyl-N-hydroxyethylnitrosamine in the drinking water three times per week for 
2 weeks. Rats were then treated with 10 g/L sodium chlorate, 10 g/L potassium chlorate in the 
drinking water, or distilled water for 25 weeks. Three other groups were treated similarly, except that 
drinking water was given in the initiation phase. Based on drinking-water consumption, the doses were 
reported to be 686 mg sodium chlorate/kg b.w. per day and 675 mg potassium chlorate/kg b.w. per day 
in the initiated rats and 654 mg sodium chlorate/kg b.w. per day and 667 mg potassium chlorate/kg 
b.w. per day in the rats consuming sodium or potassium chlorate without initiator equivalent to 535 or 
510 and  459 or 460 mg chlorate/kg b.w. per day. No animals died during the course of the 
experiment. Animals were necropsied at 27 weeks. Sodium or potassium chlorate showed no 
promoting effect on the incidences of renal neoplastic lesions, including dysplastic foci and renal cell 
tumours (Kurokawa et al., 1985). 
Conclusions 
Long-term oral exposure to sodium chlorate resulted in non-neoplastic lesions in the thyroid gland 
(follicular cell hypertrophy) of male and female rats and female mice, bone marrow (hyperplasia) of 
male rats and female mice, and spleen (hematopoietic cell proliferation) of male rats. 
There was no evidence of carcinogenic activity of sodium chlorate in male B6C3F1
 
mice. There was 
equivocal evidence of carcinogenic activity of sodium chlorate in female B6C3F1
 
mice based on 
marginally increased incidences of pancreatic islet cell adenoma and carcinoma (combined).There was 
some evidence of carcinogenic activity of sodium chlorate in male and female F344/N rats based on 
increased incidences of thyroid gland neoplasms. 
3.3.2.4. Genotoxicity 
The genotoxic potential of sodium chlorate has been evaluated in vitro and in vivo (somatic and germ 
cells). In vitro, in a majority of tests, sodium chlorate had no mutagenic activity on S.typhimurium or 
E. coli WP2 hcr. It was positive in one of the tests performed in TA1535 and negative in two others. 
Sodium chlorate was negative in a V79 hprt gene mutation assay, in an unscheduled DNS synthesis 
(UDS) on human epitheloid cervix carcinoma cell line (HeLa) S3 cells and in a micronucleus test in 
human hepatocyte carcinoma cell line (HepG2) cells. The result of a Comet assay in HepG2 cells is 
unclear. In vivo, sodium chlorate was negative in several mice micronucleus test. It was also negative 
in a chromosomal aberration test and in a sperm abnormality assay, however, the dose levels were low 
and there was no proof of exposure of the target cells. Positive results were observed in Drosophila 
and in plants. Tables 14 and 15 present an overview of the available genotoxicity studies with sodium 
and potassium chlorate in vitro and in vivo respectively. 
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Table 14:  In vitro genotoxicity tests with sodium chlorate or potassium chlorate 
Type of test 
Experimental test 
system 
Substance 
tested 
Exposure 
conditions 
Result Reference 
Reverse mutation 
assay  
S. typhimurium 
TA98, TA100, 
TA1535, TA1537 
and TA1538 
Sodium 
chlorate 
50–5 000 
µg/plate 
+ /- S9  
 
Plate 
incorporation 
test 
 
Controls
(a)
 
Negative May and 
Hodson-
Walker 
(1989)* 
Reverse mutation 
assay 
S. typhimurium 
TA98, TA100 and 
TA1537 
Sodium 
chlorate 
10–10 000 
µg/plate 
+/− S9  
 
Controls
(b) 
Negative Hossack et 
al. (1978)* 
Reverse mutation 
assay 
S. typhimurium 
TA98, TA100, 
TA1535 TA1537 
and TA1538 
Sodium 
chlorate 
up to 
3 600 µg/plate 
+/−S9  
+ S9: Positive at 
12 µM/plate in 
TA1535  
Gocke et 
al. (1981) 
Reverse mutation 
assay  
S. typhimurium 
TA97, TA98, 
TA100, TA1535, 
TA102 and TA104 
Sodium 
chlorate 
100-10 000 
µg/plate 
 
+/− S9 ** 
Negative NTP 
(2005) 
Reverse mutation 
assay 
 
S. typhimurium 
BA-13 (araD531, 
hisG46, uvrB, pK 
M101) 
Potassium 
chlorate 
 
5–100 mM 
 
 
Negative 
 
Prieto and 
Fernandez 
(1993) 
Lethal DNA 
damage 
E. coli WP2, WP67 
and CM871 
Sodium 
chlorate 
100–10 000 
µg/mL 
+/− S9  
 
Pre-incubation 
(2 hours or 
18 hours) 
 
Controls
(c) 
 
2 hours  Pre-
incubation 
 
–S9 mix: 
suggestive of 
DNA damage in 
WP67 and 
CM871 (conc. 
1 000–10 000 
µg/mL) 
 
+S9 mix: 
suggestive of 
DNA damage  
May and 
Hodson-
Walker 
(1989b)* 
Gene mutation 
assay  
(HPRT locus) 
Chinese hamster 
V79 cells 
Sodium 
chlorate 
8–5 000 µg/mL 
+/− S9  
Controls
(d) 
Negative 
(sensitivity of 
the test is low) 
Hodson-
Walker 
and 
Bootman 
(1989)* 
Gene mutation 
assay  
(HPRT locus) 
Chinese hamster 
ovary (CHO) cells 
Sodium 
chlorate 
10–5 000 
µg/mL 
+/− S9  
 
Controls
(e)
 
Negative  ECHA 
(2015a)  
Unscheduled 
DNA synthesis 
(UDS) 
Human HeLa S3 
cells 
Sodium 
chlorate 
100–10 000 
µg/mL 
+/− S9  
 
Controls
(f)
 
Negative Seeberg 
(1989)* 
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Type of test 
Experimental test 
system 
Substance 
tested 
Exposure 
conditions 
Result Reference 
Comet assay 
 
 
 
 
 
 
 
 
Micronucleus test 
Human HepG2 
cells  
(ATCC HB 8065) 
 
 
 
 
 
 
Human HepG2 
cells 
Chlorate 
solution 
 
 
 
 
 
 
 
Chlorate 
solution 
0.001–0.2 mg/L  
-S9 Incubation: 
24 hours 
Controls
(g) 
 
 
0.001–0.2 mg/L  
-S9  
Controls
(g) 
Increase % tail 
intensity at 
0.001 mg/L only 
 
Dose-dependent 
decrease in tail 
intensity 
 
 
Negative 
Feretti et 
al. (2008) 
b.w.: body weight; HepG2: human hepatocyte carcinoma cell line; HeLa: human epitheloid cervix carcinoma cell line. 
+/−S9: with/without supernatant fraction obtained from an organ (usually liver) homogenate by centrifuging 9 000 g for 
20 minutes in a suitable medium; this fraction contains cytosol and microsomes. 
(a):  Positive controls were sodium azide (−S9), 2-aminoanthracene (±S9), 9-aminoacridine (−S9), 2-nitrofluorene (−S9) and 
benzo(a)pyrene (±S9). 
(b):  Solvent control (distilled water); three compounds served as positive controls in presence of metabolic activation: β-
naphthylamine (10 µg/plate), 2-acetylaminofluorene (20 µg/plate) and neutral red (10 µg/plate). No positive control was 
tested in absence of S9. 
(c):  Solvent/negative controls: distilled water, ampicillin; Positive controls: mitomycin C (MMC) for – S9 mix, 2-
aminoanthracene (2-AA) for + S9 mix. 
(d):  Negative control: distilled water; Positive controls: Ethylmethanesulfonate (EMS), 7,-12 dimethylbenzanthracene 
(DMBA). 
(e):  Solvent/vehicle controls: medium; Positive controls: Ethylmethanesulfonate (EMS), benzo(a)pyrene (B(α)P)  
(f):  Negative control: distilled water, Positive controls: 4-nitroquinoline-N-oxide (4-NQO), benzo(a)pyrene (B(α)P), 7,-12 
dimetylbenzanthracene (DMBA). 
(g):  Negative control: untreated; Positive control: benzo(a)pyrene (B(α)P). 
* Unpublished study cited in EU DAR (2008). 
**  Aroclor 1254-induced male Sprague-Dawley rat or Syrian hamster liver. 
 
Table 15:  In vivo genotoxicity tests with sodium chlorate 
Type of test 
Experimental test 
system 
Substance 
tested 
Experimental 
conditions 
Result Reference 
Micronucleus  
Test 
 
 
 
 
 
 
 
 
 
 
Sex-linked 
recessive lethal 
assay 
NMRI mice 
 
 
 
 
 
 
 
 
 
 
 
Drosophila 
melanogaster 
(Berlin K, wild type 
and Basic) 
Sodium 
chlorate 
 
 
 
 
 
 
 
 
 
 
Sodium 
chlorate 
Intraperitoneal: 
530–2 120 
mg/kg   
Gavage: 2 128–
4 265 mg/kg 
 
Animals treated 
at 0 and 
24 hours 
Smears prepared 
at 30 hours 
 
0.25 M  
feeding solution 
Negative  
 
 
 
 
 
 
 
 
 
 
 
 
Positive 
Gocke et 
al. (1981) 
Table continued overleaf. 
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Table 15: In vivo genotoxicity tests with sodium chlorate (continued) 
Type of test 
 
Experimental test 
system 
Substance 
tested 
Experimental 
conditions 
Result Reference 
Micronucleus 
test 
CD-1 mice 
Bone marrow cells 
Sodium 
chlorate 
Oral gavage 
 
Preliminary 
cytotoxicity test: 
625–5 000 
mg/kg b.w.  
 
Main test: 200–
5 000 mg/kg 
b.w. 
 
Sacrifice: 24, 48 
or 72 hours after 
treatment 
 
Controls
(a) 
Negative  
 
No relevant 
cytotoxicity 
 
Clinical signs of 
toxicity 
Preliminary test: 
2 500 and 5 000 
mg/kg b.w.  
 
Main test: 5 000 
mg/kg b.w.  
Mackay 
and 
Bootman 
(1989)* 
Micronucleus 
test 
 
 
 
 
 
 
 
 
 
 
 
Chromosomal 
aberrations test 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sperm-head 
abnormality 
assay 
CD-1 mice 
Bone marrow cells 
 
 
 
 
 
 
 
 
 
 
 
CD-1 mice 
Bone marrow cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
Male B6C3F1 mice 
Sodium 
chlorate 
 
 
 
 
 
 
 
 
 
 
 
Sodium 
chlorate 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sodium 
chlorate 
7–33 mg/kg 
b.w. 
 
5 days oral 
gavage 
 
Sacrifice: 6 
hours after last 
administration 
 
Controls
(b) 
 
 
Single or 5 days 
oral gavage 
 
Sacrifice  
single 
administration: 
6, 24 and 48 
hours after 
administration 
5 days: 6 hours 
after last 
administration 
 
Controls
(b) 
 
5 days oral 
gavage 
 
Sacrifice: 1, 3 
and 5 weeks 
after last 
administration 
 
Controls
(c) 
Negative 
 
 
But: dose levels 
extremely low, 
no proof of 
exposure, 
clinical signs of 
exposure not 
reported, no 
data on 
PCE/NCE 
 
Negative 
 
 
But: dose levels 
extremely low, 
no proof of 
exposure, 
clinical signs of 
exposure not 
reported, MI not 
reported 
 
 
 
 
Negative 
 
 
But: dose levels 
extremely low, 
no proof of 
exposure, 
clinical signs of 
exposure not 
reported 
Meier et al. 
(1985) 
Table continued overleaf. 
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Table 15: In vivo genotoxicity tests with sodium chlorate (continued) 
Type of test 
 
Experimental test 
system 
Substance 
tested 
Experimental 
conditions 
Result Reference 
Micronucleus 
test 
B6C3F1 mouse 
Peripheral blood 
Sodium 
chlorate 
3-week oral 
administration 
in drinking 
water  
 
Up to 350–365 
mg/kg b.w. per 
day 
Negative NTP 
(2005) 
Chromosomal 
aberration test 
 
 
 
 
 
 
 
 
 
Micronucleus 
test 
Allium cepa 
 
 
 
 
 
 
 
 
 
 
Tradescantia (clone 
#4430) 
Sodium 
chlorate 
solution 
(45 %) 
 
 
 
 
 
 
 
Sodium 
chlorate 
solution 
(45 %) 
0.01–0.8 mg/L 
for 6 hours 
0.01–0.2 mg/L 
for 24 hours 
 
 
Controls
(d) 
 
 
 
 
0.1–0.8 mg/L  
24 hours 
exposure 
 
Controls
(d) 
After 6 hours: 
increase 
chromosome 
aberrations 
(0.15–0.8 mg/L) 
 
After 24 hours: 
negative 
cytotoxic at 0.1 
and 0.2 mg/L 
 
Positive at 
0.4 mg/L only 
Feretti et 
al. (2008) 
b.w.: body weight; NCE: normochromatic erythrocytes; PCE: polychromatic erythrocytes  
(a):  Solvent control: distilled water. Positive control: chlorambucil (CP). 
(b):  Solvent/negative control: deionized water. Positive control: triethylenemelamine (TEM). 
(c):  Solvent/negative control: deionized water. Positive control: ethylmethanesulfonate (EMS). 
(d):  Negative control: distilled water. Positive control: Maleic hydrazide. 
* Unpublished study cited in the EU DAR (2008). 
 
Conclusions 
Based on the available data, the CONTAM Panel concluded that chlorate is not of concern with regard 
to genotoxicity.  
3.3.2.5. Developmental and reproductive toxicity  
In a one-generation dose-range finding study, Sprague Dawley rats (groups of six males and six 
females) were given sodium chlorate in purified water by gavage at 0, 40, 200 and 1 000 mg/kg b.w. 
per day (equivalent to 0, 31, 156 and 780 mg chlorate/kg b.w. per day) (Gaoua, 2004a, unpublished 
study cited in EU DAR, 2008). The treatment started when the animals were 6 weeks old, during 
10 weeks pre-mating, during mating and in females during pregnancy and lactation. Males were 
sacrificed at the end of the mating period and females at weaning or at day 25 post-coitum if they had 
not delivered. Litters were culled on day 4 post partum (pp) to obtain four males and four females per 
litter. Other pups were sacrificed at weaning. The parental data showed no treatment-related clinical 
signs, and there were no adverse effects on reproductive performance. The reproduction NOAEL was 
1 000 mg/kg b.w. per day (equivalent to 780 mg chlorate/kg b.w. per day). Treatment related thyroid 
epithelial cell hyperplasia was observed at 200 and 1000 mg/kg b.w. per day in males and at 
1 000 mg/kg b.w. per day in females. Higher incidence and severity of presence of vacuolated cells in 
the pituitary gland pars distalis were observed in both sexes at 1 000 mg/kg b.w. per day. The parental 
NOAEL was 40 mg/kg b.w. per day in males (equivalent to 31 mg chlorate/kg b.w. per day) and 
200 mg/kg b.w. per day in females (equivalent to 156 mg chlorate/kg b.w. per day). The litter data 
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showed treatment related lower foetal b.w. and decreased b.w. gain at 1 000 mg/kg b.w. per day. The 
offspring NOAEL was 200 mg/kg b.w. per day (equivalent to 156 mg chlorate/kg b.w. per day). 
In a two-generation study following OECD guideline 416 (OECD, 2001), Sprague Dawley rats were 
given sodium chlorate in purified water at dose levels 0 (controls), 10, 70 and 500 mg/kg per day 
(equivalent to 0, 8, 55 and 390 mg chlorate/kg b.w. per day) by gavage (n = 25 males and 25 females 
in each dose group) from age 6 weeks (Gaoua, 2004b, unpublished study cited in EU DAR, 2008). F0 
adults were treated 10 weeks before mating, during mating, throughout gestation and lactation 
(females) until sacrifice at weaning of the F1 pups. F1 pups were culled at day 4 pp, and weaned on 
day 21 pp, when couples were randomly selected to produce F2 litter. From day 22 pp the F1 
generation was treated under the same experimental conditions as their parents. They were sacrificed 
at weaning of the F2 litter. F2 pups were culled at day 4 pp and sacrificed at weaning at day 22 pp.  
Parental data of the F0 and F1 generation showed that the oestrus cycle and the female reproductive 
parameters were not altered by treatment. Sperm parameters were not affected in F0 or F1 males. In 
F0 animals at sacrifice, there were small dose-related decreases in haematology values (RBC count, 
haemoglobin concentration, packed cell volume, mean cell haemoglobin concentration) that were 
statistically significant in both males and females at the 500 mg/kg b.w. per day dose, and for RBC 
count and haemoglobin concentration also at the 70 mg/kg b.w. per day dose in females. They were, 
however, within the range of the historical background data. No haematology analysis was performed 
in F1 animals. There was a dose-related increase in male spleen weights in F0 (+ 1 %, + 15 %, + 25 %, 
relative weights), this was also seen in F1 males (+ 2 %, + 5 %, + 25 %), and is expected when 
damaged RBCs are destroyed in the spleen. Higher incidences of thyroid follicular hyperplasia at 
500 mg/kg b.w. per day was seen in F0 and F1 males and females, as well as dose-related increase in 
grading of follicular hyperactivity, particularly in males. The NOAEL was 10 mg/kg b.w. per day for 
thyroid hyperactivity in males and 70 mg/kg b.w. per day in females.  
No other notable treatment-related effects were reported for the F0 or F1 parental generation. No 
effects were reported for progeny of F0 or F1 (survival or development). No significant lesions were 
observed in thyroid glands of F2 pups. The NOAEL for reproduction and offspring was 500 mg/kg 
b.w. per day, the highest dose tested. 
In a dose range finding study on teratogenicity in rats (Schroeder, 1987a, unpublished report cited in 
EU DAR, 2008), sodium chlorate was administered at 0, 10, 50, 100, 500 and 1 000 mg/kg b.w. per 
day (equivalent to 0, 8, 39, 78, 390 and 780 mg chlorate/kg b.w. per day; five animals per dose group) 
in distilled water by oral gavage to pregnant Sprague Dawley rats from day 6 to 15 of gestation. The 
treatment induced no maternal toxicity, embryotoxicity, foetotoxicity or malformations. The NOAEL 
was the highest dose tested at 1 000 mg/kg b.w. per day.  
In a teratogenicity study sodium chlorate was administered at 0, 10, 100 and 1 000 mg /kg b.w. per 
day (equivalent to 0, 8, 78 and 780 mg chlorate/kg b.w. per day; 24 animals per dose group) in 
distilled water by gavage to pregnant Sprague Dawley rats from day 6 to 15 of gestation (Schroeder, 
1987b, unpublished report cited in EU DAR, 2008). No adverse effects were reported and therefore 
the NOAEL was set at the highest dose tested, 1 000 mg/kg b.w. per day (corresponding to 780 mg 
chlorate/kg b.w. per day).  
Pregnant New Zealand white rabbits (24 animals/group) were administered 0, 100, 250, or 475 mg 
sodium chlorate/kg b.w. per day (equivalent to 0, 78, 195 and 371 mg chlorate/kg b.w. per day) by oral 
gavage in distilled water from gestation day 6 to 29 (NTP, 2002). Dams were necropsied on gestation 
day 30. Transient changes in maternal food intake, urine colour, and/or output were noted at doses of 
100 mg/kg per day and greater. Sodium chlorate did not cause any statistically significant treatment-
related developmental toxicity under the conditions of this study. 
In a 96 hours developmental toxicity test in Xenopus laevis Brennan et al. (2005) assessed four 
individual drinking water disinfection by-products, including sodium chlorate. Two replicates of 
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25 embryos were used. No chlorate-associated malformations were seen at concentrations 
< 5 000 mg/L. At 5 000 mg/L and 6 000 mg/L, gut malformation (gut coiling) was seen in 35 % and 
96 % of the embryos, respectively. The LC50 was 5 778 mg/L and the EC50 for embryonic 
malformation was 4 865 mg/L. 
Conclusions 
Four studies on reproductive and developmental toxicity in rats were identified. The lowest reported 
NOAEL was 200 mg/kg b.w. per day, equivalent to 156 mg chlorate/kg b.w. per day for lower weight 
gain in offspring in a one-generation study (Gaoua, 2004a, unpublished study cited in EU DAR, 
2008). Toxicity could be observed in the parental generation without reproductive or developmental 
toxicity. The parental effects observed at lowest level were thyroid epithelial cell hyperplasia (male 
parental NOAEL 40 mg/kg b.w. per day, equivalent to 31 mg chlorate/kg b.w. per day) and thyroid 
hyperactivity (male parental NOAEL 10 mg/kg b.w. per day, equivalent to 8 mg chlorate/kg b.w. per 
day).  
3.3.3.  Observations in humans  
3.3.3.1. Acute effects 
Death or illness resulting from accidental or intentional ingestion of herbicides containing sodium 
chlorate has been reported in the literature several times since the 1960s (Knight et al., 1967; Lee et 
al., 1970; Bloxham et al., 1979; Helliwell and Nunn, 1979; NRC 1980, 1987; Ranghino et al., 2006).  
Symptoms and signs of sodium chlorate intoxication include vomiting, abdominal pain, cyanosis, 
methaemoglobinaemia, anuria, and renal failure. According to NRC (1980) ‘the lethal dose in adults is 
estimated to be 20 to 35 g for sodium chlorate and 5 to 30 g for potassium chlorate. For a 70-kg 
human, the oral lethal dose for these salts is 71 to 500 mg/kg’. Helliwell and Nunn (1979) reported 
14 cases of sodium chlorate poisoning, with ingested amounts (1–2 g to 300 g) known in 12 of the 
cases. Nine of the cases died, and in all these the amount ingested was unknown or exceeded 100 g. 
Death occurred regardless of treatment, which in several cases included haemodialysis and exchange 
transfusion. The patient who had ingested the lowest amount (1–2 g, which corresponds to 11–23 mg 
chlorate/kg b.w.) survived. He received initial management with sodium thiosulphate (an antidote that 
inactivates the chlorate ion) and thereafter supportive management alone. Methaemoglobinaemia was 
seen in 13 of the 14 patients. It is not indicated which patient did not have methaemoglobinaemia, but 
the CONTAM panel assumes that this was the patient with the lowest dose ingested.  
Matchsticks may contain 55 % potassium chlorate. After ingestion of approximately 2 g potassium 
chlorate from 120 matchstick heads or three matchstick boxes (corresponding to 20 mg chlorate/kg 
b.w. when assuming a b.w. of 70 kg) in an attempted suicide, toxicity was reported (Mutlu et al., 
2003). The patient had decreased level of consciousness when he was brought in 24 hours after 
ingestion, and had increased blood potassium (21 mM/L), urea (21 mM/L) aspartate aminotransferase 
(58 U/L), creatine kinase (209 U/L) and low bicarbonate (4 mM/L). Methaemoglobinaemia was not 
reported. The patient underwent gastric lavage, haemodialysis and hyperbarbic oxygen treatment and 
recovered within a week.  
Matchstick head consumption has also been reported as ‘an old army trick’ against insect bites. 
Ingestion of one pack of matchsticks every 4 days during field training, corresponding to 
approximately 45 mg potassium chlorate every 4 days (equivalent to 437 µg/kg b.w. chlorate 
assuming a b.w. of 70 kg), was apparently without short term toxic symptoms (Thurlow et al., 2013).   
3.3.3.2. Controlled clinical trials 
In a controlled clinical evaluation (Lubbers et al., 1981), 10 healthy male volunteers participated in an 
acute rising-dose tolerance study (Study I). They drank one litre (0.5 L consumed within 15 minutes 
and administered twice with 4-hour intervals) of water containing increasing chlorate concentrations 
(0.01, 0.1, 0.5, 1.0, 1.8 and 2.4 mg/L) every 3rd day for 16 days. A control group consisted of 
10 volunteers. Several biochemical parameters, grouped into serum chemistry, blood count, urinalysis, 
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special tests and physical exam, were assayed every third day. In a separate study (Study II), 
10 healthy male volunteers received 2.5 mg chlorate per day administered in 0.5 L water for 12 weeks 
(corresponding to 36 µg chlorate/kg b.w. per day assuming a b.w. of 70 kg). Physical examination and 
collection of blood and urine was conducted weekly during the treatment period and in an 8-week 
follow-up period. According to the authors, no clinically important impact was observed. Some 
changes in total bilirubin, iron and methaemoglobin was seen in Study I, whereas a trend of change in 
urea nitrogen was seen in Study II (relative slope was per week 1 % of the normal physiological 
range). The authors concluded that no physiological importance may be attributed with confidence to 
the observations. The no-observed-effect level (NOEL) in the study was the highest dose tested, 
approximately 36 µg chlorate/kg b.w. per day.  
3.3.3.3. Epidemiological studies 
Several epidemiological studies have addressed possible associations between exposures to 
chlorination disinfection by-products (DBPs) and different health outcomes. The formation and 
occurrence of DBPs is dependent on many variables. Epidemiological results from one study area may 
not be extended to others because the mixtures of DBPs present in water may be different as a result of 
differences in for instance water treatment, organic content in water or pH (Nieuwenhuijsen et al., 
2009). In several epidemiological studies the type of water disinfection method has been used as a 
surrogate for chlorite and chlorate exposure. However, only studies with information on chlorate 
levels in water have been summarized below. 
A case-control study was performed in nine Italian towns (Genoa, Udine, Modena, Parma, Siena, 
Rome, L’Aquila, Naples, Catania) in 1999-2000, addressing chlorination by-products in drinking 
water and adverse pregnancy outcomes (n = 1 194, 343 preterm births, 239 small for gestational age at 
term, 612 controls) (Aggazzotti et al., 2004). Water was sampled at the mothers’ home and they filled 
in a questionnaire addressing personal habits including use of tap water, swimming pool attendance, 
shower and bath habits. Median water chlorate concentration was 76.5 µg/L (range 20–1 500) in the 
samples above the LOD (34 %). No associations were found with concentration of chlorate in water 
and adverse pregnancy outcomes.  
Righi et al. (2012) studied associations between exposure to disinfection by-products (including 
chlorate) during first trimester of pregnancy and congenital anomalies in the period 2002-2005 in a 
case-control study in Emilia-Romagna, Italy. Data on 1 917 congenital anomalies were extracted from 
the regional malformation registry. For each case, four controls matched by pregnancy period were 
randomly selected from the regional birth register. The network supplying water was linked to 
maternal address, and they used historical tap water data provided by local authorities. The chlorate 
concentration in water was 283 ± 79 µg/L. Maternal exposure to chlorate at concentrations of 
> 200 µg/L in drinking water appeared to be associated with obstructive urinary defects (odds ratio 
(OR) 2.88, 95th percentile, confidence interval (CI) 1.09–7.63), cleft palate (OR 9.60, 95th percentile, 
CI 1.04–88.9) and spina bifida (OR 4.94, 95th percentile, CI 1.10–22.0) in newborns. There was no 
information on factors such as e.g. maternal diet, alcohol and coffee consumption, smoking habits, tap 
water consumption, swimming pool attendance, shower and bath habits. Furthermore, the number of 
cases for each outcome was small (n = 13–36) and the authors concluded that the results need 
confirmation in other studies.  
3.3.3.4. Biomarkers  
The CONTAM Panel has not identified studies on biomarkers for chlorate in humans. 
3.3.4. Mode of action  
Most of the potential acute adverse health effects of exposure towards NaClO3 are associated with 
blood oxidation. The primary mechanism of chlorate toxicity is rupture of the red blood cell 
membranes with intravascular haemolysis. Steffen and Wetzel (1993) proposed that subsequent to 
initial formation of methaemoglobin, chlorate inactivates glucose-6-phosphate dehydrogenase and 
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glyceraldehyde phosphate dehydrogenase and thus interrupts the capacity of the erythrocyte to 
generate nicotinamid adenine dinucleotide phosphate (NADPH), which is also a cofactor required for 
methaemoglobin reductase. Without cellular NADPH a cascade of protein denaturation and a 
crosslinking of erythrocyte membrane proteins occurs, finally resulting in erythrocyte haemolysis. 
Chlorate-induced methaemoglobin formation is most likely caused by an autocatalytic reaction and 
thus depends on the initial methaemoglobin concentration (Steffen and Wetzel, 1993). Jung (1965) 
describes it as the rapid formation of a Hb
3+
-ClO3 complex that decomposes to methaemoglobin, 
chloride and oxygen radicals. Methaemoglobin formation also depends on the availability of other 
oxidisable substrates, such as glutathione (GSH) that could protect haemoglobin from oxidation (Allen 
and Jandl, 1961). Erythrocytes deficient in glucose-6-phosphate-dehydrogenase have low GSH levels 
due to the outward transport of oxidised glutathione (GSSG) and are therefore quite sensitive towards 
chlorate (Srivasta and Beutler, 1969). The formation of methaemoglobin is followed by its 
denaturation, a cross-linking of erythrocyte membrane proteins and an inactivation of membrane 
enzymes.  
The mechanisms causing renal failure await further clarification. Early studies considered chlorate 
induced renal effects as secondary to haemolysis and acidosis (Bing, 1943, 1944) but postulated also 
direct toxic effects of chlorate on the nephron (Oliver et al., 1951; Jackson et al., 1961). A more recent 
study provided evidence that a direct oxidative attack on the tubular epithelium is likely to be of minor 
importance. To separate indirect and direct effects of chlorate on the kidney Steffen and Wetzel (1993) 
used rabbits which are known to have a high methaemoglobin reduction capacity and thus the animals 
did not develop methaemoglobinaemia after intragastral administration of 1 g/kg b.w. sodium chlorate 
(equivalent to 0.78 g chlorate/kg b.w.). In spite of quite high serum (up to 16 ± 4.3 mM) and urine 
(246 ± 99 nM) chlorate concentrations, no changes in serum values of urea, creatinine, aspartate and 
alanine aminotransferase during the 7-day observation period were observed. The histopathological 
examination of the kidneys showed no pathological findings. The authors therefore concluded that it 
seems probable that methaemoglobinaemia is required for chlorate to exert a nephrotoxic effect. 
Chlorate is chemically similar to perchlorate, which is a well-known thyroid gland toxicant and 
chemical oxidant. Chlorate inhibits the active transport of iodine from the blood to the follicular cells 
of the thyroid via the sodium iodine symporter (NIS). This can result in decreased serum thyroid 
hormones, increased release of TSH and consequent stimulation of thyroid cell proliferation and 
thyroid gland growth (ATSDR, 2008). It is unlikely that chlorate induces thyroid gland follicular cell 
tumours through a direct genotoxic mode of action (see Section 3.3.4). Nevertheless, chlorate might 
cause oxidative damage.  
The pituitary-thyroid system is qualitatively similar in rats and humans in that the HPT feedback 
pathway maintains homeostasis in both species, however the dynamics of the system in both species 
differ substantially (NRC, 2005; FAO/WHO, 2011; Fisher et al., 2012).  
There are differences in the binding proteins for the thyroid hormones T3 and T4 between rats and 
humans. In humans the principal binding protein for T4 is thyroxine-binding globulin (TBG), 
however, in rats, T4 mainly binds to albumin and transthyretin. The rat binding proteins have a 100-
times lower binding affinity, than TBG in humans, which contributes to a higher clearance rate of T4 
in rats, causing a higher production of T4 in order to maintain normal T4 concentrations. The plasma 
half-life of T4 in rats is 12–24 hours compared with 5–9 days in humans (NRC, 2005). The higher T4 
production in rats is reflected in a more functionally active histological appearance of the rat thyroid. 
Follicular epithelium in rats is cuboidal, compared with a more flattened appearance in primates 
(NRC, 2005). 
Rats are thus considered to be highly sensitive to the effects of agents that disrupt thyroid hormone 
homeostasis. Humans are likely to be less sensitive than rats to these effects. 
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In in vitro studies comparative potency of different ions to inhibit thyroid uptake has been 
investigated. Van Sande et al. (2003) measured the uptake of 
125
I
-
 in FRTL5 cells (expressing rat NIS) 
and in COS NIS-6 cells (expressing human NIS) and studied the inhibition of the transport of 
125
I
-
 by 
competing anions e.g. ClO4
-
, ClO3
-
 and I
-
. They showed that the order of inhibitory potency, reflecting 
the affinity of the transporter was ClO4- > I
-
 > ClO3
-
. The IC50 on relative uptake (concentration that 
reduce the relative uptake of 
125
I used to half of its maximal value) of 
125
I- was 0.62 and 1 368, 
respectively in FTRL5 cells and 0.43 and 131, respectively in COS NIS-6 cells for perchlorate and 
chlorate. These cells exhibit similar transport properties as thyroid cells in slices. Di Bernardo et al. 
(2011) studied in vitro a yellow fluorescent protein variant, YFP–H148Q/I152L, as a biosensor to 
monitor the cellular uptake of NIS substrates like chlorate and perchlorate. Exposure of FRTL-5 cells 
with stable YFP–H148Q/I152L expression to extracellular anions like ClO3
-
 and ClO4
-
 resulted in a 
time- and concentration-dependent decrease in cellular fluorescence. The affinity of perchlorate for 
uptake was much higher than that of chlorate. 
These investigations also suggest a lesser inhibitory potency of chlorate as compared to perchlorate. 
3.4. Consideration of critical effects, dose response assessment and derivation of health-
based guidance values  
Following oral exposure, chlorate is rapidly absorbed, widely distributed throughout the body and 
evidence indicates that it undergoes metabolism to chloride. The main pathway of elimination is via 
urine. 
As described in the previous sections, the thyroid gland and the erythrocytes are the primary target 
organs of toxicity of chlorate identified in animal species. In repeated toxicity studies in mice, rats, 
dogs and monkeys, decreases in number of erythrocytes and haemoglobin and haematocrit levels were 
observed. Signs of accelerated erythrocytes degradation, such as spleen weight increase or signs of 
haematopoiesis in spleen or bone marrow hyperplasia were also seen after long-term exposure. The 
most sensitive toxicological effects consisted of histopathological changes in the thyroid gland (e.g. 
colloid depletion, follicular cell hypertrophy and hyperplasia) and in thyroid hormones in rats. Male 
rats were more sensitive than females. Based on the negative in vivo genotoxicity data and the nature 
of the histopathological observations, the CONTAM Panel concluded that a non-genotoxic mode of 
action was likely for the induction of thyroid tumours in rats by sodium chlorate. Sodium chlorate is of 
minimal toxicity toward reproduction in rats and not toxic toward development in rats or rabbits. No 
indication for neurotoxic effects of sodium chlorate has been seen in repeated dose studies.  
In comparison with rats, healthy adult humans have lower thyroid hormone turnover rates and larger 
reserves of iodinated thyroglobulin, allowing them to compensate for reduced hormone synthesis in 
the thyroid. Due to these differences in thyroid hormone physiology, the data from toxicological 
studies in rats are of limited relevance for humans.  
Like perchlorate, the chlorate anion is a competitive inhibitor of iodine uptake into the thyroid. 
(Goodman et al., 1980). Iodine uptake in the thyroid is a key step in the synthesis of thyroid hormones 
and its inhibition may result in the disruption of the thyroid hormone synthesis leading eventually to 
the development of hypothyroid symptoms. 
Chronic adaptive changes to compensate for a sustained inhibition of thyroid iodine uptake can lead to 
long term effects such as the development of multinodular toxic goitre, in particular in populations 
with mild to moderate iodine deficiency. Human fetuses, neonates and individuals with low iodine 
intake or genetically predisposed to develop hypothyroidism are potentially more susceptible to the 
effects of exposure to chlorate. 
Potential acute effects for fetuses in the late gestation period and for infants may therefore be 
postulated like in the case of perchlorate. However, no data are available to support this hypothesis. 
These life stages are identified as being particularly sensitive to inhibition of thyroid iodine uptake, 
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because they do not have the reserve capacity existing in adult humans (Zoeller, 2003; Scinicariello et 
al., 2005; Ginsberg et al., 2007).  
Thyroid hormones play a key role in foetal and neonatal neurological development (Zoeller et al., 
2002; Morreale de Escobar et al., 2004), and thus a transient fall in the thyroid hormone levels, as 
result of acute exposure to chlorate, could result in an adverse neurodevelopmental effect. With regard 
to the fetus, the limitations in the reserve capacity are mitigated by the maternal supply of thyroidal 
hormones. On the other hand, neonates can rely only on their hormone synthesis and thus could be 
considered as the more vulnerable population (Clewell et al., 2003; Ginsberg et al., 2007).  
In the previous assessment of perchlorate (EFSA, CONTAM Panel 2014) it was concluded that a 
complete thyroid iodine uptake inhibition for one day only would not result in a severe depletion of 
the thyroid iodine depot even in the more vulnerable population. By similarity with perchlorate, the 
CONTAM Panel noted that a single acute exposure to chlorate at levels found in food and water is 
unlikely to cause adverse effects on thyroid function, including the more vulnerable groups of the 
population. Therefore, the CONTAM Panel concluded that the establishment of an ARfD is not 
warranted based on the thyroid toxicity of chlorate. 
The information on the toxic effects of chlorate in humans comes from reports on cases of poisoning 
after oral intake. Sodium chlorate typically induces local irritation of the gastrointestinal mucous 
membranes in humans after acute exposure, which has not been reported in studies with laboratory 
rodents performed with comparable doses. Such an effect has also been observed in several animal 
species such as horses, sheep, chickens and dogs after ingestion. However, the main toxic effect in 
humans is methaemoglobin formation, and its subsequent consequences including haemolysis and 
haemoglobinuria with subsequent renal failure (acute renal tubular necrosis). Rodent species appear to 
be poorly relevant for quantification of the toxicity level of sodium chlorate.  
In humans, the acute oral toxicity of chlorate is high. US EPA (2006) reports that lethal poisonings 
occur at a dose of ca. 7.5 g or ca. 110 mg/kg b.w. or higher (US EPA, 2006). According to NRC 
(1980) ‘the lethal dose in adults is estimated to be 20 to 35 g for sodium chlorate and 5 to 30 g for 
potassium chlorate’. Based on these estimates, the lowest oral lethal dose for chlorate would be 
approximately 50 mg chlorate/kg b.w. when a body weight of 70 kg is assumed. In rats, however, 
chlorate shows only a slight acute oral toxicity (LD50 ≥ 3 861 mg/kg b.w.).  
In controlled clinical studies with adult volunteers, oral chlorate doses up to 34 µg/kg b.w. 
administered for 3 days or doses up to 36 µg/kg b.w. per day administered for 12 weeks were tolerated 
without any harmful effects (Lubbers et al., 1981). Bloxham et al. (1979) described a 29-year-old man 
who had ingested about 20 g sodium chlorate (equivalent to 230 mg chlorate/kg b.w.) who became 
cyanotic, had a severe drop in haemoglobin, and methaemoglobin and methaemoalbumin were 
detected in his plasma. A case of severe sodium chlorate poisoning was also observed within 5 hours 
after suicidal ingestion of 150–200 g sodium chlorate (117–156 mg chlorate/kg b.w.). 
Methaemoglobinaemia was the early symptom of the intoxication. Helliwell and Nunn (1979) reported 
14 cases of sodium chlorate poisoning, with ingested amounts (1–2 g to 300 g) known in 12 of the 
cases. The patient who had ingested the lowest amount (1–2 g, which corresponds to 11–23 mg 
chlorate/kg b.w.) survived. Methaemoglobinaemia was seen in 13 of the 14 patients. It is not indicated 
which patient did not have methaemoglobinaemia, but the CONTAM Panel assumes that this was the 
patient with the lowest dose ingested.  
Based on the acute hematological and renal toxicity of chlorate in humans, the CONTAM Panel 
considers that it is necessary to establish an ARfD. 
3.4.1. Derivation of a chronic health-based guidance value 
There are no in vivo human studies on the inhibition of iodine uptake by chlorate. However, 
perchlorate has a similar mode of action, and there are several observations in humans, including 
clinical studies and case reports from the medicinal use of perchlorate, volunteer studies and both 
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occupational and ecological epidemiological studies on the effects of exposure to perchlorate (EFSA 
CONTAM Panel, 2014). Both JECFA (FAO/WHO, 2011) and EFSA CONTAM Panel (2014) based 
the hazard characterization of perchlorate on the available human data and selected the human 
volunteer study of Greer et al. (2002) as the pivotal study for the dose-response assessment. They both 
considered the inhibition of thyroid iodine uptake as the critical effect for the dose-response 
assessment. The CONTAM Panel established a TDI of 0.3 µg/kg b.w. per day for perchlorate on basis 
of the reference point (RP) of 0.0012 mg/kg b.w. per day, based on a BMDL05 for thyroid iodine 
uptake inhibition and applying an overall uncertainty factor of 4 to the RP (EFSA CONTAM Panel, 
2014). 
As it was shown in the EFSA perchlorate opinion (2014), the available data indicate that a substantial 
part of the EU population, including children and pregnant and lactating women, is subject to a mild to 
moderate deficiency in iodine intake, and therefore may be more sensitive to goitrogenic effects of 
chlorate in comparison to population groups with an adequate iodine intake. The CONTAM Panel 
considered that a 5 % inhibition of iodine uptake would not lead to adverse effects in any subgroup of 
the population, and therefore no additional uncertainty factor was considered for intraspecies 
differences in toxicodynamics.  
In order to establish a chronic health based guidance value for chlorate, and as the toxicity of chlorate 
and perchlorate are both related to the inhibition of iodine uptake, the CONTAM Panel decided to use 
the TDI established for perchlorate and to apply an extrapolation factor for the difference in potency 
between chlorate and perchlorate. When comparing the NOAEL and LOAEL for thyroid follicular cell 
hypertrophy in rats, perchlorate is about 10 times more potent than chlorate (see Appendix B).  
In addition in vitro studies comparing the inhibition of thyroid iodine transport by chlorate and 
perchlorate showed that perchlorate is a more potent inhibitor than chlorate.   
On this basis, the CONTAM Panel established a TDI for chlorate of 3 µg/kg b.w. per day, based on 
the TDI established for perchlorate (0.3 µg/kg b.w. per day) and by multiplying by a factor of 10 for 
the difference in potency between the two substances. 
3.4.2. Derivation of an acute reference dose 
As explained previously, formation of methaemoglobin is the critical acute toxic effect which was 
identified in cases of poisoning. Infants (and presumably the fetus) are much more sensitive than 
adults to intracellular methaemoglobin inducers. This is due to a relative deficiency in 
methaemoglobin reductase in red blood cells of newborns, because the foetal form of haemoglobin is 
more sensitive to reducing agents, and because the fetus has a greater oxygen demand. A large 
proportion of haemoglobin in neonates and infants is in the form of foetal haemoglobin, which is more 
readily oxidized to methaemoglobin than adult haemoglobin (Steinberg and Benz, 1991; Mensinga et 
al., 2003; Sadeq et al., 2008). Also the gastric environment in infants is more alkaline than in adults, 
providing optimal conditions for growth of bacteria that promotes methaemoglobin formation and 
gastroenteritis with vomiting and diarrhoea, which is more common in infants than adults, enhances 
conditions for methaemoglobinaemia formation (ECETOC, 1988; Wright et al., 1999). However, it is 
not clear whether the newborn or the fetus may be more sensitive to the haemolytic effect of chlorate 
than adults. The extracellular autooxidative formation of methaemoglobin from lysed cells is 
irreversible and complete in both adults and fetuses, so there would be no difference in sensitivity in 
this step.  
Persons with pre-existing blood conditions, especially anaemia, or those with kidney diseases, might 
be more sensitive. Persons with genetic diseases such as hereditary methaemoglobinaemia and 
glucose-6-phosphate dehydrogenase deficiency (which increases the haemolytic susceptibility of 
humans to oxidizing agents), and other persons who may be unusually susceptible to oxidants may 
also be at greater risk than the general population.   
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The only controlled clinical study available is the study of Lubbers et al. (1981) who considered the 
impact on normal subjects (10/group) of daily ingestion of 500 mL water containing 5 mg/L sodium 
chlorate (equivalent to 36 µg chlorate/kg b.w. per day) for 12 consecutive weeks. The subjects were 
followed for 8 weeks following cessation of treatment. A control group received untreated water. An 
extensive battery of parameters was monitored to assess the biochemical and physiological response to 
the oral ingestion of sodium chlorate. No adverse physiological effects were identified. The NOEL 
was 36 µg chlorate/kg b.w. per day. 
The CONTAM Panel considers that this study can be the basis for the establishment of an ARfD. 
Lethal poisonings have been reported to occur at doses of approximately 50 mg chlorate/kg b.w. The 
NOEL from the controlled clinical study (Lubbers et al., 1981) is about 1 400-fold lower than the 
lowest lethal dose. Furthermore, it is at least 300 fold lower than the toxic level in a poisoning case 
(11–23 mg chlorate/kg b.w.) where induction of methaemoglobinaemia was not reported. Taking into 
account also that the NOEL was the highest dose tested in a study with administration daily for 
12 weeks, the CONTAM Panel concluded that these differences are sufficiently large that no 
uncertainty factor is required for more vulnerable individuals (e.g. glucose-6-phosphate 
dehydrogenase-deficient individuals or hereditary methaemoglobinaemia) and establishes an ARfD of 
36 µg chlorate/kg b.w. 
3.5. Risk characterisation  
Mean and high chronic and acute dietary exposure levels to chlorate were based on the occurrence 
dataset obtained after an ad hoc call for data on chlorate levels in food and drinking water. 
3.5.1. Risk characterisation based on current occurrence data 
3.5.1.1. Chronic 
The chronic effects of chlorate are mediated by its activity as a competitive inhibitor of iodine uptake 
via the NIS in the thyroid. Hence, the adverse effects of chlorate have to be considered in conjunction 
with the iodine status of the exposed population. The CONTAM Panel noted that a sustained and 
marked inhibition of thyroid iodine uptake could lead to the development of toxic multinodular goitre 
as a result of thyroid autoregulation to overcome the lower iodine bioavailability. This chronic effect is 
particularly relevant for populations with mild to moderate iodine intake. For this chronic effect of 
chlorate, the CONTAM Panel established a TDI of 3 μg/kg b.w. per day.  
The mean and 95th percentile chronic exposure estimates for ‘Adolescents’, ‘Adults’, ‘Elderly’, ‘Very 
elderly’, ‘Pregnant women’ and ‘Lactating women’ do not exceed the TDI.  
In ‘Infants’, the age group with the highest exposure estimates, the levels for mean and 95th percentile 
chronic dietary exposure ranged from 1.6 to 4.1 µg/kg b.w. per day and from 3.3 to 6.6 µg/kg b.w. per 
day (minimum LB–maximum UB across different dietary surveys), respectively. In ‘Toddlers’, mean 
exposure levels in the range 2.1–3.5 µg/kg b.w. per day and 95th percentile exposure levels in the 
range 3.2–5.4 µg/kg b.w. per day were calculated.  
In these younger populations (‘Infants’ and ‘Toddlers’), the TDI was exceeded at the 95th percentile in 
all surveys and in some surveys for the mean exposure estimates. 
At the 95th percentile at median and maximum UB, the TDI was also exceeded in the group ‘Other 
children’. The  95th exposure levels were in the range of 2.5–5 µg/kg b.w. per day (minimum LB – 
maximum UB across different dietary surveys).  
In all these populations groups where estimates are exceeding the TDI, the Panel noted that the main 
contributing food source is drinking water at up to 60 % in ‘Infants’, up to 50 % in ‘Toddlers’ and up 
to 40 % in ‘Other children’. 
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Overall, the CONTAM Panel concluded that the chronic dietary exposure to chlorate is of potential 
concern in particular for the high consumers in the younger age groups of the population with mild to 
moderate iodine deficiency. Fetuses, neonates, and individuals with low iodine intake or genetically 
predisposed to develop hypothyroidism are likely to be more sensitive to the effects of exposure to 
chlorate. Individuals who have sufficient iodine intake are less likely to develop adverse effects at 
such exceedances of the TDI. The effects of chlorate could be exacerbated by concurrent exposure to 
other substances that also act as antithyroid substances (e.g. perchlorate, thiocyanate and nitrate, 
among others). 
3.5.1.2. Acute 
By similarity with perchlorate, the CONTAM Panel noted that a single acute exposure to chlorate at 
levels found in food and water is unlikely to cause adverse effects on thyroid function, including the 
more vulnerable groups of the population. Even a one-day complete thyroid iodine uptake inhibition 
would not deplete the thyroid iodine content in infants with mild to moderate iodine deficiency, and 
therefore, the CONTAM Panel concluded that the establishment of an ARfD is not warranted based on 
the thyroid toxicity of chlorate. 
Because of the acute haematological and renal toxicity of chlorate in humans the CONTAM Panel  
derived an ARfD of 36 µg/kg b.w. The CONTAM Panel considered that this ARfD covered also the 
more vulnerable individuals (e.g. Glucose-6-phosphate dehydrogenase deficient indivuduals or 
hereditary methaemoglobinaemia). 
The mean and 95th percentile acute exposure estimates for all age groups are below the ARfD. In 
‘Infants’, the age group with the highest exposure estimates, the levels for 95th percentile acute dietary 
exposure ranged from 13.9–30.9 µg/kg b.w. per day (minimum to maximum UB).  
3.5.2. Risk characterization based on a hypothetical maximum residue level of 0.7 mg/kg 
3.5.2.1 Chronic 
For chronic exposures based on the current occurrence data, removing foods and drinking water 
containing more than 0.7 mg/kg chlorate from the data set would have a minimal impact and 
consequently on the risk characterisation since most of the occurrence levels in food commodities are 
substantially below 0.7 mg/kg. Thus mean and 95th percentile chronic exposure estimates for 
‘Adolescents’, ‘Adults’, ‘Elderly’, ‘Very elderly’, ‘Pregnant women’ and ‘Lactating women’ would 
not exceed the TDI. In ‘Infants’ and ‘Toddlers’, the TDI would be exceeded at mean exposures and in 
addition at 95th percentile also in ‘Other children’.  
It should be emphasised that the mean occurrence data set applies to current practice in the food 
industry under which the occurrence is, in general, substantially lower than 0.7 mg/kg. It cannot be 
predicted whether application of a MRL of 0.7 mg/kg would result in different practices leading to 
higher residue levels and higher exposures to chlorate.  
3.5.2.2. Acute 
For acute exposure based on the current occurrence data removing foods containing more than 
0.7 mg/kg chlorate from the data set would also have a minimal impact on the exposure. The level for 
average and 95
th
 percentile acute dietary exposure would all remain below the ARfD. 
3.5.3.  Risk characterization assuming an occurrence value of 0.7 mg/kg in all commodities 
Assuming an occurrence value of 0.7 mg/kg for all foods covered by Annex I of Regulation 396/2005 
and drinking water, acute exposure would increase by up to five-fold, primarily due to drinking water 
and cow’s milk. The ARfD would be exceeded at mean exposure in ‘Infants’, and at the 95th 
percentile also in ‘Toddlers’, ‘Other children’ and ‘Adults’. However, although an individual food 
commodity could contain chlorate at the hypothetical MRL of 0.7 mg/kg on some eating occasions, it 
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is implausible that all foods consumed on a single day would contain chlorate at 0.7 mg/kg and 
therefore such exceedances of the ARfD are unlikely. A potential exception would be drinking water 
which by itself contributes to a large extent to the intake of chlorate. 
When considering food commodities one by one, mean acute chlorate exposure did not exceed the 
ARfD from any food item, with the exception of drinking water. The scenario indicated that if the 
chlorate concentration in drinking water would be 0.7 mg/kg, the exposure to chlorate could be similar 
to the ARfD at mean water consumption and up to 3-fold the ARfD at high (95th percentile) water 
consumption.  
3.6. Uncertainty analysis 
The evaluation of the inherent uncertainties in the assessment of exposure to chlorate in food and 
drinking water has been performed following the guidance of the Opinion of the Scientific Committee 
related to Uncertainties in Dietary Exposure Assessment (EFSA, 2006b). In addition, the report on 
‘Characterizing and Communicating Uncertainty in Exposure Assessment’ has been considered 
(WHO/IPCS, 2008). According to the guidance provided by the EFSA opinion (2006b), the following 
sources of uncertainties have been considered: assessment objectives, exposure scenario, exposure 
model, and model input (parameters).  
3.6.1. Assessment objectives 
The objectives of the assessment were clearly specified in the terms of reference. 
3.6.2. Exposure scenario/Exposure model 
A total of 8 028 samples of which about 5 % were drinking water samples were available to estimate 
dietary exposure to chlorate. In total, 19 different European countries were reported as sampling 
country, with most of the analytical data derived from samples collected in Germany (4 839 samples); 
therefore, most probably, the dataset is not fully representative for food on the EU market. This lack of 
representativeness also affects the samples of ‘Drinking water’, which were mostly collected in one 
single country. The use of different disinfectants for drinking water disinfection across Europe could 
lead to very different levels of chlorate depending on the country or region of origin of the samples. 
No or very limited occurrence data on some food commodities such as non-alcoholic beverages (e.g. 
coffee or tea), infant/follow-on formula and beer were submitted to EFSA. Likewise, some available 
data on specific commodities such as yoghurt, meat, fish and eggs and eggs based products were not 
considered sufficiently robust to be included in the final dataset used for exposure estimation. A 
particular uncertainty arises from the indication that high levels of chlorate might be present in 
yoghurt and infant/follow-on formula.  
3.6.3. Other uncertainties 
The CONTAM Panel established a TDI of 3 µg/kg b.w. per day extrapolated from a TDI of 0.3 µg/kg 
b.w. per day derived for perchlorate (EFSA CONTAM Panel, 2014). The TDI for perchlorate was 
based on the lowest BMDL05 calculated for the thyroid iodine uptake inhibition measured in a human 
volunteer study. The CONTAM Panel concluded, based on the overall weight of evidence, that this 
effect was also the most relevant chronic effect caused by uptake of chlorate. However, since no 
human studies on inhibition of iodine uptake for chlorate exist, this conclusion adds to the overall 
uncertainty.  
In addition, all uncertainties incurred with derivation of the TDI for perchlorate and described in the 
respective opinion (EFSA CONTAM Panel, 2014) also apply for the TDI derived for chlorate and are 
described in the opinion on perchlorate.  
Based on a comparative analysis of dose levels of perchlorate and chlorate respectively inducing 
hypertrophy in the thyroid gland in subacute and subchronic rat studies supported by in vitro studies 
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suggesting a more pronounced inhibition of iodine transport of perchlorate as compared to chlorate, 
the CONTAM Panel concluded that perchlorate is about 10 times more potent than chlorate with 
respect to this effect. Different rat strains have been used for the tests with the two compounds and 
there is further uncertainty in the extrapolation of the potency difference in rats to humans and 
between endpoints (induction of thyroid hypertrophy in rats versus iodine uptake inhibition in 
humans). The in vitro studies were designed to elucidate mechanistic effects and potential differences 
in toxicokinetics and toxicodynamics of the two compounds are not reflected in their results. All these 
limitations add substantially to the overall uncertainty. 
The effects of chlorate could be exacerbated by concurrent exposure to other substances that also act 
as antithyroid substances (e.g. perchlorate, thiocyanate and nitrate, among others). 
An ARfD was set on the basis of a NOEL of 36 µg chlorate/kg b.w. per day in a human repeat dose 
study with a small number of male healthy volunteers. The NOEL was the highest dose tested and 
there is uncertainty about how much higher a LOAEL would be. An uncertainty factor was not applied 
since the NOEL from the controlled clinical study is at least 300-fold lower than the toxic level in a 
poisoning case where induction of methaemoglobinaemia was not reported However, this difference 
of 300 was derived from a single poisoning case. This adds to the overall uncertainty. 
3.6.4. Summary of uncertainties  
In Table 16, a summary of the uncertainty evaluation for chlorate is presented highlighting the main 
sources of uncertainty and indicating an estimate of whether the respective source of uncertainty might 
have led to an over- or underestimation of the exposure or the resulting risk. 
Table 16:  Summary of qualitative evaluation of the impact of uncertainties on the risk assessment of 
the dietary exposure to chlorate 
Sources of uncertainty Direction
(a)
  
Lack of representativeness of occurrence data for whole Europe, including ‘Drinking water’ +/– 
Missing occurrence data on particular food commodities  - 
Imputation of occurrence data for drinking water to beer, tea and coffee +/– 
All uncertainties incurred with derivation of tolerable daily intake for perchlorate as used as a 
basis for chlorate TDI 
+/– 
Use of different rat strains and induction of thyroid hypertrophy as endpoint for derivation of 
differential potency factor for inhibition of iodine uptake in humans 
+/– 
Use of a NOEL from a human repeat dose study  in the absence of any established effect level 
for derivation of ARfD 
+ 
Small number of volunteers (healthy males) in study used for derivation of ARfD – 
Use of a 12 week human study to set an ARfD + 
Effect dose in humans derived based on one poisoning case +/– 
The effects of chlorate could be exacerbated by concurrent exposure to other substances that 
also act as antithyroid substances (e.g. perchlorate, thiocyanate and nitrate, among others). 
– 
ARfD: acute reference dose; NOEL: no-observed-effect level; TDI: tolerable daily intake. 
(a):  +: uncertainty with potential to cause over-estimation of exposure/risk; –: uncertainty with potential to cause under-
estimation of exposure/risk. 
 
Overall, the CONTAM Panel concluded that the impact of the uncertainties on the risk assessment is 
large. 
4. Conclusions 
General 
 Chlorate is formed as a by-product when using chlorine, chlorine dioxide or hypochlorite for 
the disinfection of drinking water or water for food production. 
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 In processed food two routes of exposure are conceivable for chlorate residues, the 
disinfection of surfaces and food processing equipment, and the use of chlorinated water for 
washing and other food processing steps. 
 For the washing, blanching and cooling of vegetables, a closed water circuit is applied. Here 
the re-circulating water is repeatedly chlorinated to keep its microbial quality within safe 
limits and thus chlorate concentrates in the processing water. This might explain the high 
chlorate levels in frozen vegetables. 
 In foods of plant origin chlorate is frequently analysed after extraction with methanol by liquid 
chromatography-tandem mass spectrometry (LC-MS/MS) detection.  
 In complex matrices of animal origin, liquid chromatography-mass spectrometry (LC-MS) 
utilising a Cl
18
O3
-
 internal standard has been demonstrated to be applicable to quantify 
chlorate at low levels. 
Occurrence data 
 After a quality assessment of the analytical data and their evaluation, a total of 8 028 samples 
of which about 5 % were drinking water samples were available to estimate dietary exposure 
to chlorate.  
 In total, 19 different European countries were reported as sampling country, with most of the 
analytical data derived from samples collected in Germany (4 839 samples).  The samples 
were mainly collected between 2011 and 2014.  
 The left-censored data (analytical data below the limit of detection/limit of quantification 
(LOD/LOQ)) accounted for 71 % of the analytical results on chlorate. The largest difference 
between lower bound (LB) and upper bound (UB) concentrations was for drinking water, at 
around 26 %.  
 The most represented food groups were ‘Vegetable and vegetable products’ (n = 3 756), 
followed by ‘Fruit and fruit products’ (n = 2 607). The highest mean concentrations were 
observed for ‘Chilli pepper’ (lower bound, LB = 164 µg/kg, upper bound, UB = 169 µg/kg), 
‘Aubergines’ (LB = 157 µg/kg, UB = 164 µg/kg,) and ‘Vegetable and vegetable products, 
unspecified’ (LB = 216 µg/kg, UB = 222 µg/kg).  
 A total of 453 samples of ‘Drinking water’ were available, most of them reported as 
unspecified. Mean chlorate values for ‘Drinking water’ were 28 µg/L and 39 µg/L at the 
LB/UB scenarios, respectively. The 99th percentile at the UB scenario used to estimate acute 
exposure was 196 µg/L.  
 Overall, food commodities reported as ‘frozen’ showed the highest levels of chlorate within 
one particular food group. However, in many samples reported as ‘frozen’ the chlorate levels 
were below the limit of quantification, indicating that chlorate levels may depend on how 
processing is done in the food industry (levels of chlorine in water and rinsing) 
 There were indications that high levels of chlorate might be present in yoghurt and 
infant/follow-on formula but the data were insufficient for exposure assessment.  
Exposure assessment 
 The youngest population groups (‘Infants’, ‘Toddlers’ and ‘Other children’) showed the 
highest dietary exposure to chlorate. 
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 The CONTAM Panel concluded that a variability factor accounting for residue variation 
within composite samples of food commodities for acute exposure assessment of chlorate is 
not needed, mainly since the unit weight in frozen vegetables is small. Additionally, chlorate 
residues are highly soluble and an even distribution in processing water is expected.  
 Considering all available occurrence data, the mean chronic dietary exposure ranged between 
0.5 µg/kg body weight (b.w.) per day in ‘Adolescents’ (LB) and 4.1 µg/kg b.w. per day in 
’Infants’ (UB). At the 95th percentile, the lowest dietary exposure of 1.0 µg/kg b.w. day (LB) 
was estimated in the age classes ‘Elderly’ and ‘Very elderly’. The highest 95th percentile 
exposure was in ‘Infants’ (6.6 µg/kg b.w. per day, UB).  
 The estimates of chronic dietary exposure to chlorate in the available dietary survey on 
‘Pregnant women’ and the one on ‘Lactating women’ are similar or lower than those 
calculated in the general population.  
 Overall, in all age classes and vulnerable groups of population (pregnant and lactating women) 
the main average contributor to the chronic dietary exposure to chlorate was ‘Drinking water’. 
Range of contribution at the LB estimation: ‘Infants’ (25–58 %), ‘Toddlers’ (12–48 %), 
‘Other children’ (0–38 %), ‘Adolescents’ (0–38 %), ‘Adults’ (6.2–48 %), ‘Elderly’ (8.1–
35 %), ‘Very elderly’ (5.5–39 %). 
 Considering all available occurrence data, mean acute exposure (UB) ranged between 
1.0 µg/kg b.w. day in ‘Adolescents’ and 13 µg/kg b.w. day in ‘Infants’. At the 95th percentile, 
the estimates of acute exposure were between 2.6 µg/kg b.w. per day in ‘Adolescents’ and 
31 µg/kg b.w. per day in ‘Infants’.  
 Acute exposure through the daily consumption of individual foods, at 95th percentile (UB) 
was highest for ‘Drinking water’ (32 µg/kg b.w. per day), ‘Broccoli’ (21 µg/kg b.w. per day), 
and ‘Whey and whey products, excluding whey cheese’ (19 µg/kg b.w. per day). 
 Acute and chronic estimates of exposure when excluding the occurrence data above a 
hypothetical MRL of 0.7 mg/kg were only slightly lower than those using all available 
occurrence data. This is explained by the fact that only few commodities were excluded and 
most of them belong to food groups with a relatively low contribution to the exposure. 
 In a hypothetical scenario, acute exposures were estimated assuming that all food items 
consumed have an occurrence value of 0.7 mg/kg. This led to a substantial increase of the 
acute exposure estimates as compared to the scenario using the reported occurrence levels.  
 Estimating acute exposure assuming an occurrence value of 0.7 mg/kg for individual food 
commodities generally results in lower acute exposure as compared to the use of the reported 
occurrence data. Important exceptions were the estimates of acute exposure calculated through 
the daily consumption of ‘Drinking water’ and ‘Cow milk’ that reached values up to 
111 µg/kg and 56 µg/kg b.w. per day, respectively.  
Hazard identification and characterization 
Toxicokinetics 
 Following oral exposure in experimental animals, chlorate is rapidly absorbed, widely 
distributed throughout the body and evidence indicates that it undergoes metabolism to 
chloride. The main pathway of elimination is via urine. 
 The EFSA Panel on Contaminants in the Food Chain (CONTAM Panel) has not identified 
literature studies on the toxicokinetics of chlorate by humans after ingestion. The data 
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obtained after chlorate poisoning indicate that chlorate is bioavailable in humans after oral 
ingestion and that it is eliminated via the urine. 
Toxicity in experimental animals 
 The thyroid gland and the haematological system are the primary targets of toxicity of chlorate 
identified in animal species after repeated oral exposure. Decreases in erythrocytes, 
haemoglobin and haematocrit were observed in mice, rats, dogs and monkeys. 
Histopathological changes were noted in the thyroid gland of rats (follicular cell hypertrophy, 
increase in colloid depression and in follicular cell hyperplasia). Thyroid hormone levels were 
also altered significantly (decreases in triiodothyronine (T3) and thyroxine (T4) and increases 
in thyroid stimulating hormone (TSH)). 
 Long-term oral exposure to sodium chlorate resulted in non-neoplastic lesions in the thyroid 
gland (follicular cell hypertrophy) of male and female rats and female mice, bone marrow 
(hyperplasia) of male rats and female mice, and spleen (hematopoietic cell proliferation) of 
male rats. There was no evidence of carcinogenic activity of sodium chlorate in male B6C3F1 
mice. There was equivocal evidence of carcinogenic activity of sodium chlorate in female 
B6C3F1 mice based on marginally increased incidences of pancreatic islet cell adenoma and 
carcinoma (combined). There was some evidence of carcinogenic activity of sodium chlorate 
in male and female F344/N rats based on increased incidences of thyroid gland neoplasms. 
 Chlorate is unlikely to pose a genotoxic hazard. 
 Chlorate has not been shown to have reproductive effects in rats or developmental effects  in 
rats or rabbits.  
 No neurotoxic effects of chlorate have been demonstrated. 
Observations in humans 
 Death from acute oral sodium or potassium chlorate poisoning in adults has been reported 
from 5 g and above (50 mg chlorate/kg b.w.), caused by formation of methaemoglobinaemia, 
followed by lysis of red blood cells and renal failure. 
 Toxicity has been reported in case studies where individuals acutely ingested approximately 
11–23 mg chlorate/kg b.w. and above.  
 In a controlled clinical trial male participants received 2.5 mg chlorate (36 µg/kg b.w. per day)  
in drinking water daily for 12 weeks. No physiologically relevant effects were detected by 
biochemical parameters and physical examination. 
Mode of action 
 Chlorate-induced methaemoglobin formation is most likely caused by an autocatalytic 
reaction. Subsequently, chlorate disturbs the capacity of the erythrocyte to form nicotinamid 
adenine dinucleotid phosphate (NADPH), resulting in a cascade of protein denaturation, 
crosslinking of membrane proteins and finally haemolysis. 
 Chlorate-induced renal failure appears to be secondary to haemolysis. 
 Like perchlorate, the chlorate ion is a competitive inhibitor of iodine uptake via the sodium-
iodine symporter (NIS) in the thyroid resulting in decreased serum thyroid hormones T4 and 
T3 and increased release of TSH. Persistent stimulation of the thyroid gland by elevated levels 
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of TSH results in increases in thyroid gland size and weight, decreased colloid, hypertrophy 
and hyperplasia of thyroid follicle cells and thyroid tumours in rats. 
Hazard characterization 
 Chronic 
 Chronic adaptive changes to compensate for a sustained inhibition of thyroid iodine uptake 
could lead to long term effects such as the development of toxic multinodular goiter, in 
particular in populations with mild to moderate iodine deficiency. 
 The CONTAM Panel considered the inhibition of thyroid iodine uptake as the critical effect 
for the chronic hazard characterization.  
 Rats are highly sensitive to the effects of agents that disrupt thyroid hormone homeostasis. 
Humans are likely to be less sensitive than rats to these effects. Due to the differences in 
thyroid hormone physiology, the dose response data from toxicological studies in rats are of 
limited relevance for humans. However, there are no in vivo human studies on the inhibition of 
iodine uptake by chlorate. 
 In order to establish a chronic health-based guidance value for chlorate, the CONTAM Panel 
decided to use the tolerable daily intake (TDI) established for perchlorate and to apply an 
extrapolation factor for the difference in potency between chlorate and perchlorate. When 
comparing the no-observed-adverse-effect level (NOAEL) and the lowest-observed-
adverse-effect level (LOAEL) for thyroid follicular cell hypertrophy in rats, perchlorate is 
about 10 times more potent than chlorate.  
 The CONTAM Panel established a TDI for chlorate of 3 µg/kg b.w. per day, based on the TDI 
established for perchlorate and by multiplying by a factor of 10 for the difference in potency 
between the two substances in rats. 
Acute 
 As for perchlorate, the CONTAM Panel noted that a single acute exposure to chlorate at levels 
found in food and water is unlikely to cause adverse effects in thyroid function, including in 
the more vulnerable groups of the population. 
 Based on the acute haematological and renal toxicity of chlorate in humans observed in 
poisoning cases, the CONTAM Panel considered that it is necessary to establish an acute 
reference dose (ARfD). 
 Formation of methaemoglobin is the critical acute toxic effect which was identified in cases of 
poisoning.The CONTAM Panel considered that the no-observed-effect level (NOEL) of 36 µg 
chlorate/kg b.w. per day from the controlled clinical study can be the basis for the 
establishment of an ARfD. The CONTAM Panel concludes that the differences between the 
NOEL in the controlled clinical study and the effect levels in poisoning cases are sufficiently 
large that no uncertainty factor is required for more vulnerable individuals (e.g. glucose-6-
phosphate dehydrogenase deficient individuals or hereditary methaemoglobinaemia) and 
establishes an ARfD of 36 µg chlorate/kg b.w. 
Risk characterization based on current occurrence data 
 The mean and 95th percentile chronic exposure estimates for surveys from adolescent and 
adult age classes did not exceed the TDI. 
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 In the younger populations (‘Infants’ and ‘Toddlers’), the TDI exceeded at the 95th percentile 
in all surveys and in some surveys for the UB mean exposure estimates. At the 95th percentile 
at median (LB), the TDI was also exceeded in the group ‘Other children’.  
 Overall, the CONTAM Panel concluded that the chronic dietary exposure to chlorate is of 
potential concern in particular for the high consumers in the younger age groups of the 
population with mild to moderate iodine deficiency. Fetuses, neonates, and individuals with 
low iodine intake or genetically predisposed to develop hypothyroidism are likely to be more 
sensitive to the effects of exposure to chlorate. Individuals who have sufficient iodine intake 
are less likely to develop adverse effects at such exceedances of theTDI. 
 The mean and 95th percentile acute exposure estimates for all age groups are below the ARfD.  
Risk characterisation based on a hypothetical MRL of 0.7 mg/kg  
 For chronic exposure based on the current occurrence data removing foods containing more 
than 0.7 mg/kg chlorate from the data set would have a minimal impact on the exposure and 
consequently on the risk.  
 For acute exposure based on the current occurrence data removing foods containing more than 
0.7 mg/kg chlorate from the data set would also have a minimal impact on the exposure. The 
level for mean and 95th percentile acute dietary exposure would all remain below the ARfD. 
 It should be emphasised that the occurrence data set applies to current practice in the food 
industry under which the occurrence is, in general, substantially lower than 0.7 mg/kg. It 
cannot be predicted whether application of a MRL of 0.7 mg/kg would result in different 
practices leading to higher residue levels and higher exposures to chlorate.  
Risk characterisation assuming an occurrence value of 0.7 mg/kg in all commodities 
 Assuming an occurrence value of 0.7 mg/kg for all foods covered by Annex I of Regulation 
396/2005 and drinking water, acute exposures would increase by up to approximately five-
fold, and the ARfD would be exceeded at mean exposure in ‘Toddlers’ and at 95th percentile 
also in ‘Infants’, ‘Other children’ and ‘Adults’.  
 The CONTAM Panel considers that such exceedances of the ARfD resulting from this 
scenario are unlikely, because it is highly implausible that that all foods consumed on a single 
day would have chlorate concentrations in the range of 0.7 mg/kg. A potential exception 
would be drinking water which by itself contributes to a large extent to the intake of chlorate.  
 Chlorate concentrations of 0.7 mg/kg in drinking water could lead to exposures similar to the 
ARfD at mean water consumption and up to 3-fold the ARfD at high (95th percentile) water 
consumption. 
5. Recommendations  
 There is a need for human data on inhibition of iodine uptake by chlorate and relative potency 
compared to perchlorate. 
 There is a need for information on levels of chlorate in humans and association with possible 
effects. 
 More information about the impact of food processing (e.g. blanching) on chlorate residues in 
food is needed. 
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 Occurrence data are needed for foods for which there are currently no data (e.g. animal 
derived foods, tea, coffee, beer). 
 More data on chlorate in foods are required where there are currently indications of high 
chlorate levels such as infant/follow-on formula and yoghurt. 
 Efforts to reduce chlorate residues in food should take into account whether these would have 
an impact on microbiological food safety. 
 There is a need for a better understanding of the contribution of various dietary factors and 
contaminants to the overall thyroid iodine uptake inhibition. 
DOCUMENTATION PROVIDED TO EFSA  
Documents made available by the European Commission 
 Data and comments for the Standing Committee on the Food Chain and Animal Health 
(SCOFCAH) pesticides residues of 24-25 February 2014, point 16.01:  
BFR opinion 
Germany (DE) occurrence data and comments 
Spain (ES) occurrence data and comments 
 
 Data and comments for the SCOFCAH pesticides residues of 12-13 June 2014, point A. 
04:00:  
Belgium (BE) occurrence data and comments 
The Czech Republic (CZ) occurrence data and comments 
Studies provided by Germany (DE) 
Occurrence data from Food Drink Europe 
Occurrence data from the European Fresh Produce Association - Freshfel 
Occurrence data from the European Association of Fruit and Vegetable Processing 
Industries - PROFEL 
Overview of the Rapid Alert System for Food and Feed (RASFF) notifications 
Comments from Sweden (SE) and the United Kingdom (UK)  
 
Unpublished documents made available by the data owner of the original study reports of the EU 
sodium chlorate – EU DAR (2008) 
1. Barrett DS, 1987a. A subchronic (3-month) oral toxicity study of sodium chlorate in the rat via 
gavage. Bio/dynamics, Inc., East Hillstone, New Jersey, USA. Report n° 86-3112 GLP. 
2. Barrett DS, 1987b. A subchronic (3-month) oral toxicity study in the dog via gavage 
administration of sodium chlorate. Bio/dynamics, Inc., East Hillstone, New Jersey, USA. Report 
n° 86-3114  GLP. 
3. Bailey GP and Davies S, 1997. Sodium chlorite: Drinking water rat two-generation reproductive 
toxicity study. Quintiles England Ltd, Ledbury, Herefordshire, England. Report n° CMA/17/96 
GLP. 
4. Damske DR and Meckler FJ, 1981. Acute oral toxicity study in rats – Sodium chlorate. Litton 
Bionetics Inc., Kensington, Maryland, USA. Report n° 22097 GLP. 
5. Gaoua W, 2004a. Sodium chlorate: One-generation dose-range finding study by oral route 
(gavage) in rats. CIT, Evreux, France Report n° 22823 RSR GLP. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 64 
6. Gaoua W, 2004b. Sodium chlorate: Two-generation study (reproduction and fertility effects) by 
oral route (gavage) in rats. CIT, Evreux, France Report n° 22824 RSR GLP. 
7. George JD and Price CJ. 2002 Developmental toxicity evaluation for sodium chlorate (CAS No. 
7775-09-9) administered by gavage to New Zealand White rabbits on gestational days 6 through 
29. Center for Life Sciences & Toxicology, RTI, RTP, North Carolina, USA. Report n° TER-
97-005 GLP. 
8. Hodson-Walker G and Bootman J, 1989. Sodium chlorate: Investigation of mutagenic activity 
at the HGPRT locus in a Chinese hamster V79 cell mutation system. Life Science Research 
Limited, Suffolk, England. Report n° 89/SKR002/0631 GLP. 
9. Hossack JN, 1978. Ames metabolic test to assess the potential mutagenic effect of chlorate de 
soude. Huntingdon Research Centre, England. Report n° UKM 53/78381 GLP. 
10. Hossack DJN, Richold M, Jones E and Bellamy RP, 1978. Ames metabolic activation test to 
assess the potential mutagenic effect of chlorite de soude. Huntingdon Research Centre, 
England. Report n° UKM 53/78382 GLP. 
11. Irvine LFH, 1990. Sodium chlorite: rabbit teratology study (drinking water 
administration).Toxicol Laboratories Ltd, Ledbury, Herefordshire, England. Report n° 
CMA/3/90 GLP. 
12. Kaysen A, 1984. Chlorite de sodium (solution aqueuse à 25 %) – Evaluation de la toxicité aigüe 
chez le rat par voie orale. Centre International de Toxicologie, Miserey, Evreux, France. Report 
n° 486 TAR GLP. 
13. May K and Hodson-Walker G, 1989a. Sodium chlorate: Assessment of mutagenic potential in 
histidine auxotrophs of Salmonella typhimurium (the Ames test). Life Science Research 
Limited, Suffolk, England. Report n° 89/SKR001/0285 GLP. 
14. May K and Hodson-Walker G, 1989b. Sodium chlorate: Assessment of its ability to cause lethal 
DNA damage in strains of Escherichia coli Life Science Research Limited, Suffolk, England. 
Report n° 89/SKR004/0341, GLP. 
15. Mackay JM and Bootman J,1989. Sodium chlorate: Assessment of clastogenic action on bone 
marrow erythrocytes in the micronucleus test. Life Science Research Limited, Suffolk, England. 
Report n° 89/SKR003/0253 GLP. 
16. Ridgway P, 1992. Sodium chlorite: 13 week oral (gavage) toxicity study in the rat. Toxicol 
Laboratories Ltd, Ledbury, Herefordshire, England. Report n° CMA/13/92 GLP. 
17. Schroeder RE, 1987a. A range-finding study to evaluate the toxicity of sodium chlorate in the 
pregnant rat. Bio/dynamics Inc., East Hillstone, New Jersey, USA Report n° 86-3116 GLP. 
18. Schroeder RE, 1987b. A teratogenicity study in rats with sodium chlorate. Bio/dynamics Inc., 
East Hillstone, New Jersey, USA Report n° 86-3117 GLP. 
19. Seeberg AH, 1989. Unscheduled DNA synthesis (UDS) in HeLa S3 cells in vitro. Life Science 
Research, Roma Toxicology Centre S.P.A., Pomezia, Roma, Italy. Report n° 102002-M-02289 
GLP. 
20. Shapiro R, 1991. EPA Acute oral toxicity limit test. Product Safety Labs, East Brunswick, New 
Jersey, USA. Report n° T-488 GLP. 
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21. Thouvenin I and Pontal P-G, 2004a. Carcinogenicity study with sodium chlorate administered 
via drinking water to F344 rats. Southern Research Institute, RTP, North Carolina, USA. 
(Preliminary) Report n° TR-517a GLP. 
22. Thouvenin I and Pontal P-G, 2004b. Carcinogenicity study with sodium chlorate administered 
via drinking water to B6C3F1 mice. Southern Research Institute, RTP, North Carolina, USA. 
(Preliminary) Report n° TR-517b GLP. 
Unpublished study made available by the owner of study report (Labor Friedle GmbH) 
Labor Friedle GmbH, 2014, Chlorat-Kontamination von pflanzlichen Lebensmitteln durch 
Waschwasser, Tegernheim, 13.05.2014. 
 
REFERENCES 
Abdel-Rahman MS, Couri D and Bull RJ, 1980. Kinetics of ClO2 and effect of ClO2, ClO-2, and ClO-
3 in drinking water on blood glutathione and hemolysis in rat and chicken. Journal of 
Environmental Pathology and Toxicology, 3, 431-449. 
Abdel-Rahman MS, Couri D and Bull RJ, 1982. Metabolism and pharmacokinetics of alternate 
drinking water disinfectants. Environmental Health Perspectives, 46, 19-23. 
Abdel-Rahman MS, Couri and Bull RJ, 1984. The Kinetics of Chlorite and Chlorate in the Rat. 
Journal of the American College of Toxicology, 3(4), 261-267. 
Abdel-Rahman MS, Couri D and Bull RJ, 1985. Toxicity of chlorine dioxine in drinking water. 
Journal of Environmental Pathology, Toxicology and Oncology, 6, 105-113. 
Aggazzotti G, Righi E, Fantuzzi G, Biasotti B, Ravera G, Kanitz S, Barbone F, Sansebastiano G, 
Battaglia MA, Leoni V, Fabiani L, Triassi M, Sciacca S, 2004. Chlorination by-products (CBPs) in 
drinking water and adverse pregnancy outcomes in Italy. Journal of Water and Health, 2, 233-247. 
Allen DW and Jandl JH, 1961. Oxidative hemolysis and precipitation of hemoglobin. II. Role of thiols 
in oxidant drug action. Journal of Clinical Investigation, 40, 454-475. 
Anastassiades M, Kolberg DI, Mack D, Wildgrube C, Sigalov I and Dörk D, 2013. Quick Method for 
the Analysis of Residues of numerous Highly Polar Pesticides in Foods of Plant Origin involving 
Simultaneous Extraction with Methanol and LC-MS/MS Determination (QuPPe-Method). EU 
Reference Laboratory for pesticides requiring Single Residue Methods (EURL-SRM), 7.1, 1-44. 
Asami M, Yoshida N, Kosaka K, Ohno K and Matsui Y, 2013. Contribution of tap water to chlorate 
and perchlorate intake: A market basket study. Science of the Total Environment, 463-464, 199-
208. 
ATSDR (Agency for Toxic Substances and Disease Registry), 2008. Toxicological profile for 
perchlorates. Atlanta, GA, United States Department of Health and Human Services, Public Health 
Service. Available at: http://www.atsdr.cdc.gov/toxprofiles/tp.asp?id=895&tid=181. 
Bercz JP, Jones L, Garner L, Murray D, Ludwig DA and Boston J, 1982. Subchronic toxicity of 
chlorine dioxide and related compounds in drinking water in the nonhuman primate. Environmental 
Health Perspectives, 46, 47-55. 
Bing RJ, 1943. Etiology of renal failure following crush injuries. Proceedings of the Society for 
Experimental Biology and Medicine, 53, 29-30. 
Bing RJ, 1944. The effect of hemoglobin and related pigments on renal functions of the normal and 
acidotic dog. Bulletin of the Johns Hopkins Hospital, 74, 161-176. 
Bloxham CA, Wright N, Hoult JG, 1979. Self-poisoning by sodium chlorate – some unusual features. 
Clinical Toxicology, 15, 185-188. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 66 
Brennan LM, Toussaint MW, Kumsher DM, Dennis WE, Rosencrance AB, Brown C, van der Schalie 
WH and Gardner HS, 2005. Developmental toxicity of drinking water disinfection by-products to 
embryos of the African clawed frog (Xenopus laevis). Bulletin of Environmental Contamination 
and Toxicology, 75, 361-367.  
Bognár A, 2002. Tables on weight yield of food and retention factors of food constituents for the 
calculation of nutrient composition of cooked foods (dishes). Karlsruhe, BFE: 7-11, 41-43, 95-97. 
BfR (Bundesamt für Risikobewertung), 2013. Vorschläge des BfR zur gesundheitlichen Bewertung 
von Chloratrückständen in Lebensmitteln. Stellungnahme Nr. 028/2014. 
Chen Z, Zhu C, Han Z, 2011. Effects of aqueous chlorine dioxide treatment on nutritional components 
and shelf-life of mulberry fruit (Morus alba L.). Journal of Bioscience and Bioengineering, 111, 
675-681. 
Clewell RA, Merrill EA, Yu KO, Mahle DA, Sterner TR, Fisher JW and Gearhart JM, 2003b. 
Predicting neonatal perchlorate dose and inhibition of iodine uptake in the rat during lactation using 
physiologically-based pharmacokinetic modeling. Toxicological Sciences, 74, 416-436. 
Couri D and Abdel-Rahman, 1980. Effect of chlorine dioxide and metabolites on glutathione 
dependent system in rat, mouse and chicken blood. Journal of Environmental Pathology and 
Toxicology 3, 451-460. 
Couri D, Abdel-Rahman MS and Bull RJ, 1982. Toxicological effects of chlorine dioxide, chlorite and 
chlorate. Environmental Health Perspectives, 46, 13-17. 
CVUA (Chemisches und Veterinaeruntersuchungsamt) Stuttgart, 2014a. Fortfuehrung der Chlorat-
Untersuchungen: Befunde im Trinkwasser. Available at: https://dl.dropboxusercontent.com
/u/8384843/Homepage/CVUAS_Chlorat_InTrinkwasser_2014.pdf  
CVUA (Chemisches und Veterinaeruntersuchungsamt), 2014b. Chlorate Residues in Carrots Traced to 
Chlorinated Water Used in Post-Harvest Treatment. Available at: http://www.cvuas.de/
pub/beitrag.asp?subid=1&Thema_ID=5&ID=1853&Pdf=No&lang=EN 
CVUA (Chemisches und Veterinaeruntersuchungsamt), 2014c. Chlorate-Rueckstaende in pflanzlichen 
Lebensmitteln – ein Update. Ein Bericht aus unserem Laboralltag. Available at: https://dl. dropbox
usercontent.com/u/8384843/Homepage/CVUAS_RK_Chlorat-Update2014.pdf  
Di Bernardo J, Iosco C and Rhoden KJ, 2011. Intracellular anion fluorescence assay for sodium/iodide 
symporter substrates. Analytical Biochemistry, 415, 32-38. 
ECETOC (European Chemical Industry Ecology and Toxicology Centre). 1988. Nitrate and drinking 
water. Technical Report nr. 27. Brussels: ECETOC. 
ECHA (European Chemicals Agency), 2015a. REACH registered substances and published dossiers 
(25 February 2015). Sodium chlorate. Available at: http://apps.echa.europa.eu/
registered/data/dossiers/DISS-9ebb9719-26b5-21cb-e044-00144f67d031/DISS-9ebb9719-26b5-21
cb-e044-00144f67d031_DISS-9ebb9719-26b5-21cb-e044-00144f67d031.html 
ECHA (European Chemicals Agency), 2015b. REACH registered substances and published dossiers 
(25 February 2015). Potassium chlorate. Available at: http://apps.echa.europa.eu/
registered/data/dossiers/DISS-9ec1a4db-67d5-2851-e044-00144f67d031/DISS-9ec1a4db-67d5-
2851-e044-00144f67d031_DISS-9ec1a4db-67d5-2851-e044-00144f67d031.html 
EFSA (European Food Safety Authority), 2005. Opinion of the Scientific Panel on Plant health, Plant 
protection products and their Residues on a request from Commission related to the appropriate 
variability factor(s) to be used for acute dietary exposure assessment of pesticide residues in fruit 
and vegetables. The EFSA Journal 2005, 177, 1-61. 
EFSA (European Food Safety Authority), 2006a. Opinion of the Scientific Panel on food additives, 
flavourings, processing aids and materials in contact with food (AFC) on a request from the 
Commission related to Treatment of poultry carcasses with chlorine dioxide, acidified sodium 
chlorite, trisodium phosphate and peroxyacids. The EFSA Journal 2005, 297, 1-27. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 67 
EFSA (European Food Safety Authority), 2006b. Guidance of the Scientific Committee on a request 
from EFSA related to Uncertainties in Dietary Exposure Assessment. The EFSA Journal 2006, 
438, 1-54. 
EFSA (European Food Safety Authority), 2010a. Standard sample description for food and feed. 
EFSA Journal 2010;8(1):1457, 54 pp. doi:10.2903/j.efsa.2010.1457 
EFSA (European Food Safety Authority), 2010b. Management of left-censored data in dietary 
exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp. 
doi:10.2903/j.efsa.2010.1557 
EFSA (European Food Safety Authority), 2011a. Evaluation of the FoodEx, the food classification 
system applied to the development of the EFSA Comprehensive European Food Consumption 
Database. EFSA Journal 2011, 9(3):1970, 27 pp. doi:10.2903/j.efsa.2011.1970 
EFSA (European Food Safety Authority), 2011b. Guidance of EFSA on the use of the EFSA 
Comprehensive European Food Consumption Database in Intakes Assessment. EFSA Journal 
2011;9(3):2097, 34 pp. doi:10.2903/j.efsa.2011.2097 
EFSA CONTAM Panel (EFSA Panel on Contaminants in the Food Chain), 2014. Scientific Opinion 
on the risk to public health related to the presence of perchlorate in food, in particular fruits and 
vegetables. EFSA Journal 2014;12(10):3869, 117 pp. doi: 10.2903/j.efsa.2014.3869  
EFSA SC (EFSA Scientific Committee), 2012a. Guidance on selected default values to be used by the 
EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. 
EFSA Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579  
EFSA SC (EFSA Scientific Committee), 2012b. Scientific Opinion on Risk Assessment Terminology. 
EFSA Journal 2012;10(5):2664, 43 pp. doi:10.2903/j.efsa.2012.2664 
EU DAR (EU Draft Assessment Report), 2008. Initial risk assessment provided by the rapporteur 
Member State France for the existing active substance chlorate of the third stage (part B) of the 
review programme referred to in Article 8(2) of Council Directive 91/414/EEC. Volume 1. 
Eysseric H, Vincent F, Peoc’h M, Marka C, Aitken Y and Barret L, 2000. A fatal case of chlorate 
poisoning: Confirmation by ion chromatography of body fluids. Journal of Forensic Sciences, 45, 
474-477. 
Fantuzzi G, Aggazzotti G, Righi E, Predieri G, Giacobazzi P, Kanitz S, Barbone F, Sansebastiano G, 
Ricci C, Leoni V, Fabiani L and Triassi M, A Collsborative Group for the Study of Chlorinated 
Drinking Waters and Pregnancy, 2007. Exposure to organic halogen compounds in drinking water 
of 9 Italian regions: exposure to chlorites, chlorates, thrihalomethanes, trichloroethylene and 
tetrachloroethylene. Annali di igiene: medicina preventiva e di comunita, 19, 345-354. 
FAO/WHO (Joint FAO/WHO Expert Committee on Food Additives), 2007. Evaluation of certain 
Food Contaminants. Sixty-eighth report of the Joint FAO/WHO Expert Committee on Food 
Additives (Geneva, Switzerland). WHO Technical Report Series 947. Available at: 
http://whqlibdoc.who.int/publications/2007/9789241209472_eng.pdf 
FAO/WHO (Joint FAO/WHO Expert Committee on Food Additives), 2008. Safety evaluation of 
certain food additives. Sixty-eighth meeting of the Joint FAO/WHO Expert Committee on Food 
Additives (JEFCA). (Geneva, Switzerland). WHO Food Additives Series, 59. Available at: 
http://www.inchem.org/documents/jecfa/jecmono/v59je01.pdf 
FAO/WHO (Food and Agriculture Organisation/World Health Organization), 2011. Safety evaluation 
of certain contaminants in food prepared by the Seventy-second meeting of the Joint FAO/WHO 
Expert Committee on Food Additives (JECFA). WHO Food Additives Series 63, 685-762. 
Available at: http://www.inchem.org/documents/jecfa/jecmono/v63je01.pdf 
Feretti D, Zerbini I, Ceretti E, Villarini M, Zani C, Moretti M, Fatigoni C, Orizio G, Donato F and 
Monarca S, 2008. Evaluation of chlorite and chlorate genotoxicity using plant bioassays and in 
vitro DNA damage tests. Water Research, 42, 4075-4082. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 68 
Fisher J, Lumen A, Latendresse J and Mattie D, 2012. Extrapolation of hypothalamic-pituitary-thyroid 
axis perturbations and associated toxicity in rodents to humans: case study with perchlorate. 
Journal of Environmental Science and Health Part C, 30, 81-105. 
Garcia-Villanova RJ, Dantas Leite MVO, Hernandez-Hierro JM, de Castro Alfageme S and Garcia 
Hernandez C, 2010. Occurrence of bromate, chlorite and chlorate in drinking waters disinfected 
with hypochlorite reagents. Tracing their origins. Science of the Total Environment, 408, 2616-
2620. 
Ginsberg GL, Hattis DB, Zoeller RT and Rice DC, 2007. Evaluation of the U.S. EPA/OSWER 
preliminary remediation goal for perchlorate in groundwater: focus on exposure to nursing infants. 
Environmental Health Perspectives, 115, 361-369. 
Gocke E, King MT, Eckhardt K and Wild D, 1981. Mutagenicity of cosmetics ingredients licensed by 
the European Communities. Mutation Research, 90, 91-109. 
Goodman A, Goodman LS and Gilman A, 1980. Goodman and Gilman’s The Pharmalogical Basis of 
Therapeutics. Macmillan Publishing Co., Inc., New York, 6th Edition, 1843 pp. 
Greer MA, Goodman G, Pleus RC and Greer SE, 2002. Health Effects Assessment for the 
Environmental Perchlorate Contamination: The Dose Response for Inhibition of Thyroidal 
Radioiodine Uptake in Humans. Environmental Health Perspectives, 110, 927-937. 
Gregory DG, Miller S and Whaley MW, 1993. Chlorate toxicosis in a group of swine. Journal of 
Veterinary Diagnostic Investigation, 5, 494-496. 
Hakk H, Smith DJ and Shappell NW, 2007. Tissue residues, metabolism, and excretion of 
radiolabeled sodium chlorate (Na Cl-36 O-3) in rats. Journal of Agricultural and Food Chemistry, 
55, 2034-2042. 
Health Canada, 2008. Guidelines for Canadian Drinking Water Quality: Guideline Technical 
Document — Chlorite and Chlorate. Water Quality and Health Bureau, Healthy Environments and 
Consumer Safety Branch, Health Canada, Ottawa, Ontario. Available at: http://www.hc-
sc.gc.ca/ewh-semt/pubs/water-eau/chlorite-chlorate/index-eng.php 
Helliwell M and Nunn J, 1979. Mortality in sodium chlorate poisoning. British Medical Journal, 
1(6171), 1119. 
Heywood R, Sortwell RJ, Kelly PJ and Street AE, 1972. Toxicity of sodium chlorate to the dog. 
Veterinary Record, 90, 416-418. 
Hooth MJ, DeAngelo AB, George MH, Gaillard ET, Travlos GS, Boorman GA and Wolf DC, 2001. 
Subchronic sodium chlorate exposure in drinking water results in a concentration-dependent 
increase in rat thyroid follicular cell hyperplasia. Toxicologic Pathology, 29, 250-259. 
HSDB (Hazardous Substances data Bank), 2003. National Institute of Occupational Safety and Health, 
HSDB database available through the National Library of Medicine MEDLARS System. Available 
at: http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB 
Huybrechts I, Sioen I, Boon PE, Ruprich J, Lafay L, Turrini A, Amiano P, Hirvonen T, De Neve M, 
Arcella D, Moschandreas J, Westerlund A, Ribas-Barba L, Hilbig A, Papoutsou S, Christensen T, 
Oltarzewski M, Virtanen S, Rehurkova I, Azpiri M, Sette S, Kersting M, Walkiewicz A, 
SerraMajem L, Volatier JL, Trolle E, Tornaritis M, Busk L, Kafatos A, Fabiansson S, De Henauw 
S and Van Klaveren J, 2011. Dietary exposure assessments for children in Europe (the EXPOCHI 
project): rationale, methods and design. Archives of Public Health, 69, 4. doi: 10.1186/0778-7367-
1169-1184. 
Jackson RC, McDonnell H and Elder WJ, 1961. Sodium-Chlorate Poisoning – Complicated by Acute 
Renal Failure. Lancet, 2, 1381-1383. 
Jung F, 1965. On the reaction of methemoglobin with potassium chlorate (article in German). Acta 
Biologica et Medica Germanica, 15, 554-568. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 69 
Kaye S, 1970. Handbook of emergency toxicology: a guide for the identification, diagnosis and 
treatment of poisoning. Third Edition. Charles C. Thomas Publisher, Springfield Illinois, 514 pp. 
Khan MA, Fenton SE, Swank AE, Hester SD, Williams A and Wolf DC, 2005. A mixture of 
ammonium perchlorate and sodium chlorate enhances alterations of the pituitary-thyroid axis 
caused by the individual chemicals in adult male F344 rats. Toxicologic Pathology, 33, 776-783. 
Knight RK, Trounce JR and Cameron JS, 1967. Suicidal chlorate poisoning treated with peritoneal 
dialysis. British Medical Journal, 3, 601-602. 
Kurokawa Y, Imazawa T, Matsushima M, Takamura N and Hayashi Y, 1985. Lack of promoting 
effect of sodium-chlorate and potassium chlorate in 2-stage rat renal carcinogenesis. Journal of the 
American College of Toxicology, 4, 331-337. 
Lee DB, Brown DL, Baker LR, Littlejohns DW and Roberts PD, 1970. Haematological complications 
of chlorate poisoning. British Medical Journal, 2, 31-32. 
Lewis RJ Sr, 1996. Sax’s Dangerous Properties of Industrial Materials. 9th Edition. van Nostrand 
Reinhold, New York, NY. 2953-2954. 
Lubbers JR, Chauhan S and JR Bianchine, 1981. Controlled clinical evaluations of chlorine dioxide, 
chlorite and chlorate in man. Fundamental and applied toxicology: Official Journal of the Society 
of Toxicology, 1, 334-338. 
McCauley PT, Robinson M, Daniel FB and Olson GR, 1995. The effects of subchronic chlorate 
exposure in Sprague-Dawley rats. Drug and Chemical Toxicology, 18, 185-199. 
McLanahan ED, Campbell Jr JL, Ferguson DC, Harmon B, Hedge JM, Crofton KM, Mattie DR, 
Braverman L, Keys DA, Mumtaz M and Fisher JW, 2007. Low-Dose Effects of Ammonium 
Perchlorate on the Hypothalamic-Pituitary-Thyroid Axis of Adult Male Rats Pretreated with 
PCB126. Toxicological Science, 97, 308-317. 
Meier JR, Bull RJ, Stober JA and Cimino MC, 1985. Evaluation of chemicals used for drinking water 
disinfection for production of chromosomal damage and sperm-head abnormalities in mice. 
Environmental Mutagenesis, 7, 201-211. 
Mensinga TT, Speijers GJ and Meulenbelt J, 2003. Health implications of exposure to environmental 
nitrogenous compounds. Toxicological Reviews, 22, 41-51. 
Merten C, Ferrari P, Bakker M, Boss A, Hearty A, Leclercq C, Lindtner O, Tlustos C, Verger P, 
Volatier JL and Arcella D, 2011. Methodological characteristics of the national dietary surveys 
carried out in the European Union as included in the European Food Safety Authority (EFSA) 
Comprehensive European Food Consumption Database, Food Additives and Contaminants. Part A, 
28, 975-995. 
Michalski R, 2006. Ion Chromatography as a Reference Method for Determination of Inorganic Ions 
in Water and Wastewater. Critical reviews in Analytical Chemistry, 36, 107-127. 
Michalski R and Mathews B, 2007. Occurrence of Chlorite, Chlorate and Bromate in Disinfected 
Swimming Pool Water. Polish Journal of Environmental Studies, 16, 237-241. 
Morreale de Escobar G, Obregon MJ and Escobar del Rey F, 2004. Role of thyroid hormone during 
early brain development. European Journal of Endocrinology, 151, U25-37. 
Mutlu H, Silit E and Pekkafali Z, 2003. Cranial MR imaging findings of potassium chlorate 
intoxication. American Journal of Neuroradiology, 24, 1396-1398  
Nieuwenhuijsen MJ, Smith R, Golfinopoulos S, Best N, Bennett J, Aggazzotti G, Righi E, Fantuzzi G, 
Bucchini L, Cordier S, Villanueva CM, Moreno V, La Vecchia C, Bosetti C, Vartiainen T, Rautiu 
R, Toledano M, Iszatt N, Grazuleviciene R and Kogevinas M, 2009. Health impacts of long-term 
exposure to disinfection by-products in drinking water in Europe: HIWATE. Journal of Water and 
Health, 7.2, 185-207. 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 70 
NRC (National Research Council), 1980. Drinking water and health. Vol. 3, National Academy Press, 
Washington DC. Available at: http://www.nap.edu/catalog/324/drinking-water-and-health-volume-3 
NRC (National Research Council), 1987. Drinking water and health. Vol. 7, National Academy Press, 
Washington DC. Available at: http://www.nap.edu/openbook.php?record_id=1008 
NRC (National Research Council), 2005. Health implications of perchlorate ingestion. National 
Academics Press, Washington DC, 2005. Available at: http://www.nap.edu/openbook.
php?isbn=0309095689 
NTP (National Toxicology Program), 2002. Final Study Report on the Developmental Toxicity 
Evaluation for Sodium Chlorate (CAS No. 7775-09-9) Administered by Gavage to New Zealand 
White Rabbits on Gestational Days 6 through 29. NTP TR 97005. National Institutes of Health. 
Public Health Service U.S. Department of Health and Human Services.  
NTP (National Toxicology Program), 2005. NTP Technical Report on the Toxicology and 
carcinogenesis studies of sodium chlorate (CAS no. 7775-09-9) in f344/n rats and b6c3f
1 
mice 
(drinking water studies). NTP TR 517. NIH Publication No. 06-4457. National Institutes of Health. 
Public Health Service U.S. Department of Health and Human Services. December 2005. 
OECD (Organisation for Economic Co-operation and Development), 2001. Test No. 416: Two-
generation reproduction toxicity. OECD Guidelines for the Testing of Chemicals, Section 4, Health 
Effects. p. 13. Available at: http://www.oecd-ilibrary.org/environment/test-no-416-two-generation-
reproduction-toxicity_9789264070868-en;jsessionid=2c3adk4sfort6.x-oecd-live-03 
Oliver J, Macdowell M and Tracy A, 1951. The Pathogenesis of Acute Renal Failure Associated with 
Traumatic and Toxic Injury – Renal Ischemia, Nephrotoxic Damage and the Ischemuric Episode. 
Journal of Clinical Investigation, 30, 1307-1439 
Prieto R and Fernandez E, 1993. Toxicity of and mutagenesis by chlorate are independent of nitrate 
reductase activity in Chlamydomonas reinhardtii. Molecular Gentics and Genomics, 237, 429-438. 
Ranghino A, CostantiniL, Deprado A, Filiberti O, Fontaneto C, Ottone S, Peron M, Ternavasio 
Cameroni G, Zamponi E and Gianenrico Guida G, 2006. A case of acute sodium chlorate self-
poisoning successfully treated without conventional therapy. Nephrology Dialysis Transplant, 21, 
2971–2974.  
Rao B, Hatzinger PB, Boehlke, JK, Sturchio NC, Andraski BJ, Eckardt FD and Jackson WA, 2010. 
Natural chlorate in the environment: Application of a new IC-ESI/MS/MS method with a Cl
18
O3
-
internal standard. Environmental Science and Technology, 44, 8429-8434. 
Reubi FC, 1978. Pathogenesis and renal function in acute toxic nephropathies. Contributions to 
Nephrology, 10, 1-14. 
Righi E, Bechtold P, Tortorici D, Lauriola P, Calzolari E, Astolfi G, Nieuwenhuijsen MJ, Fantuzzi G 
and Aggazzotti G, 2012. Trihalomethanes, chlorite, chlorate in drinking water and risk of 
congenital anomalies: A population-based case-control study in Northern Italy. Environmental 
Research, 116, 66-73. 
Righi E, Fantuzzi G, Predieri G and Aggazzotti G, 2014. Bromate, chlorite, chlorate, haloacetic acids, 
and trihalomethanes occurrence in indoor swimming pool waters in Italy. Michrochemical Journal, 
113, 23-29. 
Ross V, 1925. Potassium chlorate: Its influence on the blood oxygen binding capacity (Hemoglobin 
concentration), its rate of excretion and quantities found in the blood after feeding. Journal of 
Pharmacology, 25, 47-52. 
RTECS (Registry of Toxic Effects of Chemical Substances), 1994. MEDLARS Online Information 
Retrieval System, National Library of Medicine. Available at: http://www.ccohs.ca/products/rtecs/ 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 71 
Sadeq M, Moe CL, Attarassi B, Cherkaoui I, Elaouad R and Idrissi L 2008. Drinking water nitrate and 
prevalence of methemoglobinemia among infants and children aged 1-7 years in Moroccan areas. 
International Journal of Hygiene and Environmental Health, 211, 546-554.  
Scinicariello F, Murray HE, Smith L, Wilbur S and Fowler BA, 2005. Genetic factors that might lead 
to different responses in individuals exposed to perchlorate. Environmental Health Perspectives, 
113, 1479-1484. 
Sheahan BJ, Pugh SM and Winstanley EW, 1971. Experimental sodium chlorate poisoning in dogs. 
Research in Veterinary Science, 12, 387-389. 
Siglin JC, Mattie DR, Dodd DE, Hildebrandt PK and Baker WH, 2000. A 90-day drinking water 
toxicity study in rats of the environmental contaminant ammonium perchlorate. Toxicological 
Sciences, 57, 61-74.  
Smith DJ, Anderson RC, Ellig DA and Larsen GL, 2005a. Tissue distribution, elimination, and 
metabolism of dietary sodium [
36
Cl]chlorate in beef cattle. Journal of Agricultural and Food 
Chemistry, 53, 4272-4280.  
Smith DJ, Anderson RC and Huwe JK, 2006. Effect of sodium Cl-36 chlorate dose on total radioactive 
residues and residues of parent chlorate in growing swine. Journal of Agricultural and Food 
Chemistry, 54, 8648-8653. 
Smith DJ, Byrd JA and Anderson RC, 2007. Total radioactive residues and residues of Cl-36 Chlorate 
in market size broilers. Journal of Agricultural and Food Chemistry, 55, 5898-5903. 
Smith DJ, Ernst W and Giddings JM, 2014. Distribution of Chmeical Fate of 
36
Cl-Chlorine Dioxin 
Gas during the Fumigation of Tomatoes and Cantaloupe. Journal of Agricultural and Food 
Chemistry, 62, 11756-11766.  
Smith DJ, Oliver CE, Caton JS and Anderson RC, 2005b. Effect of sodium Cl-36 chlorate dose on 
total radioactive residues and residues of parent chlorate in beef cattle. Journal of Agricultural and 
Food Chemistry, 53, 7352-7360. 
Smith DJ, Oliver CE, Taylor JB and Anderson RC, 2012. Invited review: Efficacy, metabolism, and 
toxic responses to chlorate salts in food and laboratory animals. Journal of Animal Science, 90, 
4098-4117. 
Smith DJ and Taylor JB, 2011. Chlorate analysis in matrices of animal origin. Journal of Agricultural 
and Food Chemistry, 59, 1598-1606. 
Snyder SA, Pleus RC, Vanderford BJ and Holady JC, 2006. Perchlorate and chlorate in dietary 
supplements and flavor enhancing ingredients. Analytica Chimica Acta, 567, 26-32. 
Srivastava SK and Beutler E, 1969. The Transport of Oxidized Glutathione from Human Erythrocytes. 
The Journal of Biological Chemistry, 244, 9-16. 
Steffen C and Seitz R, 1981. Severe chlorate poisoning – report of a case. Archives of Toxicology, 48, 
281-288. 
Steffen C and Wetzel E, 1993. Chlorate poisoning: mechanism of toxicity. Toxicology, 84, 217-231. 
Steinberg MH and Benz EJ, 1991. Hemoglobin synthesis, structure and function. Hematology, basic 
principles and practice, 291-302. 
Thurlow JS, Little DJ, Baker TP and Yuan CM, 2013. Possible potassium chlorate nephrotoxicity 
associated with chronic matchstick ingestion. Clinical Kidney Journal, 6, 316-318. 
US EPA (Unites States-Environmental Protection Agency), 2002.  The occurrence of disinfection by-
products (DBPs) of health concern in drinking water: Results of a nationwide DBP occurrence 
study Available at: http://www.epa.gov/athens/publications/reports/EPA_600_R02_068.pdf 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 72 
US EPA (Unites States-Environmental Protection Agency), 2006. Reregistration Eligibility Decision 
(RED) for Inorganic Chlorates. Available at: http://www.epa.gov/opp00001/reregistration/
REDs/inorganicchlorates_red.pdf 
van Sande J, Massart C, Beauwens R, Schoutens A, Costagliola S, Dumont JE, Wolff J, 2003. Anion 
Selectivity by the Sodium Iodide Symporter. Endocrinology, 144, 247-252. 
WHO (World Health Organization) 1996. Guidelines for Drinking-water Quality Volume 2: Health 
Criteria and Other Supporting Information Second edition 1996, xvi + 973 pages ISBN 92 4 
154480 5. 
WHO (World Health Organization), 2005. Chlorite and Chlorate in Drinking-water. Background 
document for development of WHO Guidelines for Drinking-water Quality. Available at: 
http://www.hc-sc.gc.ca/ewh-semt/pubs/water-eau/chlorite-chlorate/index-eng.php 
WHO (World Health Organization), 2011. Guidelines for Drinking-water Quality. Fourth Edition. 
Available at: http://whqlibdoc.who.int/publications/2011/9789241548151_eng.pdf 
WHO/IPCS (World Health Organization/International Programme on Chemical Safety), 2008. 
Uncertainty and Data Quality in Exposure Assessment. International Programme on Chemical 
Safety, Harmonization Project Document No 6. Available at: http://www.inchem.org/documents/
harmproj/harmproj/harmproj6.pdf 
WHO/IPCS (World Health Organization/International Programme on Chemical Safety), 2009. 
Principles and Methods for the Risk Assessment of Chemicals in Food. A joint publication of the 
Food and Agriculture Organization of the United Nations and the World Health Organization. 
International Programme on Chemical Safety, Environmental Health Criteria 240. Available at: 
http://whqlibdoc.who.int/ehc/WHO_EHC_240_5_eng_Chapter2.pdf 
Wright RO, Lewander WJ and Woolf AD, 1999. Methemoglobinemia: etiology, pharmacology, and 
clinical management. Annals of Emergency Medicine, 34, 646-656. 
Zoeller RT, Dowling ALS, Herzig CTA, Iannacone EA, Gauger KJ, and Bansal R, 2002. Thyroid 
hormone, brain development, and the environment. Environmental Health Perspectives, 110 
(suppl 3), 355–361. 
Zoeller RT, 2003. Challenges confronting risk analysis of potential thyroid toxicants. Risk Analysis, 
23, 143-162.  
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 73 
APPENDICES 
Appendix A.  EFSA guidance documents applied for the assessment  
 EFSA (European Food Safety Authority), 2006. Guidance of the Scientific Committee on a request 
from EFSA related to uncertainties in Dietary Exposure Assessment. The EFSA Journal 2006, 438, 
1–54.  
 EFSA (European Food Safety Authority), 2009. Guidance of the Scientific Committee on 
transparency in the scientific aspects of risk assessments carried out by EFSA. Part 2: General 
principles. The EFSA Journal 2009, 1051, 1–22. 
 EFSA (European Food Safety Authority), 2010. Management of left-censored data in dietary 
exposure assessment of chemical substances. EFSA Journal 2010;8(3):1557, 96 pp. 
doi:10.2903/j.efsa.2010.1557 
 EFSA (European Food Safety Authority), 2011. Guidance of EFSA on the use of the EFSA 
Comprehensive European Food Consumption Database in Intakes Assessment. EFSA Journal 
2011;9(3):2097, 34 pp. doi:10.2903/j.efsa.2011.2097 
 EFSA (European Food Safety Authority), 2011. Overview of the procedures currently used at 
EFSA for the assessment of dietary exposure to different chemical substances. EFSA Journal 
2011;9(12): 2490, 33 pp. doi:10.2903/j.efsa.2011.2490 
 EFSA SC (EFSA Scientific Committee), 2012. Guidance on selected default values to be used by 
the EFSA Scientific Committee, Scientific Panels and Units in the absence of actual measured data. 
EFSA Journal 2012;10(3):2579, 32 pp. doi:10.2903/j.efsa.2012.2579   
 EFSA SC (EFSA Scientific Committee), 2012. Scientific Opinion on Risk Assessment 
Terminology. EFSA Journal 2012;10(5):2664, 43 pp. doi:10.2903/j.efsa.2012.2664 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 74 
Appendix B.  Comparative evaluation of the potency of chlorate and perchlorate to induce 
thyroid gland follicular cell hypertrophy in rats 
 
B1. Chlorate 
 
For chlorate, the data included in NTP (2005) were considered. These were a 3-week dose range 
finding study, a 14-weeks study (satellite group of the 2-year study) and the 2-year chronic study in 
rats in male and female F344/N rats. In addition the 7-day study of Khan et al. (2005) in male F344/N 
rats was considered. 
Table B1:  Results from 3-week study in F344/N rats (NTP, 2005) 
 Doses (mg sodium chlorate/kg b.w. per day) 
Males 0 20 35 75 170 300 
Incidence of thyroid gland follicular cell  
Hypertrophy/number of animals 
0/10 0/10 1/10 5/10 10/10 10/10 
 Doses (mg sodium chlorate/kg b.w. per day) 
Females 0 20 40 75 150 340 
Incidence of thyroid gland follicular cell  
Hypertrophy/number of animals 
0/10 0/10 1/10 8/10 6/10 10/10 
b.w.: body weight. 
 
A no-observed-adverse-effect level (NOAEL) of 35 mg sodium chlorate/kg body weight (b.w.) per 
day, equivalent to 0.33 mM chlorate/kg b.w. per day and a lowest-observed-adverse-effect level 
(LOAEL) 75 mg sodium chlorate/kg b.w. per day, equivalent to 0.70 mM chlorate/kg b.w. per day 
were established from this study.
30
 
Table B2:  Results from the interim 14-week study in F344/N rats (satellite group of the 2-year study) 
(NTP, 2005) 
 Doses (mg sodium chlorate/kg b.w. per day)
(a)
 
Males 0 11 89 178 
Incidence thyroid gland follicular cell 
hypertrophy/number of animals 
0/10 0/10 10/10 10/10 
 Doses (mg sodium chlorate/kg b.w. per day) 
Females 0 12 93 186 
Incidence thyroid gland follicular cell 
hypertrophy/number of animals  
0/10 0/10 10/10 10/10 
b.w.: body weight. 
(a): The NTP report does not indicate estimated doses for the satellite groups of the chronic study examined after 14 weeks 
of exposure. Doses reported in the table were converted considering the EFSA default factors for subchronic exposure 
via drinking water (i.e. 0.089 and 0.093 for male and female rat, respectively) (EFSA, 2012a) applied to the tested 
concentrations of sodium chlorate (0, 125, 1 000 and 2 000 mg/L, respectively). 
 
A NOAEL of 11 mg sodium chlorate/kg b.w. per day, equivalent to 0.10 mM chlorate/kg b.w. per day 
and a LOAEL 89 mg sodium chlorate/kg b.w. per day, equivalent to 0.84 mM chlorate/kg b.w. per day 
were established in this study. 
 
 
                                                     
30 A conversion factor of 0.0094 used to convert doses from mg to mM (MW NaClO3 = 106.44 g/mol). 
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Table B3:  Results from the 2-year study in F344/N rats (NTP, 2005) 
 Doses (mg sodium chlorate/kg b.w. per day) 
Males 0 5 35 75 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals  
4/47 13/44 33/43 40/47 
 Doses (mg sodium chlorate/kg b.w. per day) 
Females 0 5 45 95 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals 
3/47 7/47 27/43 42/46 
b.w.: body weight. 
 
A LOAEL of 5 mg sodium chlorate/kg b.w. per day, equivalent to 0.047 mM chlorate/kg b.w. per day 
was established in this study. 
Table B4: Results from 7-day study in male F344/N rats (Khan et al., 2005) 
 Doses (mg sodium chlorate/kg b.w. per day) 
 0.06 3.3 16 120
(a)
 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals 
1/6 5/6 6/6 5/6 
b.w.: body weight. 
(a):  Exposure to measured concentrations in drinking water containing background concentrations of chlorate. 
 
A LOAEL of 3.310 mg sodium chlorate/kg b.w. per day, equivalent to 0.03 mM chlorate/kg b.w. per 
day was established in this study. 
B.2.  Perchlorate 
 
For perchlorate, results reported from a 2-week study with perchlorate in male SD rats (McLanahan et 
al., 2007), a 2-week and a 13-week study with ammonium perchlorate in male and female SD rats 
(Siglin et al., 2000) and from a 7-day study in with ammonium perchlorate in male F344/N rats (Khan 
et al., 2005) were considered. 
Table B5:  Results from the 2-week study in male SD rats (McLanahan et al., 2007) 
 Doses (mg perchlorate/kg b.w. per day) 
 0 0.01 0.1 1.0
(a)
 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals 
0/8 0/8 0/8 0/8 
b.w.: body weight. 
(a):  Poorly reported study. The authors state that no significant changes from control were observed during histopathological 
analysis of the thyroid, without further detail.  
 
A NOAEL of 0.01 mg perchlorate/kg b.w. per day, equivalent to 0.01 mM perchlorate/kg b.w. per day 
was established in this study.
31
 
 
                                                     
31 Conversion factor of 0.010 used to convert doses of perchlorate from mg to mM (MW ClO4
- = 99.45 g/mol). 
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Table B6:  Results from the 2-week study in male and female SD rats (Siglin et al., 2000) 
 Doses (mg ammonium perchlorate/kg b.w. per day) 
Males 0 0.01 0.05 0.2 1.0 10.0 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals 
1/8 0/10 1/10 0/10 0/10 10/10 
 Doses (mg ammonium perchlorate/kg b.w. per day) 
Females 0 0.01 0.05 0.2 1.0 10.0 
Incidence of thyroid gland follicular cell 
hypertrophy/number of animals 
0/10 0/10 0/10 0/10 0/10 7/10 
b.w.: body weight. 
 
A NOAEL of 1.0 mg ammonium perchlorate/kg b.w. per day, equivalent to 0.0085 mM perchlorate/kg 
b.w. per day and a LOAEL 10 mg ammonium perchlorate/kg b.w. per day, equivalent to 0.085 mM 
perchlorate/kg b.w. per day were established in this study.
32
 
Table B7:  Results from the 13-week study with ammonium perchlorate in male and female SD rats 
(Siglin et al., 2000) 
 Doses (mg ammonium perchlorate/kg b.w. per day) 
Males 0 0.01 0.05 0.2 1.0 10.0 
Incidence of thyroid gland follicular 
cell hypertrophy/number of animals 
2/10 0/10 0/10 0/10 1/10 8/10 
 Doses (mg ammonium perchlorate/kg b.w. per day) 
Females 0 0.01 0.05 0.2 1.0 10.0 
Incidence of thyroid gland follicular 
cell hypertrophy/number of animals 
0/10 0/10 0/10 0/10 0/10 9/10 
b.w.: body weight. 
 
A NOAEL of 1.0 mg ammonium perchlorate/kg b.w. per day, equivalent to 0.0085 mM perchlorate/kg 
b.w. per day and a LOAEL of 10 mg ammonium perchlorate/kg b.w. per day, equivalent to 0.085 mM 
perchlorate/kg b.w. per day were established in this study. 
Table B8:  Results from the 7-day study with ammonium perchlorate in male F344/N rats (Khan et 
al., 2005) 
 Doses (mg ammonium perchlorate/kg b.w. per day) 
 0 0.024 0.2 1.2
(a)
 
Incidence of thyroid gland follicular 
cell hypertrophy/number of animals 
1/6 0/5 1/6 6/6 
b.w.: body weight. 
(a):  Exposure via drinking water containing background concentrations of chlorate. The dose of chlorate (expressed as mg 
sodium chlorate/kg b.w. per day) was estimated to be 0.069, 0.091, 0.112 and 0.069 for the control group and the three 
dose groups, respectively. 
 
A NOAEL of 0.205 mg ammonium perchlorate/kg b.w. per day, equivalent to 0.0017 mM 
perchlorate/kg b.w. per day and a LOAEL of 1.170 mg ammonium perchlorate/kg b.w. per day, 
equivalent to 0.0099 mM perchlorate/kg b.w. per day were established in this study. 
                                                     
32 Conversion factor of 0.0085 used to convert doses from mg to mM (MW NH4ClO4 = 117.49 g/mol). 
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Table B9: Summary table comparing results from studies with similar duration on induction of 
thyroid gland follicular cell hyperthrophy with chlorate and perchlorate  
Study duration; 
Compound; 
Strain;  
Reference 
NOAEL 
mM/kg b.w. per day 
 
LOAEL 
mM/kg b.w. per day 
 
 perchlorate chlorate factor perchlorate chlorate factor 
1 week;  
Perchlorate and chlorate; 
F334 rats;  
Khan et al. (2005) 
0.002 n.d. n.a. 0.010 0.030 3 
2 weeks;  
Perchlorate;  
SD rats;  
Siglin et al. (2000) 
 
3 weeks; 
Chlorate; 
F334 rats;  
NTP (2005) 
0.009 0.330 37 0.085 0.700 8 
13 weeks;  
Perchlorate; 
SD rats;  
Siglin et al. (2000) 
 
14 weeks;  
 Chlorate; 
F334 rats;  
NTP (2005) 
0.009 0.100 11 0.085 0.840 10 
105 weeks;  
Chlorate,  
F334 rats;  
NTP (2005) 
n.t. n.d. n.a. n.t. 0.047 n.a 
b.w.: body weight; LOAEL: lowest-observed-adverse-effect level; n.a.: not applicable; n.d.: not derived; NOAEL: no-
observed-adverse-effect level; n.t.: not tested. 
 
Chlorate in food  
 
EFSA Journal 2015;13(6):4135 78 
Appendix C.  Dietary surveys used for the estimation of chronic and acute dietary exposure to chlorate 
Country Survey acronym Survey period 
No of days 
per subject 
 No of subjects/No of days  
Infants Toddlers 
Other 
children 
Adolescents 
(mean age) 
Adults Elderly 
Very 
elderly 
Austria  ASNS - Adults 2010–2012 2     308/726 67/181 25/85 
 ASNS - Children 2010–2012 3   128/384 237/706    
Belgium Regional Flanders 2002–2002 3  36/108 625/1 875 – – – – 
Belgium Diet National 2004 2004 2  – - 
576/1 187 
(16a) 
1 292/2 648 511/1 045 704/1 408 
Bulgaria NSFIN 2004 1    –/162 –/691 –/151 –/200 
Bulgaria NUTRICHILD 2007 2 861/1 720 428/856 433/867 – - - - 
Cyprus Childhealth 2003 3  – - 
303/909 
(13a) 
- - - 
Czech  
Republic 
SISP04 2003–2004 2  – 389/778 
298/596 
(13a) 
1 666/3 332 - - 
Denmark DANSDA 2005-08 2005–2008 7  – 298/2 085 
377/2 622 
(13a) 
1 739/12 127 274/1 916 12/84 
Denmark IAT 2006 07 2006–2007 7 826/5 771 917/6 388 - – – – – 
Estonia NDS 1997 1997 1     –/1 866 – – 
Finland DIPP 2001 2009 2001–2009 3 500/1 500 500/1 500 750/2 250 – – – – 
Finland NWSSP07 08 2007–2008 4  – – 
306/1 186 
(13a) 
– – – 
Finland FINDIET2012 2012 2  – – – 1 295/2 590 413/826 – 
France INCA2 2007 7  – 482/3 315 
973/6 728 
(14a) 
2276/15 727 264/1 824 84/571 
Germany VELS 2001–2002 6 159/927 348/1 947 293/1 610 – – – – 
Germany EsKiMo 2006 3  - 835/2 498 
393/1 179 
(11a) 
– – – 
Germany National Nutrition Survey II 2007 2  - – 
1 011/2 022 
(16a) 
10 419/20 838 2 006/4 012 490/980 
Greece Regional Crete 2004–2005 3   838/2 508 - - – – 
Greece DIET LACTATION GR 2005–2007 3  - - - 65/350 – – 
Hungary National Repr Surv 2003 3  - - - 1 074/3 222 206/618 80/240 
Ireland NANS 2012 2008–2010 4  - - - 1 274/5 096 149/596 77/308 
Italy INRAN SCAI 2005 06 2005–2006 3 16/48 36/108 193/579 
247/741 
(14a) 
2313/6 939 290/870 228/684 
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Country Survey acronym Survey period 
No of days 
per subject 
 No of subjects/No of days  
Infants Toddlers 
Other 
children 
Adolescents 
(mean age) 
Adults Elderly 
Very 
elderly 
Latvia EFSA TEST 2008 2   187/377 
453/979 
(14a) 
1 271/2 655 – – 
Latvia 
FC PREGNANTWOMEN 
2011 
2011 2  – – – 1 002/2 005 – – 
Netherlands VCP kids 2006–2007 3  322/644 957/1 914 – – – – 
Netherlands VCPBasis AVL2007 2010 2007–2010 2  – 447/894 
1 142/2 284 
(14a) 
2 057/4 114 173/346  
Netherlands VCP-Elderly 2010–2012 2  – – – – 289/578 450/900 
Poland IZZ FAO 2000 2000 1  –/79 –/409 
–/666 
(14a) 
–/2 527 –/329 –/124 
Romania Dieta Pilot Children 2012 1  – –/205 
-/567 
(14a) 
– – – 
Romania Dieta Pilot Adults 2012 7  – – – 1 254/8 770 83/581 45/315 
Slovakia SK MON 2008 2008 1  – – – 2 761 – – 
Slovenia CRP 2008 2007–2008 1  – – – 407 – – 
Spain enKid 1998–2000 2  17/34 156/312 
209/418 
(12a) 
- – – 
Spain AESAN 1999–2001 3  – – – 410/828 – – 
Spain NUT INK05 2004–2005 2   399/798 
651/1 302 
(14a) 
- – – 
Spain AESAN FIAB 2009 3  – – 
86/226 
(17a) 
981/2 748 - – 
Sweden NFA 2003 4  – 1 473/5 875 
1 018/4 047 
(12a) 
– - – 
Sweden Riksmaten 2010 2010–2011 4  – – - 1 430/5 680 295/1 167 72/288 
United  
Kingdom 
NDNS-
RollingProgrammeYears1-3 
2008–2011 4  185/737 651/2 595 
666/2 653 
(14a) 
1 266/5 040 166/662 139/552 
United 
Kingdom 
DNSIYC 2011 2011 4 1 369/5 446 1 314/5 217 – – – – – 
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Appendix D.  Chlorate occurrence values in different food commodities 
Table D:  Chlorate occurrence values in different food commodities (μg/kg). Foods were grouped at 
different FoodEx levels depending on their occurrence values before estimating dietary exposure.  
Groups(a) 
(FoodEx level 1) 
Food Commodities(b) N % LC(c) 
Mean Highest 
reliable 
percentile(d) LB UB 
Grains and grain-
based products 
Grains for human consumption (except 
rice) 
36 70 12 13 25 (P90) 
Rice 12 92 57 59 5 (P75) 
Grain milling products 31 52 26 33 100 (P90) 
Pasta (Raw) 6 0 75 75 75 (mean) 
Breakfast cereals 5 80 41 46 46 (mean) 
Fine bakery wares 1 0 33 33 33 (mean) 
Vegetables and 
vegetable products 
(including fungi) 
Vegetables and vegetable products, 
unspecified 
25 40 216 222 100 (P75) 
Root vegetables 245 78 35 41 150 (P95) 
Bulb vegetables (except garlic) 81 90 16 21 15 (P95) 
Garlic, bulb  10 70 201 208 208 (mean) 
Fruiting vegetables (except peppers, chili 
pepper and aubergines) 
1 150 80 22 29 420 (P95) 
Peppers, paprika  400 76 63 70 1 400 (P99) 
Chilli pepper  27 81 164 169 10 (P75) 
Aubergines (egg plants)  73 47 157 164 480 (P95) 
Brassica vegetables (except broccoli) 243 80 23 28 64(P95) 
Broccoli 173 30 351 358 2 400 (P95) 
Leaf vegetables (except Lettuce, excluding 
iceberg-type lettuce) 
591 70 44 48 560 (P99) 
Lettuce, excluding Iceberg-type 
lettuce  
298 66 138 144 600 (P95) 
Legume vegetables 78 86 22 35 100 (P95) 
Stem vegetables (Fresh) (except celery) 178 90 9 13 45 (P95) 
Celery  35 80 240 253 100 (P90) 
Sugar plants 9 56 41 46 46 (mean) 
Tea and herbs for infusions (Solid) 10 50 108 112 112  (mean) 
Cocoa beans and cocoa products 3 67 73 107 107 (mean) 
Vegetable products 24 50 31 41 60  (P75) 
Fungi, cultivated 66 64 29 33 162  (P95) 
Fungi, wild, edible 33 58 43 45 77  (P90) 
Starchy roots and 
tubers 
Potatoes and potatoes products 103 91 5 11 34 (P95) 
Other starchy roots and tubers 19 68 53 59 26 (P75) 
Legumes, nuts and 
oilseeds 
Legumes, beans, green, without pods 167 50 185 189 1 100 (P90) 
Legumes, beans, dried 79 62 84 88 560 (P90) 
Tree nuts 14 71 8 10 10 (P75) 
Legumes, beans, green, with pods 3 67 6 9 9 (mean) 
Fruit and fruit 
products 
Fruit and fruit products, unspecified 4 50 79 84 84 (mean) 
Citrus fruits 383 88 3 9 100 (P99) 
Pome fruits 416 82 4 13 100 (P99) 
Stone fruits 332 88 4 8 100 (P99) 
Berries and small fruits 897 87 8 13 270 (P99) 
Miscellaneous fruits 455 83 7 13 110 (P99) 
Dried fruits 99 43 35 37 134 (P95) 
Jam, marmalade and other fruit spreads 1 100 0 2 - 
Other fruit products (excluding beverages) 20 55 38 40 76 (P75) 
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Groups(a) 
(FoodEx level 1) 
Food Commodities(b) N % LC(c) 
Mean Highest 
reliable 
percentile(d) LB UB 
Milk and dairy 
products 
Milk and dairy products, unspecified 43 74 16 23 67 (P90) 
Liquid milk 38 71 10 17 39 (P90) 
Milk based beverages 2 100 0 10 – 
Concentrated milk 6 67 128 135 135 (mean) 
Whey and whey products (excl. whey 
cheese) 
23 9 347 348 618 (P75) 
Cream and cream products 6 33 32 36 36 (mean) 
Fermented milk products 38 71 10 17 38.5 (P90) 
Milk derivatives 7 43 40 44 44 (mean) 
Cheese 3 67 76 83 83 (mean) 
Sugar and 
confectionary 
Sugars 6 67 109 116 116 (mean) 
Chocolate (Cocoa) products 4 50 32 57 57 (mean) 
Honey 2 100 0 10 – 
Animal and 
vegetable fats and 
oils 
Animal fat 3 67 85 92 92 (mean) 
Fruit and vegetable 
juices 
Fruit juice 33 48 55 57 127 (P90) 
Concentrated fruit juice 4 50 11 16 16 (mean) 
Fruit nectar 27 59 34 39 12 (P75) 
Mixed fruit juice 3 67 8 12 12 (mean) 
Non-alcoholic 
beverages 
(excepting milk 
based beverages) 
Soft drinks 2 0 62 62 62 (mean) 
Tea (Infusion) –(e) 31 28 39 196 (P99) 
Coffee (Beverage) –(e) 31 28 39 196 (P99) 
Alcoholic beverages Beer and beer-like beverage – (e) 31 28 39 196 (P99) 
Wine 37 97 0 3 5 (P90) 
Drinking water  Drinking water  453 31 28 39 196 (P99) 
Herbs, spices and 
condiments 
Herbs 325 51 450 454 8 500 (P99) 
Spices (except paprika powder) 30 90 8 17 72 (P90) 
Paprika powder 11 27 5 118 5 119 5 119 (mean) 
Herb and spice mixtures 7 0 450 450 450 (mean) 
Seasoning or extracts 1 100 0 10 - 
Flavourings or essences 1 100 0 10 - 
Baking ingredients 1 0 26 26 26 (mean) 
Food for infants and 
small children 
Cereal-based food for infants and young 
children 
3 100 0 2 – 
Ready-to-eat meal for infants and young 
children 
20 55 10 13 23 (P75) 
Fruit juice and herbal tea for infants and 
young children 
21 100 0 5 - 
Products for special 
nutritional use 
Dietary supplements 3 67 18 25 25 (mean) 
Composite food 
(including frozen 
products) 
Rice-based meals 1 0 120 120 120 (mean) 
Vegetable-based meals 1 0 55 55 55 (mean) 
Ready to eat soups 11 18 27 29 29 (mean) 
Prepared salads 53 4 129 130 491 (P90) 
LB: Lower bound; P75, 90, 95: 75th, 90th, 95th percentile; UB: Upper bound.  
(a):  Food samples were grouped at FoodEx level 1 to better explain their contribution to the dietary exposure.  
(b):  Within each food group and depending on their reported occurrence values, the samples were grouped at FoodEx level 1 
(bold), level 2 (normal), level 3 (italic), before being linked with the EFSA Comprehensive Food Consumption 
Database. 
(c):  Percentage of left-censored data. 
(d):   The selection of the highest reliable percentiles (at the UB) in each food/food group was based on the number of 
samples available, 60 samples for the 5th and 95th percentile, 11 samples for 25th and 75th percentile, and six samples 
for the median. Otherwise, the percentiles may not be statistically robust. 
(e):  Mean value obtained from the average concentration of 453 samples of ‘Drinking water’ at FoodEx level 1. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Infants 
Grains and grain-based products  3 3    
Vegetables and vegetable products (including fungi)  2  4   
Starchy roots and tubers 3 3     
Legumes, nuts and oilseeds 3 1 2    
Fruit and fruit products  6     
Milk and dairy products    4 2  
Sugar and confectionary 2 3 1    
Animal and vegetable fats and oils 4 2     
Fruit and vegetable juices 2 3 1    
Non-alcoholic beverages (excepting milk based beverages) 2 3  1   
Alcoholic beverages 6      
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
    3 3 
Herbs, spices and condiments 6      
Food for infants and small children 1 3 1 1   
Products for special nutritional use 6      
Composite food (including frozen products) 4 2     
Toddlers 
Grains and grain-based products   7 3   
Vegetables and vegetable products (including fungi)   9 1   
Starchy roots and tubers 5 5     
Legumes, nuts and oilseeds 1 6 3    
Fruit and fruit products  10     
Milk and dairy products    9 1  
Sugar and confectionary 2 8     
Animal and vegetable fats and oils 7 3     
Table continued overleaf. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate (continued) 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Toddlers 
Fruit and vegetable juices  2 3 4 1  
Non-alcoholic beverages (excepting milk based beverages) 2 2 2 3 1  
Alcoholic beverages 10      
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
   2 8  
Herbs, spices and condiments 9 1     
Food for infants and small children 7 3     
Products for special nutritional use 10      
Composite food (including frozen products) 6 3 1    
Other children 
Grains and grain-based products   9 9   
Vegetables and vegetable products (including fungi)  5 11 2   
Starchy roots and tubers 9 9     
Legumes, nuts and oilseeds 7 7 4    
Fruit and fruit products  18     
Milk and dairy products   2 15  1 
Sugar and confectionary 2 16     
Animal and vegetable fats and oils 11 7     
Fruit and vegetable juices 1 1 5 11   
Non-alcoholic beverages (excepting milk based beverages)  3 4 7 4  
Alcoholic beverages 18      
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
1  1 6 10  
Herbs, spices and condiments 14 4     
Food for infants and small children 18      
Products for special nutritional use 18      
Composite food (including frozen products) 9 6 1 2   
Table continued overleaf. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate (continued) 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Adolescents 
Grains and grain-based products   6 11   
Vegetables and vegetable products (including fungi)  4 10 3   
Starchy roots and tubers 8 9     
Legumes, nuts and oilseeds 5 6 6    
Fruit and fruit products 1 16     
Milk and dairy products   8 9   
Sugar and confectionary 1 16     
Animal and vegetable fats and oils 13 4     
Fruit and vegetable juices 1 1 10 5   
Non-alcoholic beverages (excepting milk based beverages)   2 9 6  
Alcoholic beverages 12 5     
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
1  1 5 10 
 
Herbs, spices and condiments 13 4     
Food for infants and small children 17      
Products for special nutritional use 17      
Composite food (including frozen products) 8 5 3 1   
Adults 
Grains and grain-based products  3 13 1   
Vegetables and vegetable products (including fungi)  3 8 5 1  
Starchy roots and tubers 11 6     
Legumes, nuts and oilseeds 6 8 3    
Fruit and fruit products  17     
Milk and dairy products  1 12 4   
Sugar and confectionary 4 12 1    
Table continued overleaf. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate (continued) 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Adults 
Animal and vegetable fats and oils 12 5     
Fruit and vegetable juices 2 10 4 1   
Non-alcoholic beverages (excepting milk based beverages)   3 4 10  
Alcoholic beverages  11 5 1   
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
  2 2 13 
 
Herbs, spices and condiments 11 5 1    
Food for infants and small children 17      
Products for special nutritional use 17      
Composite food (including frozen products) 8 6 1 1 1  
Elderly 
Grains and grain-based products  4 7 3   
Vegetables and vegetable products (including fungi)   7 6 1  
Starchy roots and tubers 6 8     
Legumes, nuts and oilseeds 4 8 2    
Fruit and fruit products  14     
Milk and dairy products  1 12 1   
Sugar and confectionary 3 10 1    
Animal and vegetable fats and oils 8 6     
Fruit and vegetable juices 1 11 2    
Non-alcoholic beverages (excepting milk based beverages)   1 4 9  
Alcoholic beverages 1 8 5    
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
  1 5 8 
 
Herbs, spices and condiments 11 2 1    
Food for infants and small children 14      
Products for special nutritional use 14      
Composite food (including frozen products) 7 4 1 2   
Table continued overleaf. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate (continued) 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Very elderly 
Grains and grain-based products  3 6 3   
Vegetables and vegetable products (including fungi)  1 5 5 1  
Starchy roots and tubers 5 7     
Legumes, nuts and oilseeds 3 6 3    
Fruit and fruit products  12     
Milk and dairy products  1 8 3   
Sugar and confectionary 4 7 1    
Animal and vegetable fats and oils 5 7     
Fruit and vegetable juices 2 9 1    
Non-alcoholic beverages (excepting milk based beverages)   1 5 6  
Alcoholic beverages 2 9 1    
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
  1 6 5 
 
Herbs, spices and condiments 9 2  1   
Food for infants and small children 12      
Products for special nutritional use 12      
Composite food (including frozen products) 5 4 1 2   
Vulnerable 
groups  
Pregnant women 
Grains and grain-based products    1   
Vegetables and vegetable products (including fungi)   1    
Starchy roots and tubers  1     
Legumes, nuts and oilseeds  1     
Fruit and fruit products  1     
Milk and dairy products    1   
Sugar and confectionary  1     
Animal and vegetable fats and oils  1     
Table continued overleaf. 
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Appendix E:  Average contribution of the FoodEx Level 1 category to the total average chronic dietary exposure to chlorate (continued) 
Age class FoodEx Level 1 category 
Number of dietary surveys 
(% average contribution under the Middle Bound scenario) 
 
< 1 % 1–5 % 5–10 % 10–25 % 25–50 % 50–75 % 
Vulnerable 
groups  
Pregnant women 
Fruit and vegetable juices  1     
Non-alcoholic beverages (excepting milk based beverages)    1   
Alcoholic beverages 1      
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
   1  
 
Herbs, spices and condiments  1     
Food for infants and small children 1      
Products for special nutritional use 1      
Composite food (including frozen products) 1      
Vulnerable 
groups  
Lactating women 
Grains and grain-based products    1   
Vegetables and vegetable products (including fungi)    1   
Starchy roots and tubers 1      
Legumes, nuts and oilseeds  1     
Fruit and fruit products  1     
Milk and dairy products    1   
Sugar and confectionary  1     
Animal and vegetable fats and oils 1      
Fruit and vegetable juices    1   
Non-alcoholic beverages (excepting milk based beverages)    1   
Alcoholic beverages  1     
Drinking water (water without any additives except carbon dioxide; 
includes water ice for consumption) 
1     
 
Herbs, spices and condiments 1      
Food for infants and small children 1      
Products for special nutritional use 1      
Composite food (including frozen products)   1    
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Appendix F.  Exposure estimates for chlorate obtained in different dietary surveys 
Table F:  Mean and 95th percentile (P95) chronic dietary exposure to chlorate (µg/kg b.w. per day) for total population in lower-bound (LB) and upper-
bound (UB) scenario 
Dietary surveys 
 Range of dietary exposure (LB–UB) (µg/kg b.w. per day) 
Infants Toddlers Other children Adolescents Adults Elderly Very elderly 
Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 
ASNS - Adults         1.2–1.5 2.3–2.8 0.88–1.1 1.5–1.7 1.1–1.4 –(a) 
ASNS – Children     2.1–2.5 3.9–4.3 1.2–1.4 2.3–2.6       
Regional Flanders   2.8–3.3 –(a) 2.3–2.7 3.9–4.5         
Diet National 2004       1.2–1.4 2.0–2.3 1.2–1.4 2.0–2.3 0.89–1.1 1.5–1.9 0.82–1.0 1.4–1.8 
NUTRICHILD 2.4–3.1 5.0–6.6 2.6–3.2 4.1–5.2 2.3–2.9 4.1–5.0         
Childhealth       0.53–0.62 1.1–1.2       
SISP04     1.9–2.3 3.4–4.2 1.4–1.7 2.6–3.0 1.1–1.4 1.8–2.3     
DANSDA 2005-08     1.9–2.4 3.2–4.0 1.3–1.6 2.2–2.6 1.3–1.6 2.1–2.7 1.1–1.4 1.9–2.5 1.2–1.6 –(a) 
IAT 2006 07 2.1–2.8 3.6–4.7 2.1–2.8 3.2–4.2           
DIPP 2001 2009 1.7–2.1 3.4–4.2 2.7–3.5 4.1–5.3 2.1–2.6 3.2–3.8         
NWSSP07 08       1.1–1.4 1.7–2.1       
FINDIET2012         1.1–1.4 1.9–2.3 0.86–1.1 1.4–1.8   
INCA2     1.9–2.4 3.2–4.0 1.0–1.3 1.8–2.2 1.0–1.3 1.8–2.2 0.96–1.2 1.6–2.0 0.92–1.2 1.7–2.2 
VELS 1.8–2.4 3.3–4.3 2.7–3.2 4.8–5.4 2.3–2.7 3.5–4.0         
EsKiMo     2.0–2.4 3.3–3.8 1.6–1.9 2.6–3.0       
National Nutrition Survey II       1.2–1.5 2.2–2.6 1.3–1.6 2.1–2.6 1.1–1.4 1.7–2.2 1.0–1.3 1.6–2.1 
Regional Crete     1.9–2.1 3.7–3.9         
DIET LACTATION GR         0.55–0.65 0.96–1.1     
National Repr Surv         0.66–0.81 1.2–1.4 0.56–0.69 0.97–1.2 0.57–0.69 0.98–1.2 
NANS 2012         0.93–1.2 1.7–2.2 0.85–1.1 1.6–2.1 0.75–0.96 1.2–1.6 
INRAN SCAI 2005 06 2.9–4.1 –(a) 2.6–3.3 –(a) 1.9–2.4 3.3–4.2 1.2–1.4 2.0–2.4 0.87–1.1 1.5–1.8 0.77–0.97 1.2–1.6 0.8–1.0 1.2–1.6 
EFSA TEST     1.3–1.5 2.5–2.7 0.9–1.1 1.8–2.0 0.69–0.84 1.3–1.5     
FC PREGNANTWOMEN 2011         0.83–1.1 1.4–1.8     
VCP kids   2.3–2.9 4.0–5.0 2.0–2.5 3.9–4.5         
VCPBasis AVL2007 2010     1.8–2.1 3.0–3.3 1.3–1.5 2.2–2.5 1.2–1.4 2.0–2.4 0.95–1.2 1.6–2.0   
VCP-Elderly           0.96–1.2 1.5–1.9 0.91–1.2 1.4–1.9 
Dieta Pilot Adults         0.73–0.90 1.4–1.8 0.67–0.83 1.3–1.8 0.71–0.87 –(a) 
enKid   2.2–2.9 –(a) 1.6–2.1 3.2–3.9 0.94–1.2 1.7–2.1       
AESAN         0.78–0.97 1.5–1.9     
NUT INK05     1.7–2.2 2.7–3.4 1.1–1.4 1.8–2.2       
AESAN FIAB       0.81–1.0 1.4–1.8 0.79–0.99 1.6–1.9     
NFA     1.6–1.9 2.8–3.2 1.0–1.2 1.9–2.2       
Riksmaten 2010         0.95–1.2 1.7–2.0 0.8–1.0 1.4–1.8 0.8–1.1 1.4–1.8 
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Dietary surveys 
 Range of dietary exposure (LB–UB) (µg/kg b.w. per day) 
Infants Toddlers Other children Adolescents Adults Elderly Very elderly 
Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 Mean P95 
NDNS-RollingProgrammeYears1-3   2.6–3.2 4.3–5.2 2.0–2.4 3.2–3.8 1.1–1.3 2.0–2.4 1.0–1.3 1.8–2.2 0.90–1.1 1.5–1.8 0.9–1.1 1.4–1.8 
DNSIYC 2011 1.6–2.0 3.4–4.1 2.3–2.9 4.0–4.8           
b.w.: body weight; LB: lower bound; P95: 95th percentile; UB: upper bound. 
(a):  95th percentile calculated over a number of observations lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b). 
(b):  Details on the dietary surveys and the number of subjects are given in Appendix C. 
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Appendix G.  Range of acute exposure estimates for individual food commodities assuming an occurrence value of 0.7 mg/kg 
Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown.  
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Alcoholic beverages Beer and beer-like beverage Beer and beer-like beverage 0.75–15.62 7.78–37.38 
Wine Wine, red 0.01–3.93 0.01–8.28 
Wine 0.09–4.46 1.98–8.24 
Wine, white 0.00–10.61 0.01–8.18 
Drinking water  Drinking water  Drinking water  1.15–47.66 3.33–111.31 
Fruit and fruit products Pome fruits Pear (Pyrus communis) 0.16–7.33 2.08–19.77 
Apple (Malus domesticus) 0.90–9.52 1.62–16.20 
Berries and small fruits Raspberries (Rubus idaeus) 0.01–8.54 0.15–4.58 
Blueberries (Vaccinium corymbosum) 0.06–3.97 1.03–4.02 
Strawberries (Fragaria × ananassa) 0.05–7.09 0.49–10.50 
Table grapes (Vitis euvitis) 0.35–6.29 1.28–10.00 
Bilberry or whortleberry (Vaccinium spp.) 0.25–3.20 0.68–6.86 
Blackberries (Rubus fruticosus) 0.04–4.79 – 
Cranberries (Vaccinium macrocarpon) 0.03–3.25 – 
Cranberry (Vaccinium spp.) 0.14–0.59 – 
Physalis (Physalis peruviana) 0.38–0.65 – 
Currants (red, black and white)  0.00–7.37 0.00–3.32 
Gooseberries (Ribes uva-crispa) 0.08–4.14 1.62–1.62 
Berries and small fruits 0.16–4.94 1.05–1.36 
Rose hips (Rosa canina) 0.02–1.48 3.21–3.70 
Wine grapes (Vitis euvitis) 0.90–2.34 3.27–3.65 
Lingonberry (Vaccinium vitis-idaea) 0.08–0.96 1.67–2.85 
Citrus fruits Mandarins (Citrus reticulata) 0.21–11.29 1.08–11.57 
Oranges (Citrus sinensis) 0.19–10.63 1.01–9.80 
Citrus fruits 0.77–7.39 3.74–5.83 
Grapefruit (Citrus paradisi) 0.09–10.43 0.19–2.74 
Lemons (Citrus limon) 0.00–1.66 0.00–1.75 
Limes (Citrus aurantifolia) 0.02–1.31 – 
Pomelo (Citrus grandis) 0.75–10.61 – 
Table continued overleaf. 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued)  
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Fruit and fruit products Stone fruits Plums (Prunus domestica) 0.18–5.30 0.98–7.00 
Sweet cherry (Prunus avium) 0.02–5.25 1.74–10.08 
Peaches (Prunus persica) 0.15–12.36 1.67–9.38 
Apricots (Prunus armeniaca) 0.05–4.70 0.88–4.67 
Sour cherry (Prunus cerasus) 0.34–6.02 1.43–3.14 
Greengage (Prunus domestica var italica) 0.24–10.77 3.36–3.36 
Mirabelle (Prunus domestica var syriaca) 0.30–7.86 – 
Dried fruits Dried prunes (Prunus domestica) 0.01–1.26 0.20–3.98 
Dried vine fruits (currants, raisins and sultanas) 0.02–2.10 0.09–3.00 
Dried bananas (Musa × paradisica) 0.05–3.45 0.28–0.38 
Dried mangoes (Mangifera indica) 0.16–1.28 – 
Dried pears  (Pyrus communis) 0.03–0.37 – 
Pome fruits Medlar (Mespilus germanica) 0.50–3.13 – 
Nashi pear (Pyrus pyrifolia) 2.65–2.65 – 
Quince (Cydonia oblonga) 0.02–1.42 – 
Miscellaneous fruits Bananas (Musa × paradisica) 0.82–7.33 1.36–13.53 
Avocados (Persea americana) 0.11–5.56 1.34–9.02 
Kiwi (Actinidia deliciosa syn. A. chinensis) 0.31–5.79 1.18–9.01 
Pineapples (Ananas comosus) 0.09–6.15 1.63–8.95 
Mangoes (Mangifera indica) 0.51–5.20 2.11–8.10 
Persimmon (Sharon fruit) (Diospyros kaki) 0.27–6.28 0.70–3.25 
Papaya (Carica papaya) 0.01–6.28 0.24–0.24 
American persimmon (Virginia kaki) - 0.35–0.35 – 
Carambola (Averrhoa carambola) 0.55–2.92 – 
Cherimoya (Annona cherimola) 1.13–1.56 – 
Dates (Phoenix dactylifera) 0.09–1.42 – 
Table continued overleaf. 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Fruit and fruit products Miscellaneous fruits Figs (Ficus carica) 0.08–3.89 – 
Longan fruit (Dimocarpus longan) 2.13–2.13 – 
Lychee (Litchi) (Litchi chinensis) 0.14–5.08 – 
Miscellaneous fruits 0.56–3.60 – 
Passion fruit (Passiflora edulis) 0.12–1.20 – 
Pomegranate (Punica granatum) 0.14–5.17 – 
Prickly pear (cactus fruit)  0.71–5.00 – 
Jam, marmalade and other fruit 
spreads 
Jam 0.17–2.32 0.43–6.43 
Other fruit products (excluding 
beverages) 
Fruit, purèe 0.63–8.39 3.25–12.86 
Fruit compote 0.09–7.27 2.40–18.85 
Fruit, canned 0.23–4.91 1.31–14.15 
Other fruit products (excluding beverages) 0.00–7.88 0.04–0.06 
Fruit and vegetable 
juices 
Fruit juice Juice, Apple 0.80–14.12 3.14–28.50 
Juice, Orange 0.80–13.92 2.36–25.67 
Juice, Grape 0.08–30.56 5.25–18.04 
Juice, Passion fruit 0.03–3.30 0.72–0.72 
Juice, Pear 0.07–7.27 – 
Juice, Prune 0.26–7.52 – 
Mixed fruit juice 
Juice, Strawberry-Cherry 1.72–1.72 – 
Mixed fruit juice 1.41–6.10 – 
Concentrated fruit juice Concentrated fruit juice 0.00–6.16 0.52–24.82 
Fruit nectar Nectar, Apple 1.70–11.64 20.00–20.00 
Fruit nectar 0.45–12.89 7.09–18.10 
Nectar, Banana 1.07–10.45 – 
Nectar, Mango 0.71–5.15 – 
Nectar, Pear 1.90–13.37 – 
Nectar, Pineapple 2.31–6.78 – 
Table continued overleaf. 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Grains and grain-based 
products 
Grains for human consumption Rice 0.16–13.13 0.57–12.18 
Corn grain 0.08–10.37 0.25–6.03 
Wheat grain 0.00–3.19 0.01–5.83 
Millet grain 0.12–3.17 1.31–1.31 
Barley grain 0.05–2.93 0.39–0.91 
Buckwheat grain 0.02–2.69 – 
Oats, grain 0.01–1.93 – 
Spelt grain 0.36–1.20 – 
Grain milling products 
Corn milling products 0.01–2.68 0.08–3.46 
Rye milling products 0.02–2.50 0.06–1.75 
Other milling products 0.03–4.55 0.51–1.50 
Oat milling products 0.06–1.94 0.72–0.72 
Spelt milling products 0.07–0.35 – 
Wheat milling products 0.05–2.94 0.10–6.09 
Pasta (Raw) Pasta (Raw) 0.05–4.67 0.65–11.41 
Pasta, wheat flour, without eggs 0.32–5.26 0.75–9.00 
Fine bakery wares Pastries and cakes 0.53–5.14 1.35–9.10 
Breakfast cereals Cereal flakes 0.10–2.40 0.39–4.94 
Mixed breakfast cereals 0.13–2.54 0.65–4.50 
Herbs, spices and 
condiments 
Spices Pepper, black and white (Piper nigrum) 0.00–2.62 0.00–2.60 
Ginger (Zingiber officinale) 0.00–0.52 0.11–0.23 
Cloves (Syzygium aromaticum) 0.00–0.07 – 
Spices 0.00–0.27 0.00–0.09 
Paprika powder 0.00–0.39 0.01–0.07 
Turmeric (Curcuma) 0.00–0.03 0.02–0.07 
Herbs Chervil, herb (Anthriscus cerefolium) 0.00–0.51 – 
Chives, herb (Allium schoenoprasum) 0.00–0.52 0.02–0.92 
Herbs 0.00–0.32 0.00–0.50 
Parsley, herb (Petroselinum crispum) 0.00–0.23 0.01–0.38 
Dill, herb (Anethum graveolens) 0.00–0.20 0.02–0.18 
Table continued overleaf. 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Herbs, spices and 
condiments 
Herbs Basil, herb (Ocimum basilicum) 0.00–0.11 0.03–0.15 
Thyme, herb (Thymus spp.) 0.00–0.06 0.01–0.04 
Sage, herb (Salvia officinalis) 0.00–0.22 0.01–0.01 
Rosemary, herb (Rosmarinus officinalis) 0.00–0.05 – 
Tarragon, herb (Artemisia dracunculus) 0.00–0.09 – 
Seasoning or extracts Salt 0.00–0.16 0.01–0.35 
Herb and spice mixtures Mixed herbs 0.03–1.28 0.05–0.14 
Flavourings or essences Vanilla pods  0.00–0.03 0.04–0.06 
Legumes, nuts and 
oilseeds 
Legumes, beans, dried Beans (Phaseolus vulgaris) 0.21–4.84 0.56–13.13 
Lentils (Lens culinaris syn. L. esculenta) 0.08–8.71 0.77–8.24 
Broad bean (Vicia faba) 0.07–3.54 4.73–4.73 
Mung bean (Phaseolus aureus) 0.20–1.76 0.77–4.52 
Black eye bean (Vigna unguiculata) 2.59–5.07 4.29–4.29 
Chick pea (Cicer arietinum) 0.05–4.37 1.27–4.16 
Peas (Pisum sativum) 0.04–4.47 0.15–3.30 
Peanut (Arachis hypogea) 0.05–4.32 0.50–2.06 
Soya beans (Glycine max) 0.05–3.78 0.61–1.36 
Legumes, beans, dried 0.35–6.98 – 
Legumes, beans, green, without 
pods 
 
Peas, green, without pods (Pisum sativum) 0.08–5.95 0.18–9.44 
Beans, green, without pods (Phaseolus vulgaris) 0.04–4.31 2.06–4.60 
Legumes, beans, green, without pods 0.31–3.97 – 
Lentils, green (Lens culinaris syn. L. esculenta) 0.09–1.95 – 
Tree nuts Chestnuts (Castanea sativa) 0.05–2.31 2.01–2.01 
Walnuts (Juglans regia) 0.02–1.45 0.34–1.71 
Hazelnuts (Corylus avellana) 0.00–2.50 0.26–1.49 
Cashew nuts (Anacardium occidentale) 0.03–2.06 0.52–1.25 
Pistachios (Pistachia vera) 0.02–5.60 0.67–0.67 
Coconuts (Cocos nucifera) 0.00–1.62 0.10–0.45 
Almond, bitter (Prunus amygalus amara) 0.01–0.56 – 
Table continued overleaf. 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Milk and dairy products Liquid milk Cow milk 0.91–25.42 3.07–55.95 
Liquid milk 0.15–17.35 4.59–43.08 
Milk based beverages Flavoured milk 0.17–11.90 4.67–30.27 
Milk derivatives Lactose 0.00–0.44 0.01–1.33 
Fermented milk products Fermented milk products 0.83–14.20 1.62–32.40 
Cheese Cheese 0.08–4.53 0.24–7.78 
Cream and cream products Cream 0.07–1.82 0.32–3.13 
Cream and cream products 0.10–0.78 0.00–0.00 
Concentrated milk Dried milk 0.02–10.05 0.08–1.84 
Whey and whey products 
(excluding whey cheese) 
Whey dried 0.00–0.72 0.00–1.78 
Whey and whey products (exc. whey cheese) 0.28–6.37 1.27–1.27 
Non-alcoholic beverages 
(excepting milk-based 
beverages) 
Tea (Infusion) Tea (Infusion) 0.80–13.84 3.65–26.73 
Coffee (Beverage) Coffee (Beverage) 0.06–14.48 2.34–14.08 
Soft drinks Soft drinks 0.21–12.28 2.87–26.25 
Cola beverages, caffeinic 0.88–9.66 4.70–19.94 
Starchy roots and tubers Potatoes and potatoes products Main-crop potatoes 0.09–7.29 1.48–14.51 
New potatoes 0.36–7.78 1.19–7.00 
Potatoes and potatoes products 0.44–5.89 1.52–12.21 
Potato boiled 1.21–7.76 2.19–11.50 
Other starchy roots and tubers Sweet potatoes (Ipomoea batatas) 0.28–5.65 4.92–7.32 
Jerusalem artichokes tubers  0.44–4.01 – 
Other starchy roots and tubers 1.34–1.34 – 
Sugar and confectionary Sugars White sugar 0.07–1.70 0.23–4.39 
Chocolate (Cocoa) products Chocolate (Cocoa) products 0.07–1.28 0.40–3.16 
Chocolate bar 0.22–3.14 0.93–2.35 
Bitter chocolate 0.06–1.39 0.36–2.33 
White chocolate 0.05–1.94 1.90–1.93 
Sugars Sugars 0.10–0.59 0.30–2.19 
Honey Honey 0.02–0.94 0.06–1.31 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Vegetables and vegetable 
products (including fungi) 
Brassica vegetables Head cabbage  0.44–4.99 1.04–9.31 
Kohlrabi  0.13–4.47 0.78–7.78 
Cauliflower (Brassica oleracea var. botrytis) 0.06–8.48 0.58–6.60 
Broccoli (Brassica oleracea var. italica) 0.36–7.29 1.07–6.21 
Brussels sprouts  0.12–5.37 0.25–3.21 
Kale (Brassica oleracea convar. Acephalea) 0.04–3.24 0.04–3.11 
Brassica vegetables 0.41–1.48 1.72–1.77 
Chinese cabbage (Brassica pekinensis) 0.09–4.18 0.80–1.56 
Bulb vegetables Onions, bulb (Allium cepa) 0.10–1.33 0.33–3.50 
Spring onions, bulb (Allium cepa) 0.03–2.43 0.07–1.78 
Garlic, bulb (Allium sativum) 0.00–0.58 0.02–0.90 
Shallots, bulb  0.04–0.40 0.17–0.23 
Cocoa beans and cocoa products Cocoa powder 0.02–1.08 0.03–1.73 
Cocoa beans and cocoa products 0.63–0.74 – 
Fruiting vegetables Melons (Cucumis melo) 0.20–11.74 2.85–13.48 
Watermelons (Citrullus lanatus) 0.62–11.86 1.58–12.00 
Cucumbers (Cucumis sativus) 0.17–3.13 0.42–9.21 
Tomatoes (Lycopersicum esculentum) 0.26–3.77 0.88–8.97 
Courgettes (Zucchini)  0.14–4.07 0.92–6.92 
Sweet corn (Zea mays var. saccharata) 0.10–6.13 0.27–6.79 
Gherkins (Cucumis sativus) 0.06–3.80 0.27–5.59 
Peppers, paprika (Capsicum annuum, var. grossum 
and var. longum) 
0.09–1.35 0.30–4.22 
Pumpkins (Cucurbita maxima) 0.00–8.26 0.03–3.47 
Aubergines (egg plants) (Solanum melongena) 0.09–5.64 0.46–3.39 
Chilli pepper (Capsicum frutescens) 0.01–0.45 0.11–0.91 
Okra, lady’s fingers (Hibiscus esculentus) 0.10–4.01 – 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Vegetables and vegetable 
products (including 
fungi) 
Fungi, cultivated Cultivated mushroom (syn. Button mushroom)  0.16–3.73 0.52–3.50 
Fungi, cultivated 0.05–4.00 0.99–2.80 
Oyster mushroom (Pleurotus ostreatus) 0.20–1.09 – 
Shiitake mushroom (Lentinus edodes) 0.20–1.14 – 
Fungi, wild, edible Boletus (Boletus (and other) spp.) 0.39–4.94 2.50–2.50 
Fungi, wild, edible 0.04–1.75 1.07–2.07 
Cantharelle (Cantharellus cibarius) 0.05–1.41 – 
Leaf vegetables Spinach (fresh) (Spinacia oleracea) 0.10–7.40 0.73–6.75 
Leaf vegetables 0.01–3.32 0.48–6.73 
Spinach  (Spinacia oleracea), preserved, deep-frozen 
or frozen 
0.22–3.94 1.53–6.67 
Endive, scarole (broad-leaf endive)  0.01–4.40 0.70–5.38 
Beet leaves (Beta vulgaris) 0.09–3.22 1.57–4.02 
Witloof (Cichorium intybus. var. foliosum) 0.39–2.54 1.50–3.72 
Lettuce, excluding Iceberg-type lettuce  0.14–11.31 0.35–3.57 
Iceberg-type lettuce 0.00–2.42 0.24–2.61 
Lamb's lettuce (Valerianella locusta) 0.08–1.14 0.71–1.00 
Rocket, Rucola (Eruca sativa, Diplotaxis spec.) 0.04–1.02 0.36–0.77 
Water cress (Nasturtium officinale) 0.01–0.79 0.38–0.38 
Cress (Lepidium sativum) 0.02–1.26 – 
Dandelion leaf (Taraxacum officinalis) 0.00–3.75 – 
Land cress (Barbarea verna) 0.05–0.13 – 
Sorrel (Rumex spp.) 0.00–9.33 – 
Vine leaves (grape leaves) (Vitis euvitis) 0.01–0.53 – 
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Table G:  Range of estimates of acute exposure to chlorate food by food across dietary surveys (µg/kg b.w. per day, only consumers) assuming an 
occurrence value of 0.7 mg/kg in all food commodities. Mean and 95th percentile acute exposures are shown. (continued) 
FoodEx Level 1 FoodEx Level 2 FoodEx Level 3 
Range of acute exposure (µg/kg b.w. per day)
(a)
 
Mean exposure P95 dietary exposure
(b)
 
Vegetables and vegetable 
products (including 
fungi) 
Legume vegetables Beans, with pods (Phaseolus vulgaris) 0.03–7.10 0.31–5.65 
Peas, with pods (Pisum sativum) 0.28–2.21 0.67–2.41 
Legume vegetables 0.03–1.23 0.09–0.64 
Root vegetables Carrots (Daucus carota) 0.10–4.69 0.27–10.35 
Parsnips (Pastinaca sativa) 0.03–8.43 0.35–4.13 
Beetroot (Beta vulgaris subsp. vulgaris) 0.06–3.28 0.43–3.89 
Salsify (Tragopogon porrifolius) 0.22–2.25 2.23–3.72 
Turnips (Brassica rapa) 0.07–4.38 0.20–3.46 
Radishes (Raphanus sativus var. sativus) 0.01–2.10 0.43–2.06 
Celeriac (Apium graveolens var. rapaceum) 0.01–9.38 0.01–1.84 
Parsley root (Petroselinum crispum) 0.02–1.12 0.03–1.20 
Stem vegetables (Fresh) Leek (Allium porrum) 0.03–2.88 0.16–4.36 
Asparagus (Asparagus officinalis) 0.08–3.40 0.40–4.30 
Celery (Apium graveolens var. dulce) 0.02–3.85 0.15–3.64 
Fennel (Foeniculum vulgare) 0.02–4.76 0.07–3.24 
Globe artichokes (Cynara scolymus) 0.08–2.30 1.67–3.09 
Rhubarb (Rheum × hybridum) 0.08–6.19 0.13–0.87 
Sugar plants Chicory roots (Cichorium intybus) 0.88–2.96 2.80–3.28 
Tea and herbs for infusions 
(Solid) 
Peppermint (Mentha × piperita) 0.00–0.09 – 
Vegetable products Sauerkraut 0.45–2.28 1.17–5.83 
Tomato purée 0.02–1.19 0.08–4.27 
Sun-dried tomatoes 0.07–0.87 – 
b.w.: body weight; P95: 95th percentile.  
(a):  Range of acute exposure food by food across dietary surveys and age classes. 
(b):  The 95th percentile estimates obtained on dietary surveys/age classes with less than 60 observations may not be statistically robust (EFSA, 2011b). Those estimates were not included in this 
table.  
(c):   In specific dietary surveys the consumption of drinking water is missing (‘Regional Crete’ and ‘Childhealth’) or underreported (‘National Dietary Survey’ and ‘National Repr Surv’). 
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GLOSSARY  
Acidophilic cells of the 
pituitary gland 
Summary term for the two different types of cells of the anterior 
pituitary gland, somatothrophes (which generate somatropin, i.e. 
growth hormone) and mammotrophs (which generate prolactin). 
Hofmeister or lyotropic series Classification of ions in their ability to decrease or increase the 
solubility of nonpolar molecules. 
Anuria (Complete) absence of urinary output. 
Ataxia Lack of coordination of the voluntary muscles, resulting in 
irregular movements of the body. 
Blood osmotic fragility Degree/proportion of haemolysis of red blood cells under osmotic 
stress (placement in hypotonic solution). 
Chaotropic Ability to destabilize hydrogen bonding and hydrophobic 
interactions. 
Chromophobic cells of the 
pituitary gland 
One of three cell types (basophiles and acidophiles being the 
others) of the pituitary gland. 
Codocytes (leptocytes) Red blood cells, characterized by a disproportional increase in the 
surface membrane area to volume ratio and decreased osmotic 
fragility. 
Echinocytes Red blood cells which have become crenated/have an abnormal 
cell membrane. 
Extramedullary 
haematopoiesis  
Refers to haematopoiesis occurring outside of the medulla of the 
bone. 
Haematuria Presence of blood or red blood cells in the urine. 
Haemoglobinaemia Presence of excessive free haemoglobin in the blood plasma. 
Haemoglobinuria The presence of haemoglobin in the urine. 
Haemolysis  Disintegration of red blood cells, with the release of haemoglobin, 
occurring in the living organism or in a blood sample. 
Hyperthyroidism Overproduction of the thyroid hormone by excessive activity of 
the thyroid gland; characterized by increased basal metabolism. 
Hypothalamic-pituitary-
thyroid (HPT) feedback 
pathway 
Part of the endocrine system responsible for the regulation of 
metabolism; it depends upon the hypothalamus, pituitary gland 
and thyroid gland. 
Hypothyroidism Insufficient production of thyroid hormones by insufficient 
functioning of the thyroid gland. 
Intravascular coagulation Formation of blood clots within one or more blood vessels. 
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Methaemoglobin Is a form of the oxygen-carrying metalloprotein haemoglobin, in 
which the iron in the haem group is in the Fe
3+
 (ferric) state and 
not the Fe
2+
 (ferrous) state of normal haemoglobin. 
Multinodular toxic goitre A thyroid gland that contains autonomously functioning thyroid 
nodules, with resulting hyperthyroidism. 
Reticulocyte Immature red blood cells 
Segmented neutrophils Subdivision of neutrophil granulocytes/neutrophils; 2nd 
subdivision banded neutrophils. 
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ABBREVIATIONS  
2-AA 2-aminoanthracene 
4-NQO 4-nitroquinoline-N-oxide 
ADI Acceptable Daily Intake 
AFC Panel 
EFSA Panel on Food Additives, Flavourings, Processing Aids and Materials in 
Contact with Food 
ALT Alanine aminotransferase 
AOEL Acceptable Operator Exposure Level 
ARfD Acute Reference Dose 
ASC Acidified Sodium Chlorite 
AST Aspartate aminotransferase 
B(a)P Benzo(a)pyrene 
BE Belgium 
BfR Bundesamt für Risikobewertung (Germany) 
BMDL10 Benchmark dose lower confidence limit 
BMD Benchmark dose 
b.w. Body weight 
CHO Chinese Hamster Ovary  
CI Confidence interval 
ClO3
-
 Chlorate 
ClO2
-
 Chlorite 
Cl
-
 Chloride 
CONTAM Panel EFSA Panel on Contaminants in the Food Chain 
CP Chlorambucil 
CVUA Chemisches und Veterinaeruntersuchungsamt Stuttgart 
CZ The Czech Republic 
DAR Draft Assessment Report (EU) 
DATA Unit EFSA Evidence Management Unit 
DBPs Disinfection by-products 
DE Germany 
DIPP Dietary survey 
DMBA 7, 12-dimethylbenzanthracene 
DNEL Derived no effect level 
EC European Commission 
EC50 Half maximal effective concentration 
ECD Electrical conductivity detection 
ECETOC European Centre for Ecotoxicology and Toxicology of Chemicals 
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ECHA European Chemicals Agency 
EMS Ethylmethanesulfonate 
ES Spain 
FAO Food and Agriculture Organization of the United Nations 
FoodEx EFSA Food classification and description system for exposure assessment 
Freshfel European Fresh Produce Association 
GSH Glutathione 
GSSG Oxidised glutathione 
HeLa Human Epitheloid Cervix Carcinoma Cell Line 
HepG2 Human Hepatocyte Carcinoma Cell Line 
HPLC High Performance Liquid Chromatography 
HPT Hypothalamic-Pituitary-Thyroid (feedback pathway) 
I Iodine 
IC50 Half maximal inhibitory concentration 
JECFA Joint FAO/WHO Expert Committee on Food Additives 
KClO3 Potassium chlorate 
LB Lower Bound 
LC50 Medium lethal concentration 
LC Left-censored (data) 
LC-MS Liquid Chromatography-Mass Spectrometry 
LC-MS/MS Liquid Chromatography-tandem Mass Spectrometry 
LD50 Medium lethal dose 
LOAEL Lowest Observed Adverse Effect Level 
LOD Limit of Detection 
LOQ Limit of Quantification 
MMC Mitomycin C 
MRL Maximum Residue Limit 
MS Mass Spectrometry 
MS/MS Tandem Mass Spectrometry 
n.a. not applicable 
NaCl Sodium chloride 
NaClO3 Sodium chlorate 
n.d. not derived 
NADPH Nicotinamide Adenine Dinucleotid Phosphate 
NCE Normochromatic erythrocytes  
NIS Sodium-Iodine Symporter 
NOAEL No Observed Adverse Effect Level 
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NOEL No Observed Effect Level 
NRC National Research Council of the National Academics (U.S.) 
n.t. not tested 
NTP National Toxicology Program 
OECD Organisation for Economic Co-operation and Development 
O2 Oxygen 
OR Odds ratio 
PCE Polychromatic erythrocytes 
pp Post partum 
PRIMo Pesticide Residue Intake Model 
PROFEL European Association of Fruit and Vegetable Processors 
QuPPe Quick Polar Pesticide Method 
RASFF Rapid Alert System for Food and Feed 
RBC Red blood cell 
RED Reregistration Eligibility Decision 
RfD Chronic Reference Dose 
RP Reference Point 
S9 
Supernatant fraction obtained from an organ (usually liver) homogenate by 
centrifuging at 9 000 g for 20 minutes in a suitable medium; this fraction 
contains cytosol and microsomes 
SCOFCAH Standing Committee on the Food Chain and Animal Health (UK) 
T3 Triiodothyronine 
T4 Thyroxine 
TBG Thyroxine-Binding Globulin 
TDI Tolerable Daily Intake 
TEM Triethylenemelamine 
TRR Total Radioactive Residues 
TSH Thyroid Stimulating Hormone 
UB Upper Bound 
UDS Unscheduled DNA Synthesis 
USA United States of America 
US EPA United States Environmental Protection Agency 
WHO World Health Organization 
WHO/IPCS World Health Organization/International Program on Chemical Safety 
 
